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 "It is a good principle in science not to believe any 'fact'---however well attested---until 
it fits into some accepted frame of reference. Occasionally, of course, an observation 
can shatter the frame and force the construction of a new one...” 
Arthur C. Clarke (2061: Odyssey Three) 
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 ABSTRACT 
 
K+-Cl- cotransporter 2 (KCC2) maintains a low intracellular Cl- concentration required 
for fast hyperpolarizing responses of neurons to classical inhibitory neurotransmitters ?-
aminobutyric acid (GABA) and glycine. Decreased Cl- extrusion observed in genetically 
modified KCC2-deficient mice leads to depolarizing GABA responses, impaired brain 
inhibition, and as a consequence to epileptic seizures. Identification of mechanisms 
regulating activity of the SLC12A5 gene, which encodes the KCC2 cotransporter, in 
normal and pathological conditions is, thus, of extreme importance. 
 
Multiple reports have previously elucidated in details a spatio-temporal pattern of KCC2 
expression. Among the characteristic features are an exclusive neuronal specificity, a 
dramatic upregulation during embryonic and early postnatal development, and a 
significant downregulation by neuronal trauma. Numerous studies confirmed these 
expressional features, however transcriptional mechanisms predetermining the SLC12A5 
gene behaviour are still unknown. The aim of the presented thesis is to recognize such 
transcriptional mechanisms and, on their basis, to create a transcriptional model that 
would explain the established SLC12A5 gene behaviour. 
 
Up to recently, only one KCC2 transcript has been thought to exist. A particular novelty 
of the presented work is the identification of two SLC12A5 gene promoters (SLC12A5-
1a and SLC12A5-1b) that produce at least two KCC2 isoforms (KCC2a and KCC2b) 
differing by their N-terminal parts. Even though a functional 86Rb+ assay reveals no 
significant difference between transport activities of the isoforms, consensus sites for 
several protein kinases, found in KCC2a but not in KCC2b, imply a distinct kinetic 
regulation. 
 
As a logical continuation, the current work presents a detailed analysis of the KCC2a 
and KCC2b expression patterns. This analysis shows an exclusively neuron-specific 
pattern and similar expression levels for both isoforms during embryonic and neonatal 
development in rodents. During subsequent postnatal development, the KCC2b 
expression dramatically increases, while KCC2a expression, depending on central 
nervous system (CNS) area, either remains at the same level or moderately decreases. 
 
In an attempt to explain both the neuronal specificity and the distinct expressional 
kinetics of the KCC2a and KCC2b isoforms during postnatal development, the 
corresponding SLC12A5-1a and SLC12A5-1b promoters have been subjected to a 
comprehensive bioinformatical analysis. Binding sites of several transcription factors 
(TFs), conserved in the mammalian SLC12A5 gene orthologs, have been identified that 
might shed light on the observed behaviour of the SLC12A5 gene. Possible roles of these 
TFs in the regulating of the SLC12A5 gene expression have been elucidated in 
subsequent experiments and are discussed in the current thesis. 
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1 REVIEW OF THE 
LITERATURE 
1.1 CATION-CHLORIDE 
COTRANSPORTERS  
K+-Cl- Cotransporter 2 (KCC2) is a large 
(~140 kDa) membrane protein mediating 
electroneutral cotransport of K+ and  Cl- 
ions across plasmalemma. KCC2 belongs 
to  a  family  of  cation-chloride 
cotransporters (CCC), which embraces 
nine members (Gamba, 2005). CCC 
proteins are encoded by corresponding 
genes constituting a solute  carrier 12 
(SLC12) gene family (Table 1). Twelve-
transmembrane (TM) structure has been 
predicted by Kyte-Doolittle hydropathy 
analysis (Kyte & Doolittle, 1982) for all 
CCC members except CCC9 (Fig. 1), but 
the experimental confirmation of this fact 
has been performed so far only for one 
CCC member - Na+-K+-2Cl- cotransporter 
1 (NKCC1) (Gerelsaikhan & Turner, 
2000;Gerelsaikhan et al., 2006). CCC 
proteins are secondary active cotransport-
ers: they derive energy for Cl- cotransport 
from K+ or  Na+ gradients, which are pre-
established by the Na+/K+-ATPase. 
The CCC family is subdivided into 
three branches (Fig. 2). First branch 
includes Na+-dependent K+-Cl- cotrans-
porters NKCC1 and NKCC2, as well as a 
Na+-dependent Cl- cotransporter NCC. 
These proteins mediate electro-neutral 
Na+-driven Cl- transport, regardless of 
their usage of K+, and share ~55% 
homology in amino acid sequences. 
Second branch includes four K+-dependent 
Cl- cotransporters KCC1, KCC2, KCC3, 
and KCC4, which mediate electroneutral 
K+-coupled Cl- transport and share ~70% 
identity. These two aforementioned CCC 
branches are only about 25% homologous 
between each other. The third CCC branch 
is represented by two orphan CCC 
members - cation chloride cotransporter 9 
(CCC9) and CCC-interacting protein 1 
(CIP1), which demonstrate only ~20-25% 
identity with other CCCs (Gamba, 2005). 
1.2 DIVERSITY OF CCC PROTEINS 
Table 1 and Figure 2 do not fully reflect 
the real diversity of the CCC proteins; the 
presented situation is oversimplified 
because of multiple splice variants 
identified for the CCC members. It is well 
known that usage of alternative splicing 
plays an important role in generating 
complexity required for the highly 
elaborated molecular systems. More than 
50% of human genes are regulated by 
putative alternative promoters, resulting in 
a wide variety of transcripts obtained by 
this mechanism (Kimura et al., 2006). 
Moreover, about 95% of human genes can 
generate differentially spliced transcripts 
(Wang et al., 2008;Pan et al., 2008). The 
proteins obtained in a result of alternative 
splicing may possess different expression 
patterns and demonstrate different tertiary 
structures, phosphorylation patterns, 
and/or subcellular localizations. All this 
substantially increases multiformity of 
proteins and provides a molecular 
mechanism for fine tuning of gene 
function (Landry et al., 2003). As an 
example, thousands of neurexin protein 
isoforms are generated from only three 
neurexin genes by usage of alternative 
promoters and alternative splicing (Missler 
& Sudhof, 1998). 
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Table 1. Members of the CCC family 
 
 
1.2.1 N(K)CC branch 
1.2.1.1 NKCC2 (SLC12A1 gene) 
Several splice isoforms exhibiting 
different localization and ion affinities 
were described for the Na+-K+-2Cl- 
cotransporter 2 (NKCC2). At least six 
NKCC2 isoforms exist in mouse kidney 
due to combination of two independent 
splicing events for the SLC12A1 gene 
(Mount et al., 1999a). First splicing 
generates  A,  B,  and  F  variants  as  a  result  
of alternative usage of corresponding 
cassette 4th exons A, B, and F, which 
encode a relatively small 32-amino acids 
(aa) fragment carrying a part of the second 
TM segment (TM2) and the whole 
intracellular loop between TM2 and TM3 
(Payne & Forbush, III, 1994; Igarashi et 
al., 1995;Simon et al., 1996a;Yang et al., 
1996). Out of 32 amino acid positions, 20 
are identical in A/B/F splice variants and 
CCC 
member 
Gene 
name 
Transported 
ions 
Full length/ 
N-terminal, aa Cloning 
NKCC2 SLC12A1 Na+, K+, Cl- 1099/178 (Payne & Forbush, III, 1994;Gamba et al., 1994) 
NKCC1 SLC12A2 Na+, K+, Cl- 1191/262 (Xu et al., 1994;Delpire et al., 1994) 
NCC SLC12A3 Na+, Cl- 1023/143 (Gamba et al., 1993) 
KCC1 SLC12A4 K+, Cl- 1085/123 (Gillen et al., 1996) 
KCC2 SLC12A5 K+, Cl- 1116/104 (Payne et al., 1996) 
KCC3 SLC12A6 K+, Cl- 1150/190 (Hiki et al., 1999;Mount et al., 1999b;Race et al., 1999) 
KCC4 SLC12A7 K+, Cl- 1083/123 (Mount et al., 1999b) 
CCC9 SLC12A8 unknown 714/44 (Hewett et al., 2002) 
CIP SLC12A9 unknown 915/44 (Caron et al., 2000) 
3 
 
only 3 are completely distinct. Most of the 
sequence difference is observed in the part 
corresponding to the TM2, but not to the 
intracellular loop. These NKCC2 variants 
are differentially distributed in kidney 
along the thick ascending limb of Henle 
(TALH): B- in cortex, F- in medulla, and 
A- equally in cortex and medulla (Payne 
& Forbush, III, 1994). In addition, these 
splice variants demonstrate different ion 
affinities (B>A>F), corresponding to the 
diverse Na+ and Cl- concentrations present 
along the TALH (Plata et al., 2002). In an 
attempt to explain the structural properties 
defining the ion affinities of the NKCC2 
protein, Gagnon and coworkers suggested 
that the intracellular loop between TM2 
and TM3 segments contributes mainly to 
the Cl- affinity (Gagnon et al., 2004). In 
addition, Isenring and coauthors suggested 
that amino acid residues within the TM2 
of human NKCC1 protein participate in 
the cation binding (Isenring et al., 1998). 
Surprisingly, but the suggested residues 
are well conserved in the B/F/A isoforms 
of NKCC2, thus it is not clear how they 
could mediate the observed difference in 
the ion affinities of the A/B/F isoforms. 
Not only binding affinities, but also 
transport capacities were reported to be 
different for the NKCC2-A/B/F variants 
(A>B>F) (Plata et al., 2002). By using a 
functional 86Rb+ assay the authors 
demonstrated an increased transport 
activity for NKCC2-A compared to other 
isoforms: NKCC2A-100%, NKCC2B-
68%, and NKCC2F-62%. On the other 
hand, green fluorescent protein (GFP)-
NKCC2-A/B/F fusion products have also 
demonstrated a different degree of 
incorporation into plasma membrane: 
NKCC2A-100%, NKCC2B-89%, and 
NKCC2F-64%. Thus, the different 
transport capacities of the A/B/F variants 
observed by Plata et al. (Plata et al., 2002) 
might be partially explained by different 
incorporation of the transporters into 
plasma membrane, rather than the 
different kinetic regulation. 
Figure 1. Domain struc-
ture of the CCC proteins. 
Twelve transmembrane seg-
ments were predicted for all 
CCC members except CCC9 
(Gamba, 2005). This pre-
diction has so far been 
experimentally confirmed 
only for the NKCC1 protein. 
A large extracellular loop, 
containing up to 4 putative 
glycosylation sites, was 
predicted in each of the CCC 
members. 
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A second splicing event, which 
significantly shortens the C-terminal 
domain of the NKCC2 protein, was 
observed only in mouse kidney (Mount et 
al., 1999a). Utilization of the extra 
polyadenylation site in intron-16 results in 
a truncation of the C-terminal domain by 
last 383 aa and in the appearance of a new 
55-aa fragment. This short NKCC2-S 
variant retains an N-terminal domain and 
all twelve TM segments identical with the 
full length NKCC2-L isoform, but has a 
significantly shorter C-terminal part. 
Functionally, this C-terminally truncated 
NKCC2-S protein exhibits two, in a way, 
opposite activities. Under normal 
osmolarity, the protein manifests no 
inherent transport activity and plays even a 
dominant negative role by inhibiting 
transport activity of the long NKCC2-L 
isoform (Plata et al., 1999). However, 
under hypotonic conditions, NKCC2-S 
gains properties of the loop diuretic-
sensitive, K+-independent Na+-Cl- 
cotransporter (Plata et al., 2001). 
Conversion from the dominant negative 
molecule into the active cotransporter 
upon hypoosmotic shock is accompanied 
by active translocation of the NKCC2-S 
protein from cytosol to plasma membrane 
(Plata et al., 2001). Interestingly, both the 
dominant negative and the transporter 
activities are inhibited by cAMP. 
1.2.1.2 NKCC1 (SLC12A2 gene) 
In contrast to NKCC2, only two NKCC1 
splice variants exist, which differ by the 
presence or absence of the 16-aa fragment 
in the distal C-terminal part (Randall et 
al., 1997). These two NKCC1 isoforms 
arise in a result of alternative splicing of 
the 48-base pairs (bp) long exon-21 in the 
SLC12A2 gene. The two splice isoforms 
are differentially expressed in human 
tissues: NKCC1a is preferentially 
expressed in placenta, spleen, lung, heart, 
stomach, and salivary gland, while 
NKCC1b is a major isoform in brain; 
equal expressions of the two isoforms are 
Figure 2. Phylogenetic tree of the 
CCC family. The CCC family 
(shaded in green) is currently 
subdivided into three branches 
representing the N(K)CC, KCC, 
and orphan members. Outgroup is 
represented by three members of 
the SLC7 family. Analysis of the 
phylogenetic tree was performed 
using the Clustalw Tree program 
(Biology Workbench). Bootstrap 
values (a percentage of how often 
each branch is presented in all re-
sampled trees) are indicated near 
the branches. Branch length 
corresponds to an average number 
of amino acid substitutions per site 
in the aligned sequences. The scale 
bar corresponds to 0.1 substitu-
tions per site. 
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detected in muscle, liver, and kidney 
(Vibat et al., 2001). The 16-aa fragment 
absent in the NKCC1b contains a putative 
protein kinase A (PKA) phosphorylation 
site, thus different kinetic regulation of the 
isoforms cannot be excluded. 
Two complementary deoxyribo-
nucleic acids (cDNAs) encoding slightly 
different variants of the NKCC1 protein in 
A.anguilla (European eel) were observed 
(Cutler & Cramb, 2002). Northern blot 
analysis revealed a ~13-kilobase pairs (kb) 
NKCC1a transcript, which is expressed 
broadly and a ~ 6-kb NKCC1b transcript, 
which is brain specific. NKCC1a and 
NKCC1b proteins share about 80% 
identity (Cutler & Cramb, 2002) and, most 
probably, have originated in a result of 
genome duplication that occurred during 
evolution of the ray-finned fish lineage 
(Van de Peer, 2004). Consistent with this, 
available complete fish genomes of 
T.nigroviridis, T.rubripes, O.latipes, D.rerio 
and G.aculeatus contain two genes encoding 
the NKCC1 protein (ensembl.org). 
Interestingly, ENSEMBL analysis of the 
aforementioned fish genomes suggests 
that, in addition to NKCC1, only two other 
CCC members, namely KCC2 and KCC4, 
have their genes duplicated in the fish. 
1.2.1.3 NCC (SLC12A3 gene) 
Rat Na+-Cl- cotransporter (NCC), which is 
expressed only in kidney, has two 
alternative variants exhibiting identical 
open reading frames (ORFs), but differing 
in their 3’-untranslated regions (UTRs) 
(Gamba et al., 1994). Since messenger 
ribonucleic acid (mRNA) stability motifs 
are often located in 3’-UTRs (Shyu et al., 
2008), it is possible that these mRNA 
isoforms have different half life. 
Two variants of human NCC protein, 
differing only by a 9-aa sequence (Simon 
et al., 1996b;Mastroianni et al., 1996), 
arise in a result of alternative usage of a 
splice donor site in exon-20, that  leads to 
incorporation of 27 additional  nucleotides 
into one of these NCC transcripts (Shao et 
al., 2008). Of note, the resultant 9-aa 
peptide contains a putative PKA 
phosphorylation site (Gamba, 2005), that 
might also result in exceptional regulation 
of the human NCC ortholog. The sequence 
corresponding to exon-20 in human is also 
present in rabbit NCC, but absent from rat 
and mouse orthologs. 
Northern blot identified two NCC 
mRNA variants in flatfish P.americanus: a 
major ~3.7-kb transcript in the urinary 
bladder and a minor ~3.0-kb transcript in 
several other tissues with an expression 
level ~100 times lower (Gamba et al., 
1993). The short NCC isoform is the result 
of alternative splicing, during which the 
whole N-terminal cytoplasmic domain and 
first three TM segments are lost (totally 
229 aa), that most probably results in a 
non-functional NCC variant. 
1.2.2 KCC branch 
1.2.2.1 KCC1 (SLC12A4 gene) 
Northern blot analysis of multiple rat 
tissues has detected at least three different 
KCC1 transcripts: widespread major ~3.8-
kb and minor ~4.4-kb species, as well as a 
~2.4-kb transcript expressed only in brain 
(Gillen et al., 1996). In addition, both N- 
and C- terminal heterogeneity have been 
described for the KCC1, thus substantially 
increasing the protein multiplicity. N-
terminal heterogeneity is represented by 
two promoters as well as by four 
alternative first exons (1, 1a, 1b, and 1c), 
which are spliced to exon-2 (Crable et al., 
2005). Two promoters are situated ~2 kb 
apart from each other and control 
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expression of the KCC1 transcripts 
containing either exon-1 or exon-1b as a 
starting exon (Crable et al., 2005). Exons 
1 and 1b encode 39 and 7 unique amino 
acids, respectively (Fig. 3). These splice 
isoforms are known to be differentially 
expressed in sickle compared to normal 
reticulocytes (Crable et al., 2005). Human 
expression sequence tag (EST) clones 
containing exons 1a and 1c spliced to 
exon-2 have also been found, but no 
further characterization of the 
corresponding transcripts exists so far 
(Fig. 3). 
Analysis of the KCC1 C-terminal 
splice isoforms also revealed a quite 
complicated picture. In addition to the 
full-length major KCC1 isoform, there are 
several C-terminal isoforms that are 
formed in a result of inclusion of introns -
21, -22, and -23 of the SLC12A4 gene 
(Pellegrino et al., 1998; Adragna et al., 
2004; Crable et al., 2005). Insertion of 
either intron-22 or intron-23, both of 
which contain premature stop codons, 
results in truncation of the full-length 
KCC1 protein from the C-terminus by 74 
or 17 amino acids, respectively (Pellegrino 
et al., 1998;Adragna et al., 2004). On the 
contrary, failure to splice intron-21 (210 
bp long) leads to inclusion of an additional 
70-aa fragment; intermediate products 
have also been described that are formed 
in a result of incomplete splicing of both 
intron-21 and intron-22 (Crable et al., 
2005). The physiological role of these 
different KCC1 splice variants is 
unknown, however the last 18 C-terminal 
amino acids, highly conserved in all CCC 
members, are known to be essential for 
interaction of the KCC3 protein with a 
brain-type creatine kinase (Salin-Cantegrel 
et al., 2008). 
1.2.2.2 KCC2 (SLC12A5 gene) 
Until recently only one isoform of the 
KCC2 protein was known (Payne et al., 
1996) and initial efforts failed to detect 
additional splicing isoforms (Blaesse et 
al., 2006). However, a new isoform of the 
KCC2 protein, named KCC2a, has 
recently been characterized by our group 
(I). This KCC2 variant is a result of 
alternative splicing of a new exon-1a, 
transcribed by a novel promoter, to exon-
2, which is common for both isoforms. 
The originally characterized KCC2 
transcript (Payne et al., 1996), which 
contains exon-1b instead of exon-1a, has 
been renamed as KCC2b. Exons 1a and 1b 
encode 40 and 17 amino acids, 
respectively. Distinct phosphorylation 
patterns, present in the KCC2a and 
KCC2b variants, imply different 
regulation of these isoforms (II). 
1.2.2.3 KCC3 (SLC12A6 gene) 
Similar to KCC1, extensive N-terminal 
heterogeneity is observed for the KCC3 
protein. Initial cloning of KCC3 
simultaneously by three groups (Mount et 
Figure 3. N-terminal heterogeneity of KCC1. Four N-terminally distinct KCC1 isoforms are 
generated by splicing of four alternative 1st exons to exon-2 of the SLC12A4 gene. Common 
parts of the KCC1 isoforms encoded by exon-2 are shaded in grey. 
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al., 1999b; Hiki et al., 1999; Race et al., 
1999) revealed existence of two KCC3 
variants with different N-terminal parts. A 
more recent study has described totally 
seven N-terminally heterogeneous KCC3 
transcripts (Fig. 4A) generated by the 
SLC12A6 gene  as  a  result  of  two  
alternative promoters (1a and 1b), four 
alternative first exons (1a, 1b, 1c, 1d), 
three alternative acceptor splice sites 
within flanking exon-1a (marked by * and 
** in Fig. 4A), and one alternatively 
spliced exon-2 (Mercado et al., 2005). 
Since exons 1c and 1d are noncoding, 
there are only five KCC3 protein variants 
differing in their N-terminal sequences 
(Fig. 4B). A very distinct pattern of the 
putative phosphorylation sites was 
revealed for the KCC3 variants, implying 
complex kinetic regulation. All KCC3 
Figure 4. N-terminal heterogeneity of KCC3. (A)  Seven  N-terminally heterogeneous 
KCC3 transcripts are generated by two alternative promoters (1a and 1b), four alternative 
first exons (1a, 1b, 1c, 1d), three alternative acceptor splice sites within flanking exon-1a 
(marked by * and **), and one alternatively spliced exon-2 of the SLC12A6 gene. (B) Since 
exons 1c and 1d are noncoding, there are only five KCC3 protein variants differing in their 
N-termini. Designations S and x2M in the names of the KCC3a isoforms reflect the N-
terminal truncations (result of the alternative splice sites) and the alternative splicing of the 
exon-2, correspondently. Modified from Mercado et al., 2005. 
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isoforms were found to be functional, but 
they demonstrated different transport 
activities in oocytes (Mercado et al., 
2005). For example, while all KCC3a-
derived variants together with the full-
length KCC3b isoform showed a very 
similar 86Rb+ uptake in a broad range of 
extracellular osmolarity, the truncated 
KCC3b-x2M protein exhibited more than 
10-fold lower activity. The rate of 
activation upon osmotic shock was also 
different for the KCC3 variants: the full-
length KCC3a and KCC3b isoforms were 
activated ~50% slower compared to the 
truncated KCC3a-x2M and KCC3-S 
isoforms. It is interesting that exon-2 is 
alternatively spliced in neuronal and glial 
cells: expression of the KCC3a-x2M 
isoform has been detected in neurons but 
not in glia, while the full-length KCC3a 
isoform demonstrated the opposite 
expression pattern (Le Rouzic et al., 
2006). 
SLC12A6 gene mutations, associated 
with hereditary motor and sensory 
neuropathy with agenesis of the corpus 
callosum (HMSN/ACC) disease (Dupre et 
al., 2003), often lead to C-terminal 
truncations and, as a consequence, to the 
inactivation of the KCC3 protein (Howard 
et al., 2002;Uyanik et al., 2006;Salin-
Cantegrel et al., 2007). All these truncated 
isoforms lack the 18 most C-terminal 
amino acids, required for interaction of the 
KCC3 (Salin-Cantegrel et al., 2008) and 
probably KCC2 (Inoue et al., 2004) 
proteins with a brain-type creatine kinase. 
1.2.2.4 KCC4 (SLC12A7 gene) 
Two isoforms of the KCC4 protein have 
been reported so far. The first was 
identified by Mount and coworkers in their 
original study describing the cloning and 
characterization of KCC4 (Mount et al., 
1999b). The second isoform, which differs 
only by five additional amino acids 
inserted into the C-terminal part of KCC4 
protein, was detected in olfactory 
epithelium but not in kidney (Nickell et 
al., 2007). Encoded by a novel short (15 
bp) exon and situated in between 
previously known exons 22 and 23, the 
same 5-aa peptide is present in the KCC2 
protein sequence, thus suggesting a similar 
putative alternative splicing for the 
SLC12A5 gene as well. 
Recently, in an attempt to identify 
new putative promoters and/or upstream 
exons for the SLC12A7 gene, encoding the 
KCC4 protein, I have identified an EST 
clone (BB662276, mouse P16 heart) 
containing a previously unknown exon 
(named exon-1a) spliced to exons 2, 3, and 
4 of the SLC12A7 gene (unpublished 
observation). This new isoform has been 
named KCC4a in contrast to the 
previously characterized KCC4b isoform. 
Exon-1a encodes for a novel 70-aa N-
terminal KCC4a fragment instead of a 41-
aa peptide encoded by exon-1b in the 
KCC4b variant. A CpG island is found in 
the close proximity of exon-1a, thus 
indicating the presence of a putative 
promoter region. Of special interest is a 
consensus sequence for a Ste20-related 
proline alanine rich kinase (SPAK) 
binding site detected in the N-terminus of 
the KCC4a, but not of the KCC4b variant. 
The presence of SPAK binding sites in all 
members of N(K)CC and KCC branches 
except KCC1 (Fig. 5), presumably points 
at  a  special  role  of  the  SPAK  kinase  in  
regulation of the CCC proteins. 
1.2.3 Orphan CCC members 
1.2.3.1 CCC9 (SLC12A8 gene) 
Multiple alternatively spliced transcripts 
for the SLC12A8 gene have been reported 
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(Hewett et al., 2002). The authors 
identified at least 13 exons that are spliced 
alternatively to produce totally six CCC9 
isoforms. Importantly, the ultimate 
number of exons for the SLC12A8 gene is 
definitely more than thirteen, because 
Hewett and coauthors in addition 
amplified a 456-bp 5’-fragment of CCC9 
cDNA that they have not mapped 
properly. In agreement with this, splicing 
of 19 exons is known to form a 4079-bp 
long mRNA (XM_516709) encoding one 
of the putative CCC9 protein isoforms in 
P.troglodytes. 
1.2.3.2 CIP1 (SLC12A9 gene) 
No isoforms for the CIP1 protein are 
currently known (Caron et al., 2000). 
1.2.3.3 CIP1 and CCC9: should they 
belong to the CCC family? 
Although CIP1 possesses a secondary 
structure with twelve TM segments 
common for CCC proteins, it has 
extremely  low if  any  Na+/K+/Cl- transport 
activity (Caron et al., 2000). One 
possibility is that CIP1 protein requires 
other partners to reveal its transport 
activity- as in the case of the glycoprotein-
associated amino acid transporters 
(gpaAT) family members (SLC7A5-11), 
which perform as functional transporters 
only upon interaction with members of the 
SLC3 gene family (Verrey et al., 2004). 
On the contrary,  it  may also be that  CIP1 
does not hold any transport activity, but 
itself is required for regulation of the 
N(K)CC- and KCC- mediated 
cotransporter activity. Indeed, CIP1 has 
been reported to form heteromers with and 
inhibit transport activity of the NKCC1 
protein in human embryonic kidney 
(HEK) 293 cells (Caron et al., 2000). 
Moreover, recent data suggest that CIP1 
may interact with and increase 86Rb+ flux 
mediated by KCC2 in HEK293 cells 
(Wenz et al., 2009). However, 
experiments failed to detect interaction of 
CIP1 with other CCC members- NKCC2 
and KCC1 transporters (Caron et al., 
2000), and even more, another group 
failed to confirm CIP1 interaction with 
NKCC1 (Parvin et al., 2007). The 
Drosophila homolog of the SLC12A9 gene 
is strongly expressed in embryos 
(particularly in larval brains), as well as in 
adult bodies (Filippov et al., 2003). A 
specific deletion of the gene did not affect 
survival rates in response to different salt 
concentrations (Filippov et al., 2003). 
Thus, CIP1 may render a rather subtle 
regulatory effect on the transport activity 
mediated by other CCC proteins. 
The SLC12A8 gene encoding the 
CCC9 protein was associated with 
psoriasis-susceptibility locus on chromo-
some 3q21 (Hewett et al., 2002). The 
original as well as all subsequent papers 
predicted only eleven TM segments for the
Figure 5. Conservation of the SPAK 
binding consensus among the CCC 
proteins. The SPAK binding consensus is 
found in all N(K)CC and KCC members 
except  KCC1.  The  NKCC1  protein  has  two  
SPAK binding sites separated by 54 aa. 
Asterisk (*) marks +1 position of the 
consensus, while numbers on the right 
indicate the location of the consensuses in the 
CCC proteins. Note that the SPAK binding 
consensuses are situated exclusively in the N-
terminal parts. 
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CCC9 protein (Fig. 1). However, analysis 
of the Kyte-Doolittle hydropathy plots 
does not exclude the common for all 
CCCs 12-TM structure with small N- and 
C-terminal domains and a large cytoplas-
mic loop between the 10th and 11th TM 
segments (Filippov et al., 2003) (Fig. 6). 
Similar to CIP1, the CCC9 protein does 
not mediate Na+,  K+,  or  Cl- transport 
activity. Examining of its predicted N- and 
Figure 6. Hydropathy plots for NKCC1, KCC2, and CCC9 proteins. The Kyte-
Doolittle hydropathy analysis (on the left) does not rule out for the CCC9 protein (C) the 
same 12-TM structure that has been previously proposed for NKCC1 (A) and KCC2 (B) 
members. Schematic model of the NKCC1 (A), KCC2 (B), and CCC9 (C) proteins with 
12 TM segments is presented on the right. The window parameter used in the presented 
Kyte-Doolittle analysis was 15 aa. 
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C- terminal domains suggests that they are 
much shorter than those in the N(K)CC or 
KCC proteins. It has previously been 
shown that deletion or significant 
shortening of either the N-terminal 
(Casula et al., 2001; Li et al., 2007) or the 
C-terminal (Plata et al., 1999; Hekmat-
Scafe et al., 2006) domains in the CCC 
proteins may result in their partial or full 
inactivation and even in acquisitioning by 
these truncated proteins the dominant 
negative properties. Thus, one possibility 
is that the currently known CCC9 protein 
sequence is incomplete. Indeed, one of the 
recent NCBI entries (XM_516709) 
predicts a significant extension for the 
SLC12A8 gene increasing the N-terminal 
part of the CCC9 protein totally by 227 aa. 
Another possibility may be that CCC9 
uses other substrates for transport. In 
agreement with this hypothesis, a recent 
report from Paul Isenring’s group has 
indicated that the CCC9 protein (the 
original short version) might be involved 
in polyamine and amino acid transport 
(Daigle et al., 2009). 
An open question is whether CIP1 
and CCC9 should belong to the CCC 
family. So far these proteins have failed to 
demonstrate any cation-dependent Cl- 
transport - a property inherent for other 
CCC members. Proteins from many other 
SLC families (Jack et al., 2000; Hediger et 
al., 2004) also contain a similar 12-TM 
structure. In particular, a phylogenetic 
analysis of human Refseq proteins 
disposes CIP1 and CCC9 outside the 
N(K)CC/KCC branches (Fig. 2). A 
relatively low sequence similarity (~20-
25%) with other CCC members does not 
allow prescribing unequivocally CIP1 and 
CCC9 proteins to the CCC family. One 
member of the cationic amino acid (CAT) 
family – CAT-2 protein (Park & Saier, 
1996), encoded by a SLC7A2 gene, reveals 
the highest homology to the CCC 
members (Fig. 2). The recent finding that 
CCC9 uses amino acids and polyamines as 
a substrate implies that CCC9 may 
possibly belong to one of the previously 
described amino acid transporter families. 
In this connection, it will be interesting to 
investigate whether CIP1, similar to 
CCC9, can transport other substrates. It 
might also be interesting to test whether 
CCC9, similar to CIP1, is able to regulate 
the transport activity of other CCC 
members. In any case, more experimental 
data are needed to answer these questions 
and to reveal the biological significance of 
CIP1 and CCC9 proteins. 
1.2.4 CCC diversity: implications 
Bioinformatics analysis of the available 
data on the different CCC splice isoforms 
has several implications. First, analysis of 
the multiple N- and C-terminal CCC 
variants has confirmed the importance of 
the N- and C-terminal domains in 
regulating the transport activity of CCC 
proteins. Truncation of the most C- 
terminal sequences, which are highly 
conserved among CCC members, often 
results in functional inactivation of the 
cotransporters. The situation with the N-
terminal variants is more puzzling. On the 
one hand, there is a tremendous heteroge-
neity in the N-termini of different CCC 
proteins, thus decreasing the chance to 
find any conserved structural motifs. On 
the other hand, N-terminal truncations lead 
to functional inactivation of the 
cotransporters (Casula et al., 2001; Li et 
al., 2007), thus indicating that these 
sequences are important. Analysis of the 
CCC proteins revealed the presence of 
many putative phosphorylation sites in the 
N-terminal parts. It is also possible that 
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some N-terminal sequences are required 
for correct processing, transport, and/or 
incorporation of the cotransporters into the 
plasma membrane. 
Second, simultaneous analysis of all 
CCC members together with their multiple 
isoforms may help to understand the role 
of different structural parts of CCC 
proteins involved in ion transport. Up to 
recently, no crystal structure for any of the 
CCC members has been obtained, and 
there is no convincing model describing 
what parts of the cotransporters may be 
responsible for ion binding (Gamba, 
2005). Nevertheless, multiple alignments 
of CCC protein sequences present in the 
Ensembl Database (ensembl.org), including 
all splice variants from different species 
(totally 241 sequences for the KCC 
branch, and 216 sequences for the 
N(K)CC branch), suggest several potential 
regions for ion binding (Fig. 7A and 7B). 
Figure 7A depicts the rat KCC2a protein 
sequence with amino acid positions that 
are conserved in 87% out of 241 analyzed 
sequences. The most conserved region 
occurs to be a part of the second 
intracellular loop between TM2 and TM3 
together with the whole TM3 segment. 
Interestingly, an analogous analysis 
performed for the N(K)CC sequences 
(87% conservation, 216 sequences) 
identified the most conserved amino acids 
also in the  intracellular loop between 
TM2 and TM3, but in addition in TM1 
and TM6 (Fig. 7B). Although the analyzed 
sequences belong to species as distinct as 
C.elegans and H.sapiens, they still share 
one common feature – cation-coupled Cl- 
transport. This suggests that these regions 
are important for ion binding/transport 
across the plasma membrane. One could 
also speculate that the identified 
conservation of the KCC proteins in the 
second intracellular loop and TM3 is 
important for K+-driven Cl- extrusion. On 
the other hand, TM1 and TM6 regions as 
well as the second intracellular loop in 
N(K)CC  proteins  are  central  for  the  Na+-
driven inward Cl- transport. 
Third, the analyzed splicing data will 
be used in the subsequent chapters to 
interpret results obtained from the existing 
CCC knockout (KO) models, especially 
when a genetic targeting of an 
alternatively spliced exon has been 
performed. Disruption of the first exon 
might result in inactivation of only the 
isoform containing the targeted exon. 
Given that different isoforms may display 
different expression, regulatory, and/or 
kinetic properties, information on what 
exon exactly has been targeted is crucial 
for the interpretation of the KO mouse 
data, as in the case of the KCC2b KO mice 
(see below). 
Fourth, the existence of multiple CCC 
variants should also be kept in mind when 
interpreting published data on spatial and 
temporal expression of these isoforms. For 
example, the KCC4 (Karadsheh et al., 
2004) and KCC2 (Hubner et al., 2001) 
antibodies characterized previously would 
recognize only the KCC4b and KCC2b 
isoforms, respectively, but not the KCC4a 
and KCC2a isoforms. Another example is 
the popular T4 monoclonal antibody 
derived against the NKCC1 C-terminal 
part that is highly conserved among 
N(K)CC proteins (Cutler & Cramb, 2002). 
Multiple expression and localization 
studies that have exploited T4 antibody 
should be regarded with a great concern, 
because this antibody seems to recognize 
differentially the C-terminal splice 
variants of NKCC1 (Zhang et al., 2007).
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Figure 7. Conservation of the KCC and N(K)CC proteins. (A) Schematic drawing of rat 
KCC2a protein. Amino acid positions marked in green are conserved in at least 87 percent of 
all KCC sequences available at the moment via Ensembl (totally 241). The most conserved 
region occurs to be a part of the second intracellular loop between TM2 and TM3 together 
with the whole TM3 segment. (B) Similar analysis performed for the N(K)CC sequences (87% 
conservation, 216 sequences) identified the most conserved positions (orange) in TM1 and 
TM6, as well as in the intracellular loop between TM2 and TM3. Rat NKCC1 protein 
sequence is depicted for illustration. 
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1.3 SPATIO-TEMPORAL PATTERN 
OF KCC2 EXPRESSION  
1.3.1 Strategies, tools, and precautions 
Gene expression can be assessed at three 
levels: DNA, RNA, and protein. 
Evaluation of gene expression by 
analyzing RNA and protein levels is more 
common and better presented from the 
methodological point of view. Classical 
methods to quantify RNA abundance 
include: Northern blot, ribonuclease 
protection assay (RPA), reverse transcript-
tion followed by polymerase chain 
reaction (RT-PCR), in situ hybridization, 
in situ PCR, and DNA microarray 
analysis. Protein expression is usually 
studied by Western blot, co-immuno-
precipitation (coIP), and immunohisto-
chemistry (IHC) or immunocytochemis-
try (ICC). Information on gene activity 
can be obtained also on the DNA level by 
analyzing genomic DNA regulatory 
regions that control transcription: 
promoters, enhancers, repressors, etc. 
These regions can be studied by analyzing 
the methylation status, chromatin 
modifications, and occupancy by TFs. 
Among available methods here are: 
bisulfite sequencing, methyl-sensitive 
PCR, chromatin immunoprecipitation 
(ChIP), genome-wide location analysis 
(ChIP-on-Chip), Whole-Genome Chromatin 
IP sequencing (Chip-Seq), and analysis of 
the reporter activity in vitro (cell lines) as 
well as in vivo (transgenic mice models). 
Many of the aforementioned methods 
have been utilized so far to study KCC2 
expression. However, before reviewing the 
spatio-temporal expression of the SLC12A5 
gene, encoding the KCC2 protein, the 
most notorious pitfalls of these methods 
should be considered. First, RNA-based 
methods require intact and high quality 
RNA, thus additional controls ensuring 
RNA quality are essential; this especially 
concerns Northern blot analysis. As 
discussed previously, RNA-based methods 
may lead to erroneous conclusions if the 
information about possible splice isoforms 
is not taken into account. Thus, sequences 
of PCR primers, as well as of in situ, RPA, 
and  DNA  microarray  probes  in  all  of  the  
KCC2 expression studies performed so far 
need to be carefully verified. Moreover, 
possible formation of RNA hairpin 
structures in regions detected by RT-PCR 
primers, RPA and in situ probes may 
reduce intensity of the signal and thus 
affect interpretation of the results. Putative 
antisense transcripts produced by pseudo-
genes (Korneev et al., 1999) or by 
additional promoters (Morris et al., 2008) 
may distort gene expression data, and thus 
have to be analyzed as well. 
Pitfalls of the protein-based 
quantification methods are mainly 
associated with specificity of antibodies. 
The type of tissue fixation (paraformal-
dehyde (PFA), methanol, etc) and 
embedding (cryo, paraffin), various 
strategies of epitope retrieval (e.g. 
microwave heating), and different sensi-
tivity to permeabilizing reagents (NP40, 
Nonidet-P40, Triton-X100, SDS, etc) 
greatly affect the performance of 
antibodies (Fritschy, 2008). Inclusion of 
proper positive and especially negative 
controls is absolutely necessary to ensure 
specificity of the expression pattern 
obtained via usage of a particular 
antibody. Thus, to analyze gene 
expression a good strategy is to collect 
data on several levels (DNA, RNA, and 
protein), and preferably to use various 
methods on each of the levels. 
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1.3.2 Characteristic features of the 
SLC12A5 gene expression 
A vast amount of information concerning 
KCC2 expression has accumulated since 
the first KCC2 paper was published 
(Payne et al., 1996). To rationalize this 
data, the following three general rules 
have been formulated in recent reviews 
dedicated to KCC2 expression (Ben Ari, 
2002; Mercado et al., 2004; Rivera et al., 
2005; Gamba, 2005; Blaesse et al., 2009): 
1) KCC2 is expressed only in 
neurons of the CNS (exclusively 
CNS-specific pattern). 
2) As a whole, KCC2 expression is 
upregulated during embryonic and 
early postnatal CNS development 
(developmental upregulation). 
3) In adulthood, only a few 
subpopulations of CNS neurons 
are devoid of KCC2 (broad 
expression in adult CNS). 
Below an attempt will be taken to ensure 
whether and how well the original KCC2 
expression data conform to these three 
rules. Another reason to re-review the 
available literature on the KCC2 spatio-
temporal expression is to reveal possible 
mechanisms mediating the exclusive CNS 
specificity and the developmental up-
regulation of KCC2. 
1.3.3 KCC2 expression: CNS neuronal 
specificity 
1.3.3.1 Rodents  
First evidence that KCC2 is not expressed 
in nonneural tissues emerged from the 
original paper published by John Payne 
and coauthors (Payne et al., 1996). By 
using Northern blot analysis with a 783-bp 
probe corresponding to the 3’-UTR region, 
KCC2 mRNA was detected in rat brain, 
but not in seven nonneural tissues (colon, 
heart, kidney, liver, lung, spleen, 
stomach). RT-PCR analysis, designed to 
amplify an exon1-exon4 fragment of 
KCC2, failed to detect KCC2 mRNA in 
rat primary astrocytes as well as in C6 and 
PC12 cell lines, which were derived from 
rat peripheral nervous system (PNS), thus 
suggesting even stricter – CNS neuronal 
pattern of the SLC12A5 gene expression. 
At the protein level, the neuronal 
specificity was later confirmed by Payne’s 
team via successful development of an 
anti-KCC2 antibody against a 112-aa 
(amino acids 932-1043) C-terminal 
fragment of rat KCC2 (Williams et al., 
1999). Western blot analysis using this 
antibody detected KCC2 protein in neural 
(cortex, hippocampus, cerebellum, 
brainstem, and spinal cord), but not in 
nonneural (skeletal muscle, heart, lung, 
liver, kidney, and testis) lysates. Of note, 
KCC2 protein was not found in the sciatic 
nerve, thus excluding KCC2 expression in 
peripheral glial cells. Astrocytes and 
various cell lines of neural origin (C6, SH-
SY5Y, GT1-7, PC12, NG-108, and N1E-
115) also failed to demonstrate KCC2 
protein expression. IHC analysis exhibited 
no colocalization of the KCC2 protein 
with glial fibrillary acidic protein (GFAP) 
in rat cerebellum, thus confirming again 
the exclusively neuronal expression 
(Williams et al., 1999). In addition, KCC2 
protein was not present in glial cells 
derived from primary chick retinal 
cultures. 
The exclusively CNS-specific pattern 
of KCC2 mRNA expression throughout 
adult rat brain was next confirmed in a 
detailed in situ hybridization study 
performed by Sato’s group, who used two 
36-bp anti-KCC2 probes complementary 
to either exon 9 or 24 (Kanaka et al., 
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2001). Neither of these probes was able to 
detect KCC2 expression in choroid plexus. 
Later, Okabe and coauthors used the same 
in situ probes and confirmed once more 
the CNS-specific pattern of the KCC2 
mRNA expression in hippocampus (Okabe 
et al., 2003). Absence of KCC2 mRNA in 
the choroid plexus has been confirmed by 
RT-PCR (Brown et al., 2004). 
Another study of KCC2 mRNA and 
protein expression in developing mouse, 
starting from embryonic day (E) 10.5 up to 
postnatal day (P) 15 confirmed the 
exclusive CNS specificity of the SLC12A5 
gene expression (Stein et al., 2004). No 
KCC2 transcripts were detected in 
peripheral ganglia or other parts of PNS 
with a long (about 500 bp) in situ 
hybridization probe spanning through 
exons 3 to 7. In addition, KCC2 mRNA 
was absent in CNS large white matter 
fiber tracts like corpus callosum and 
anterior commissure, thus pointing at the 
neuronal specificity of the expression 
(Stein et al., 2004). In agreement with this, 
no KCC2 expression was detected in glia 
of cochlear nucleus (Vale et al., 2005), in 
erythroid cells (Crable et al., 2005), and in 
cultured mouse cortical astrocytes 
(Molinaro et al., 2008). RT-PCR with 
primers specific to exons 24 and 25, 
showed no KCC2 mRNA expression in 
nonneural tissues (kidney, liver, and 
pancreas), while detecting strong KCC2 
signals in rat cerebellum and hippocampus 
(Le Rouzic et al., 2006). Moreover, the 
same study detected KCC2 transcripts in 
pure neuronal cultures, but not in mixed 
glial or in astrocytic cultures, thus again 
confirming the neuron-specific pattern of 
KCC2 expression. 
1.3.3.2 Human 
The CNS-specific pattern of human KCC2 
expression was first reported by Mount 
and coworkers (Song et al., 2002). 
Northern blot analysis with a 3’-UTR 
probe detected very clear KCC2 mRNA 
expression in brain, but not in seven 
nonneural tissues. In agreement with the 
previous results (Payne et al., 1996), 
KCC2 transcripts were not detected in 
several cell lines (NT2, HUVEC, K562, 
and JEG3). Interestingly, neuronal 
differentiation of the teratocarcinoma NT2 
cell line, which was derived from human 
testicular cancer, by retinoic acid into 
NT2-N cells resulted in prominent KCC2 
expression as detected by the same 3’-
UTR probe (Song et al., 2002). 
Absence of KCC2 expression in the 
undifferentiated NT2 cells has been 
recently confirmed on the DNA level via a 
histone mapping of human chromosome 
20q13.12 (Akan et al., 2009). Using a 
nonbiased ChIP-on-Chip method, the 
authors revealed a strong enrichment in 
tri-methylated lysine 27 of histone H3 
(H3K27me3) throughout the SLC12A5 
gene. The H3K27me3 modification is 
known to be associated with transcrip-
tionally repressed genomic regions (Cao et 
al., 2002). Accordingly, neither KCC2 
mRNA expression nor SLC12A5 gene 
promoter activity was detected in NT2 
clone D1 (NT2/D1) (Akan et al., 2009). 
Interestingly, Akan and coauthors found 
that the 3’UTR region of the SLC12A5 
gene is situated within a CpG island, 
which are often associated with promoter 
regions. In addition, the 3’UTR region of 
the SLC12A5 gene was moderately 
enriched with H3K4me3 and H3K4me2, 
which in their turn are known to be 
associated with potentially transcribed 
regions. The authors suggested the 
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presence of a new putative promoter in the 
3’UTR region that may drive an antisense 
RNA transcription to ensure the effective 
silencing of the SLC12A5 gene in non-
neuronal cells (Akan et al., 2009). 
As for other human cells, the absence 
of KCC2 protein and mRNA expression 
was detected in corneal epithelial cells 
(Capo-Aponte et al., 2007), in lens 
epithelial B3 (HLE-B3) cell line, and in 
human cataractous lens tissues (Misri et 
al., 2006). 
1.3.4 KCC2 expression: exceptions 
from the CNS neuronal specificity 
1.3.4.1 KCC2 expression outside nervous 
system 
The first report suggesting that KCC2 
mRNA might also be expressed in 
nonneural tissues, even though at a very 
low level, came from Friauf’s group 
(Balakrishnan et al., 2003). RT-PCR 
analysis with 3’-UTR KCC2 primers 
detected KCC2 transcripts in kidney, 
heart, lung, stomach, and liver in P0 and 
P16 rats. However, KCC2 mRNA 
expression in neuronal samples, although 
not quantified, was clearly much stronger. 
KCC2 mRNA expression was also 
detected in A549 human pulmonary cells 
by microarray (Malard et al., 2007). The 
authors demonstrated that KCC2 mRNA 
expression was upregulated upon exposure 
of the cells to cobalt. The time course of 
the KCC2 mRNA expression after cobalt 
application was studied by real time RT-
PCR. Unfortunately, both primers utilized 
in the study belong to exon 26, thus 
amplification of genomic DNA or 
presence of antisense transcripts derived 
from a putative 3’UTR promoter (Akan et 
al., 2009) cannot be excluded. Two studies 
also exploited a microarray approach and 
reported presence of KCC2 mRNA in 
oocytes (Bermudez et al., 2004;Lee et al., 
2008), but these data have not been 
confirmed by other methods so far. 
KCC2 mRNA expression has been 
detected in a human FHL124 cell line by 
RT-PCR (Lauf et al., 2008). This cell line 
resembles freshly obtained human lens 
epithelial cells (James et al., 2005). Two 
primer pairs were used to detect KCC2 in 
this study (exon6-exon10 and 3’UTR-
3’UTR), while a negative control 
confirmed specificity of the PCR reaction. 
However, the level of KCC2 mRNA 
expression in these cells remains unclear. 
Another example of KCC2 expression in a 
nonneuronal cell line was presented by 
Kerschbaums’ group (Zierler et al., 2008). 
A KCC2 cDNA fragment was amplified 
from BV-2 microglial cells with primers 
spanning exons 7 and 9, and identity of the 
KCC2 product was confirmed by 
sequencing. Moreover, negative controls 
were performed to exclude contamination 
or amplification from genomic DNA 
(Zierler et al., 2008). 
Additional evidence for possible 
KCC2 expression outside the nervous 
system came from an unconventional 
direction. Two papers, using nonbiased 
approaches, reported that the KCC2 gene 
might play an important role in hepatitis C 
virus (HCV) replication (Ng et al., 2007; 
Tai et al., 2009). In the first paper, a high 
throughput screening of a small interfering 
ribonucleic acid (siRNA) library was 
performed in HCV infected NS3-NS5B 
cells (derivative of human  hepatoma cell 
line Huh7) to identify genes important for 
replication of the virus. NS3-NS5B cells 
transfected with SMARTpool siRNA 
(consisting of four individual siRNAs 
against each of about 4000 human genes) 
were first analyzed by secreted alkaline 
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phosphatase (SEAP) reporter assay. The 
activity of the SEAP reporter is known to 
be proportional to the replication of HCV 
RNA; more than 200 siRNAs significantly 
inhibited HCV replication and were 
chosen for a further analysis. At the 
second step, these siRNAs were again 
transfected into the NS3-NS5B cells, but 
now real-time PCR was used to quantify 
RNA copy numbers both of HCV and of a 
housekeeping gene ?-actin. From the more 
than 200 initial hits only 9 host genes were 
identified to be involved in HCV 
replication. Two of the identified genes 
were SLC12A4 and SLC12A5 genes, 
which encode KCC1 and KCC2 proteins, 
respectively. SLC12A4 and SLC12A5 
siRNAs inhibited HCV replication by 
more than 90%. The ability of the KCC2 
siRNA to efficiently inhibit HCV 
replication was recently confirmed by an 
independent study (Tai et al., 2009). 
1.3.4.2 KCC2 expression in PNS 
One initial challenge against the CNS-
specificity of KCC2 expression was a 
report by the group of Eric Delpire (Lu et 
al., 1999). This study used an anti-KCC2 
antibody against almost the same C-
terminal fragment (amino acids 931-1034) 
of the KCC2, as previously produced by 
John Payne (Williams et al., 1999). 
Although IHC of rat brain sections with 
this antibody confirmed the absence of 
KCC2 protein in glial cells, surprisingly, it 
detected KCC2 in some large dorsal root 
ganglia (DRG) neurons, thus arguing 
against the excusive CNS specificity of 
KCC2 expression. To support their 
immunostaining results, the authors used 
RT-PCR followed by Southern blot 
analysis and demonstrated a strong KCC2 
specific signal in DRG (Lu et al., 1999). 
Yet, the same group has recently reported 
that KCC2 mRNA is expressed neither in 
mouse nor in rat DRG (Geng et al., 2009). 
This time, cDNA from mouse brain served 
as a positive control and produced a strong 
signal as detected by RT-PCR with exon-1 
and exon-4 specific primers. 
A barely detectable KCC2 mRNA 
expression in rat DRG was reported by 
Kaila’s group (Rivera et al., 1999), who 
used the same PCR primer pair (exon1-
exon4) as in the paper previously 
published by Payne and coauthors (Payne 
et al., 1996). In contrast to these results, 
Kanaka et al. could not detect KCC2 
mRNA expression in rat DRG neurons 
(Kanaka et al., 2001). One explanation for 
this discrepancy is the different sensitivity 
of the methods used: in situ hybridization 
with a 36-bp long oligonucleotide probe 
(Kanaka et al., 2001) is substantially less 
sensitive than RT-PCR (Rivera et al., 
1999). Alternatively, it is possible that a 
small contamination by spinal cord tissue 
may be left in the isolated DRG. 
By using Western blot with an anti-
KCC2 antibody (Upstate Biotechnology), 
Coull and coauthors found very strong 
KCC2 immunoreactivity (KCC2-ir) in the 
superficial dorsal horn neurons, while 
KCC2  signal  was  absent  in  DRGs  (Coull  
et al., 2003). Upstate Biotechnology 
produces two anti-KCC2 antibodies: one 
is directed against the C-terminal part of 
the KCC2 protein, while the other is 
directed against the most N-terminal 18-aa 
peptide of KCC2b; unfortunately, the 
authors did not specify which antibody 
they used. To exclude the possibility that 
the KCC2 protein is shuttled away from 
DRG cell bodies to central terminals of 
primary afferents, Coull and coauthors 
used electron microscopy and demon-
strated the absence of KCC2-ir in central 
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boutons of synaptic glomeruli in laminae I 
and II (Coull et al., 2003). 
Expression of all CCC members in rat 
DRG was recently analyzed by Möhrlen’s 
group using a semiquantitative RT-PCR 
(Gilbert et al., 2007). They found a strong 
expression of CIP1, KCC1, KCC3, KCC4 
and NKCC1, much weaker expression of 
CCC9, KCC2 and NCC, while no 
expression of NKCC2, which is known to 
be exclusively kidney specific. KCC2 
primers effectively amplified an exon6-
exon10 fragment in this experiment. 
Moreover, IHC with an anti-KCC2 
specific antibody (Santa Cruz Biotech, 
#sc-19420, goat) revealed weak KCC2 
protein expression in DRG, supporting the 
RT-PCR results. The same authors one 
year later confirmed their results on KCC2 
expression in DRG neurons (Funk et al., 
2008). These two last reports are in line 
with the results of Rivera and coauthors 
(Rivera et al., 1999) suggesting a weak but 
still detectable KCC2 expression in rodent 
DRG. 
An attempt to measure quantitatively 
the difference between KCC2 expression 
in DRG and other neuronal samples was 
performed by the group of Homayouni 
(Ledoux et al., 2006), who used a 
microarray approach to search for genes 
that are enriched in adult mouse spinal 
cord compared to DRG. The authors 
selected totally 112 genes that 
demonstrated at least 10-fold stronger 
expression in spinal cord versus DRG 
samples, and SLC12A5 was among the 
most enriched genes (fourth in the list). 
According to the microarray data, KCC2 
expression was 153-fold stronger in spinal 
cord compared to DRG. These data 
probably explain the abovementioned 
contradictory reports on KCC2 expression 
in DRG: KCC2 mRNA and protein 
expression in DRG is very low compared 
to either brain regions or spinal cord, and 
can be detected only by relatively sensitive 
methods like microarray analysis and RT-
PCR, but not by less sensitive methods 
like in situ hybridization or Western blot. 
Another interesting example of 
putative KCC2 expression outside CNS is 
the olfactory epithelium. The olfactory 
system is known to be comprised of the 
olfactory epithelium, which resides in the 
PNS, and the olfactory bulb, which resides 
in the CNS (Barnett, 2004). 
Transformation of an odor stimulus into a 
receptor current is mediated by Ca2+-
activated Cl- channels: the resulting 
outward Cl- current accounts for about 
90% of the transduction current in isolated 
mouse olfactory receptor neurons (ORNs) 
(Boccaccio & Menini, 2007). The 
depolarizing responses of ORNs require 
an active mechanism to accumulate Cl- 
inside the neurons. In an attempt to 
identify transport proteins mediating the 
Cl- accumulation, the group of Steven 
Kleene exploited RT-PCR to screen for 21 
Cl- transporters (5 SLC4 anion exchangers, 
9 SLC12 cation-chloride cotransporters, 
and 7 members of SLC26 family) in 
mouse nasal tissue containing the 
olfactory mucosa (Nickell et al., 2007). 
RNA transcripts of 20 transporters, 
including KCC2, were effectively 
detected, and the identities of the PCR 
products were confirmed by sequencing. 
The  primers  used  for  the  KCC2  
amplification span exons 13 to 17, thus 
eliminating the possibility of genomic 
DNA detection. KCC2 expression in the 
nasal mucosa was rather weak compared 
to that in cerebellum (positive control)  
(Nickell et al., 2007). These results are in 
line with a microarray analysis of highly 
enriched preparations of mature ORNs, in 
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which the expression of KCC2, KCC3, 
KCC4, CIP1, PAT1, AE2, and NKCC1 
was detected (Sammeta et al., 2007). In 
contrast to these reports, the group of 
Thomas Gensch was not able to detect 
KCC2 transcripts in rat olfactory sensory 
neurons by amplifying the exon10-exon16 
KCC2 fragment (Kaneko et al., 2004). 
KCC2 mRNA expression outside the 
CNS was also reported in rat cochlear by 
RT-PCR with primers specific to exons 3 
and 5 of the SLC12A5 gene (Yang et al., 
2008). A PCR fragment of 248 bp was 
amplified from the cochlear and brain 
samples, but not from the negative control 
sample, in which the reverse transcriptase 
was omitted during cDNA synthesis. 
However, the size of the obtained PCR 
product (248 bp) was smaller than the 
predicted size (268 bp) of the KCC2-
specific PCR product that should have 
been amplified with the declared primers. 
Presence of a 250 bp ladder lane on the gel 
allowed easy detection of this discrepancy. 
Thus, this report should be treated with 
caution, as one cannot exclude that a 
putative KCC2 splice isoform or some 
unspecific gene fragment was amplified in 
the experiment. 
1.3.4.3 Neuronal versus glial KCC2 
expression  
The idea that KCC2 is expressed 
exclusively in neurons but not in glia has 
also been challenged (Malek et al., 2003). 
By using an anti-KCC2 antibody 
(Chemicon, fragment 932-1043 aa), the 
authors detected KCC2 expression in cell 
bodies of oligodendrocytes in rat optic 
nerve. However, the only negative control 
for the staining was an omission of the 
primary antibody that showed no 
unspecific signal. 
1.3.5 CNS neuronal specificity of 
KCC2: conclusions 
Even though most of the reviewed data are 
consistent with an exclusive CNS neuron-
specific pattern of KCC2 expression, 
several reports suggest that some 
exceptions from this rule may exist in cell 
lines (Zierler et al., 2008), glia (Malek et 
al., 2003), peripheral sensory neurons (Lu 
et al., 1999;Rivera et al., 1999;Nickell et 
al., 2007;Gilbert et al., 2007;Yang et al., 
2008;Funk et al., 2008), and even outside 
nervous system (Balakrishnan et al., 
2003;Bermudez et al., 2004;Malard et al., 
2007;Ng et al., 2007;Lee et al., 2008;Tai 
et al., 2009). While reviewing these 
sometimes controversial results, it is 
important to take into account the 
technical aspects. For example, unusually 
high amount of total RNA (20 ?g) 
compared to standard protocols (1-5 ?g) 
was used by Balakrishnan and coauthors 
(Balakrishnan et al., 2003) that might had 
resulted in a significantly increased 
sensitivity of the PCR detection. Similarly, 
the extreme sensitivity may explain the 
apparent KCC2 signal in DRG observed 
by Lu and coauthors (Lu et al., 1999), as 
in  this  case  RT-PCR  detection  was  
additionally enhanced by subsequent 
Southern blot hybridization. In some cases 
(Yang et al., 2008), it was not clearly 
stated whether the obtained KCC2 PCR 
fragments were sequenced, thus the 
identity of these products remained under 
a question. This is especially important in 
this particular case, because the size of the 
observed PCR product differed from the 
predicted one (Yang et al., 2008). On the 
other hand, the absence of proper negative 
and/or positive controls (especially in 
protein based methods) does not allow 
making a final conclusion on the KCC2 
expression (Lu et al., 1999). Omitting of 
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the primary antibody (Malek et al., 2003) 
is not a good enough control and cannot 
exclude that some nonspecific signal was 
still produced by the KCC2 antibody in 
oligodendrocytes. 
siRNA mediated gene knockdown 
has nowadays become a powerful tool to 
assay gene function (Kumar & Clarke, 
2007), but it is important to remember 
about the OFF target effects sometimes 
produced by siRNAs. As an example, two 
independent papers (Ng et al., 2007; Tai et 
al., 2009) recently reported a strong 
inhibition of HCV replication by KCC2 
siRNAs in human hepatoma (Huh7)-
derived cells. However, these papers did 
not present any evidence of KCC2 
expression in this cell line! Authors of the 
first paper (Ng et al., 2007) did not study 
KCC2 expression in their model system at 
all, while authors of the second paper (Tai 
et al., 2009) reported to have been unable 
to detect KCC2, but provided no 
information about the methods of 
detection or even whether KCC2 mRNA 
or protein had been assessed. 
Importantly, technical aspects alone 
definitely may not explain the discrepancy 
observed by different groups regarding 
KCC2 expression outside CNS. One report 
(Song et al., 2002) has demonstrated that 
KCC2 expression can be detected after the 
retinoic acid induced neuronal 
differentiation of NT2 cells, which 
otherwise show no KCC2 mRNA. This 
implies, that it might not be the model 
system  per  se  that  once  and  for  all  
determines whether KCC2 is expressed or 
not, but it is rather a complex 
transcriptional regulation that defines 
whether SLC12A5 gene is fully silenced or 
actively transcribed in the particular 
system. 
To conclude, the reviewed literature 
shows that KCC2 expression is substan-
tially CNS neuron-specific, although weak 
KCC2 expression in some PNS neurons 
(in DRG and olfactory epithelium), and in 
some cell lines cannot be excluded. 
Unfortunately, lack of experimental details 
and proper controls in some of the 
reviewed reports do not allow making a 
final decision, whether the observed 
KCC2 expression is genuine or represents 
a methodological artefact. Possible 
mechanisms mediating the CNS-
specificity of KCC2 expression will be 
reviewed later in this thesis. 
1.3.6 KCC2 expression: developmental 
upregulation 
Developmental upregulation of KCC2 
expression is well established by 
numerous experiments and described in 
multiple reviews (Ben Ari, 2002;Mercado 
et al., 2004;Rivera et al., 2005;Gamba, 
2005;Blaesse et al., 2009). Different 
model systems – human (Dzhala et al., 
2005), mouse (Li et al., 2002;Hubner et 
al., 2001;Balakrishnan et al., 2003;Ludwig 
et al., 2003;Hubner et al., 2004;Stein et 
al., 2004;Zhu et al., 2005;Fiumelli et al., 
2005;Takayama & Inoue, 2006;Liu et al., 
2006;Takayama & Inoue, 2007;Simat et 
al., 2007;Zhang et al., 2007;Delpy et al., 
2008;Sipila et al., 2009;Chambers et al., 
2009;Bortone & Polleux, 2009), rat 
(Clayton et al., 1998;Lu et al., 1999;Vu et 
al., 2000;Gulyas et al., 2001;Shimizu-
Okabe et al., 2002;Li et al., 2002;Wang et 
al., 2002;Mikawa et al., 2002;Ikeda et al., 
2003;Balakrishnan et al., 2003;Shibata et 
al., 2004;Lohrke et al., 2005;Vale et al., 
2005;Dzhala et al., 2005;Jean-Xavier et 
al., 2006;Blaesse et al., 2006), guinea pig 
(Rivera et al., 1999), gerbil (Milenkovic 
et al., 2007), ferret (Zhang et al., 2006), 
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chicken (Liu et al., 2006), turtle 
(Sernagor et al., 2003;Zhang et al., 2007), 
cat (Kanold & Shatz, 2006) - have been 
used to study the KCC2 developmental 
upregulation. Among these multiple 
reports only a few have so far observed 
certain decrease in KCC2 expression level 
during development (Wang et al., 2002; 
Lohrke et al., 2005). All other data show 
that in any CNS region (except for a few 
areas where KCC2 is not expressed) 
KCC2 expression appears at some 
developmental stage, increases up to a 
certain level, and then remains at that level 
throughout adulthood. The moment, when 
KCC2 expression begins, depends on CNS 
area. Moreover, kinetics of the KCC2 
upregulation even for the same brain area 
may vary dramatically, when different 
species are compared. 
Several important methodological 
considerations should be mentioned before 
reviewing the KCC2 expression literature. 
First one concerns the sensitivity of 
different methods used to study the KCC2 
developmental upregulation. More 
sensitive methods can reveal the KCC2 
expression earlier, thus resulting in a 
possible discrepancy between different 
reports. Another problem is that most of 
the quantitative and semiquantitative 
methods (e.g. RT-PCR, RNAse protection 
assay, Northern blot, Western blot, etc) 
require normalization by either some 
reference gene (cyclophilin, tubulin, 
GAPDH, actin, etc) or by total RNA or 
protein amounts. Usage of the different 
normalization methods thus also might 
lead to some discrepancy between 
different reports. 
Despite enormous amounts of data on 
the developmental upregulation of KCC2 
expression, the signals and mechanisms 
mediating the upregulation are still 
elusive. Even more, it is not clear whether 
these mechanisms are the same in different 
CNS regions. The subsequent literature 
analysis will be performed mostly for the 
individual CNS areas, because most of the 
reports concentrated only on one or a few 
CNS parts, but rarely embraced the CNS 
as a whole. This, hopefully, will give some 
cues concerning putative signals and 
mechanisms mediating the KCC2 
developmental upregulation in these areas. 
1.3.6.1 Whole CNS studies 
First evidence that KCC2 mRNA levels 
steeply increase in the developing CNS 
was demonstrated by the group of Roderic 
Smith (Clayton et al., 1998). The authors 
performed RPA by hybridizing total RNA 
isolated from E15, P0, P7, P21, and adult 
rat whole brains with a KCC2 specific 
probe; the RPA results were normalized to 
cyclophilin. The RPA probe (168 bp) 
included the KCC2 cDNA sequence 
corresponding to nucleotides 119-286 of 
the coding sequence. First data showing 
that KCC2 protein levels significantly 
increase in the developing rat brain came 
from Eric Delpire’s group (Lu et al., 
1999). Using Western blot analysis, they 
detected ~4-fold upregulation of the KCC2 
protein expression in rat whole brain 
between  P1  and  P28;  the  results  were  
normalized to total protein content. The 
same authors confirmed previous results 
obtained by Clayton et al. on the KCC2 
mRNA developmental upregulation: 
Northern blot analysis revealed ~7-fold 
increase in the KCC2 mRNA levels 
between P1 and adult whole brain 
samples. Even though no reference genes 
were used for normalization, equal 
amounts of total RNA were loaded. 
Unfortunately, no information on the 
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sequence of the KCC2 specific probe was 
provided. 
However, in situ hybridization studies 
have indicated that analysis of the 
developmental KCC2 upregulation from 
whole brain samples by RPA or Western 
blot might have certain limitations. The 
major problem is the spatially restricted 
pattern of KCC2 expression in the 
embryonic and early postnatal rodent brain 
(Li et al., 2002; Wang et al., 2002). Li and 
coworkers found, that KCC2 mRNA was 
strongly expressed only in diencephalon 
and rhombencephalon, but was almost 
completely absent in telencephalon in 
E14.5 mouse brain. Moreover, even at P0, 
the whole cortical area in rat and mouse 
brains is mostly devoid of KCC2 mRNA 
(Li et al., 2002). These results were 
confirmed by Wang and coauthors using 
rat brain at E18 and P1 (Wang et al., 
2002). Thus, the sampling of the whole 
brain  at  P0  mixes  the  areas  with  high  
KCC2 expression and those where KCC2 
is absent. 
One important conclusion suggested 
by these first reports (Li et al., 2002; 
Wang et al., 2002) was that KCC2 
expression seems to follow the maturation 
of individual neurons. First neurons arise 
in rat CNS around E12-E13 in the spinal 
cord and medulla. Neurons in thalamus, 
hypothalamus, and amygdale originate on 
E13-E16, while in neocortex most 
principal neurons appear only on E16-E18. 
Moreover, hippocampal pyramidal 
neurons originate on E17-E19, while 
dentate granule cells appear mostly after 
birth (Wang et al., 2002). Indeed, Li and 
coauthors found that in rat CNS at E12.5 
the KCC2 mRNA was primarily expressed 
in the ventral part of the spinal cord. Later, 
on E14.5, the expression was already 
observed in more rostral levels of pons, in 
hypothalamus and basal ganglia, as well as 
in the ventrolateral parts of the developing 
olfactory bulb (Li et al., 2002). Around 
P0,  the KCC2 mRNA levels  were high in 
thalamus, hypothalamus, amygdala, and 
olfactory bulb, but they were still very low 
in neocortex and hippocampus (Li et al., 
2002; Wang et al., 2002). In contrast, at 
P15 KCC2 expression in cortex and 
hippocampus was very strong and almost 
indistinguishable from that at P40 (Wang 
et al., 2002). In agreement with this, the 
group of Fukuda published results on the 
developmental KCC2 upregulation in rat 
cortex (Shimizu-Okabe et al., 2002). The 
authors observed an absence of KCC2 
mRNA expression in neuronal progenitors, 
thus confirming the idea regarding KCC2 
as a marker of neuronal differentiation. 
Another interesting observation of Li 
and coauthors was an apparent 
developmental spreading of KCC2 
expression along the dorsoventral axis. At 
E12.5 the KCC2 expression was detected 
primarily in the ventral part of the spinal 
cord. Later, at E14.5, in the diencephalon, 
the strong KCC2 expression was restricted 
to the ventral thalamus and the ventral 
lateral geniculate complex, whereas only 
moderate levels were observed in the 
dorsal part. In addition, it was the 
ventrolateral part of the developing 
olfactory bulb that revealed strong KCC2 
expression at the same age (Li et al., 
2002). 
The idea that KCC2 expression 
parallels neuronal differentiation was 
confirmed by groups of Christian Hübner 
and Thomas Jentsch (Stein et al., 2004). 
The authors exploited Western blot and in 
situ hybridization to study the KCC2 
developmental upregulation in mouse 
CNS. The in situ hybridization probe 
corresponded to the KCC2 sequence 
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downstream of exon-3, whereas their anti-
KCC2 antibody (Hubner et al., 2001) 
recognized the most N-terminal 15-aa 
KCC2 sequence (15N-KCC2). Western 
blot analysis confirmed the previous 
results obtained by Lu and coauthors (Lu 
et al., 1999). In agreement with Li et al., 
in situ hybridization showed that the 
upregulation of KCC2 expression in mice 
started on average two days earlier than in 
rats. First KCC2 transcripts were detected 
in the ventral part of spinal cord and in the 
immature brainstem already around E10.5. 
At E15.5, KCC2 expression had spread 
over the transverse section of the spinal 
cord and the medulla; the adult level of 
KCC2 expression in spinal cord was 
reached at birth. In agreement with Wang 
et al., the KCC2 expression pattern in 
brain after P15 was similar to that in 
adulthood. Similar to Li et al. 2002, Stein 
and coauthors also found that KCC2 
expression developed in a caudal-to-rostral 
fashion. In situ hybridization data, 
presented by Stein et al., were confirmed 
the same year by Hübner and coauthors 
(Hubner et al., 2004). 
1.3.6.2 Spinal cord 
Only a few reports have specifically 
studied the developmental upregulation of 
KCC2 in the spinal cord (Hubner et al., 
2001; Jean-Xavier et al., 2006;Delpy et 
al., 2008;Vinay & Jean-Xavier, 2008). 
First data came from the group of Thomas 
Jentsch (Hubner et al., 2001). Using in situ 
hybridization with a probe corresponding 
to nucleotides 59 to 557 (amino acids 63 
to 229), the authors demonstrated a strong 
KCC2 expression already at E12.5 in the 
ventral but not in the dorsal part of the 
mouse spinal cord; at E18.5 it became 
strong throughout the spinal cord (Hubner 
et al., 2001). These in situ hybridization 
data have been confirmed on the protein 
level by the group of Pascal Branchereau 
(Delpy et al., 2008). Using IHC with a C-
terminal KCC2 antibody, the authors 
analyzed the developmental expression of 
KCC2 protein in mouse spinal cord from 
E11.5 until P0. KCC2-ir was detected 
already at E11.5 in the ventral part of the 
spinal cord, specifically in the future grey 
matter, but not in the marginal or dorsal 
parts. Later, the KCC2-ir expanded 
dorsally: at E12.5 the whole ventral area 
demonstrated KCC2 expression, at E13.5 
the KCC2 signal expanded into the medial 
part of the dorsal spinal cord, and at E14.5 
the whole transverse section of the spinal 
cord expressed the KCC2 protein, yet still 
stronger in the ventral part. The gradient 
of the KCC2-ir along the dorsoventral axis 
almost disappeared at E16.6 and was not 
anymore observed at P0 (Delpy et al., 
2008). Interestingly, a quantitative 
analysis  of  the  mean  KCC2-ir  in  the  
ventral part of the lumbar spinal cord 
revealed no statistical difference during 
the course of development between E11.5 
and P0. Thus, once started around E11.5 in 
the ventral spinal cord, KCC2 expression 
remained there at the same level. 
An attempt to reveal mechanisms 
regulating the KCC2 upregulation in 
spinal cord has been undertaken by the 
group of Laurent Vinay (Jean-Xavier et 
al., 2006). They used IHC to show that 
KCC2 expression in the adult lumbar 
spinal cord significantly decreased after 
transection of the spinal cord at the 
thoracic level at P0. The authors suggested 
that the neonatal spinal cord transection, 
by removing certain signals from 
brainstem, perhaps prevents or at least 
delays the developmental upregulation of 
KCC2 (Jean-Xavier et al., 2006). 
25 
 
To sum up, KCC2 expression in the 
mouse spinal cord arises around E11 in the 
ventral part. Between E11 and E16, the 
expression expands gradually along the 
dorsoventral axis, and reaches the adult 
pattern around birth. KCC2 expression 
seems to remain at the same level in the 
ventral part of the spinal cord during the 
development course. The KCC2 up-
regulation is ~2 days delayed in rat 
compared to mouse spinal cord. 
1.3.6.3 Brainstem 
The earliest KCC2 mRNA expression in 
the developing mouse brainstem has been 
detected already at E9.5 by the group of 
Andrew Lumsden (Chambers et al., 2009). 
The authors used a microarray analysis to 
identify genes expressed preferentially in 
even rhombomeres and the SLC12A5 
gene, encoding KCC2, was identified 
among such genes. The microarray data 
were confirmed by subsequent in situ 
hybridization analysis, which detected 
specific expression of the KCC2 mRNA in 
rhombomere 4 at E9.5. Expression of 
genes encoding transcription factors 
(Hoxb1, Gata2, bHLHb5, and Lmo1), 
retinoic acid receptor ? (RAR?), 
glutathione peroxidase 3 (Gpx3), aldolase 
C (AldoC), and glycine receptor alpha1 
(Glra1) was also enriched in rhombomere 
4 (Chambers et al., 2009). Later on, 
around E14.5-E15.5 KCC2 expression 
spreads into medulla (Stein et al., 2004) 
and to more rostral part of pons (Li et al., 
2002). 
Information on KCC2 upregulation in 
the postnatal brainstem is more 
inconsistent. On the one hand, Stein and 
coauthors, by using immunoblotting with 
15N-KCC2 antibody, demonstrated that 
KCC2 protein levels continually increased 
in mouse brainstem throughout E15.5, 
E18.5, P3 and P7 time points (Stein et al., 
2004). On the other hand, Friauf’s group, 
by using RT-PCR and Western blot (with 
a C-terminal anti-KCC2 antibody (Lu et 
al., 1999)), showed that KCC2 expression 
was constant in rat brainstem between P1-
3 and P12-16 (Balakrishnan et al., 2003). 
Certain areas of auditory brainstem, 
namely the superior olivary complex 
(SOC), were studied in more details by in 
situ hybridization. Among the four major 
SOC nuclei, the authors detected a minor 
KCC2 increase in medial nucleus of 
trapezoid body (MNTB), but no KCC2 
upregulation in lateral superior olive 
(LSO), medial superior olive (MSO), or 
superior paraolivary nucleus (SPN) 
(Balakrishnan et al., 2003). Single-cell 
RT-PCR confirmed the in situ hybrid-
ization results: all 20 analyzed LSO 
neurons (10 from P3 and 10 from P12 
mice) expressed KCC2 regardless of age 
(Balakrishnan et al., 2003). Surprisingly, 
another group failed to confirm these 
results (Shibata et al., 2004). Using a very 
similar single-cell RT-PCR approach, 
these authors found KCC2 expression in 
every LSO neuron isolated from P13-16 
rats and only in 2 out of 7 LSO neurons 
from P0-3 rats. They suggested that KCC2 
mRNA levels in neonatal LSO neurons 
were too low to be detected by single-cell 
PCR. However, Friauf’s group gave 
further support to their results by 
analyzing KCC2 expression in SOC nuclei 
by IHC (Lohrke et al., 2005). Using a 
polyclonal KCC2 antibody from Upstate, 
Lohrke and coworkers observed 
downregulation of the KCC2-ir signal 
between P0 and P8 in LSO, MSO, and 
SPN nuclei, and no change of KCC2-ir in 
MNTB. Lack of postnatal KCC2 
upregulation in the developing brainstem 
has been further confirmed by the group of 
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Nothwang (Blaesse et al., 2006). The 
authors used their own anti-KCC2 
antibody against amino acid residues 1-93 
of KCC2 (N93-KCC2). Western blot 
analysis, performed with this antibody, 
detected similar protein levels in P2 and 
P30 rat brainstem samples. The KCC2-ir 
was found to be strong already in P4 rat 
brainstem and did not change significantly 
at P12. In agreement with the 
abovementioned reports, no KCC2 
postnatal upregulation was detected in the 
cochlear nucleus - another part of the 
auditory brainstem (Vale et al., 2005). The 
KCC2 protein levels, analyzed by 
immunoblotting with a polyclonal anti-
KCC2 antibody from Upstate, were 
indistinguishable between P4 and P40 in 
cochlear nucleus samples. Similarly, no 
KCC2 upregulation was revealed in the 
anteroventral cochlear nucleus of gerbil 
during the postnatal development 
(Milenkovic et al., 2007). 
In sum, KCC2 expression in rodent 
brainstem first arises in the forth 
rhombomere around E9.5, spreads 
throughout the medulla and pons until 
E15, and finally reaches its adult levels by 
birth. The apparently inconsistent results 
in postnatal brainstem may be explained 
partially by methodological problems. 
Single cell PCR approach is unreliable to 
quantify the gene expression at different 
time points. Even worse, instead of using 
quantitative real-time PCR, both groups 
exploited a conventional nested RT-PCR 
with two rounds of amplification! Usage 
of different anti-KCC2 antibodies might 
also be a reason for the observed 
controversy, given that several isoforms of 
KCC2 protein exist (see below). However, 
in general, the analyzed data confirm the 
hypothesis that KCC2 expression follows 
neuronal maturation. 
1.3.6.4 Thalamus 
Only three reports have described KCC2 
upregulation specifically in developing 
thalamus (Li et al., 2002; Wang et al., 
2002; Ikeda et al., 2003). In agreement 
with the hypothesis that KCC2 follows 
neuronal differentiation, Li with 
coworkers detected a strong KCC2 mRNA 
expression in the ventral part of 
diencephalon in E14.5 mouse brain (Li et 
al., 2002). During that time, the strong 
KCC2 expression was restricted to the 
ventral thalamus as well as to the ventral 
lateral geniculate complex, while only 
moderate levels were observed in the 
dorsal part. Later, KCC2 expression 
continued to spread throughout 
diencephalon until birth. After birth, 
KCC2 expression was unchanged in most 
thalamic subareas (Wang et al., 2002; 
Ikeda et al., 2003), but it slightly 
decreased in ventral posterior thalamic 
nucleus (Wang et al., 2002). The last 
report is one of only two cases known 
when KCC2 is downregulated during 
postnatal development. 
1.3.6.5 Cerebellum 
Developing cerebellum is an important 
model to study mechanisms of KCC2 
upregulation. The time course of KCC2 
upregulation is prolonged and varies 
significantly in different cell types and in 
different cerebellar subregions. Purkinje 
cells (PCs) – the principal output cells of 
cerebellum - are the first cells to differen-
tiate in the cerebellar cortex. PCs are 
generated in the ventricular zone near the 
4th ventricle of the brainstem. Newly 
generated postmitotic PCs migrate radially 
to accumulate in one layer called the 
cerebellar plate. Later, PCs become 
aligned  and  form  the  Purkinje cell  layer 
(PCL) (Sanes et al., 2000). Takayama and 
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Inoue examined the KCC2 protein 
expression in developing mouse 
cerebellum using their own anti-KCC2 
antibody raised in guinea pig (Takayama 
& Inoue, 2006) against amino acid 
residues 1022-1042 of mouse KCC2. 
KCC2 expression was detected already at 
E15 in the PCL of the anterior-dorsal part 
of the cerebellar hemisphere, but not in the 
vermis (Takayama & Inoue, 2007). At 
E17, KCC2-ir was observed in all PCs in 
hemisphere and vermis. Importantly, 
ventricular zone, intermediate zone, and 
external granular layer were devoid of 
KCC2-ir throughout the course of 
embryonic development (Takayama & 
Inoue, 2007). To study mechanisms of 
KCC2 upregulation in PCs, the authors 
performed a double immunostaining for 
KCC2 and synaptophysin. IHC results 
suggested that induction of KCC2 
expression in mouse PCs might be closely 
related to synapse formation: the more 
synaptophysin-positive dots were found in 
close proximity to PCs, the stronger 
KCC2-ir was observed. Moreover, the 
KCC2 expression pattern in PCs 
correlated well with the development of 
climbing fiber innervations on the PCs 
(Takayama & Inoue, 2007). 
Granular cell (GC) progenitors arise 
in a separate progenitor zone called 
rhombic lip and leave it around E13 in 
mouse (Hatten & Heintz, 1995). They 
migrate over the top of the developing PCs 
to form at E15 a secondary zone of 
neurogenesis, called the external granular 
layer (EGL). The GCs continue to 
proliferate in EGL until the third postnatal 
week, generating more of the GC progeny 
(Sanes et al., 2000). Differentiation of 
GCs in EGL starts around birth; following 
mitosis, immature GCs migrate through 
the molecular layer, through the PCL, and 
finally, between P5 and P20, arrive into 
the internal granular layer (IGL) (Espinosa 
& Luo, 2008). In mouse, they start to form 
excitatory synapses with mossy fibers 
around P3, and inhibitory synapses with 
Golgi cells (Go) after P7. First KCC2-ir 
was  detected  in  GCs  of  IGL  only  on  P5,  
after formation of first excitatory synapses 
with mossy fiber terminals (Takayama & 
Inoue, 2006). Importantly, almost all 
KCC2 expressing cells had formed 
synapses with mossy fiber terminals at P5. 
After P5, KCC2 expression in GCs 
increased constantly and reached its adult 
level around P21. Thus, Takayama and 
Inoue suggested that neuronal differen-
tiation per se was not sufficient to induce 
KCC2 expression in GCs: in addition, 
excitatory synapses were required as a 
trigger. 
Stellate and basket cells – cerebellar 
interneurons – are generated similar to 
PCs in the ventricular zone (Zhang & 
Goldman, 1996). They proliferate in 
mouse cerebellum until P7 and migrate 
into the molecular layer during second 
postnatal week (Yamanaka et al., 2004). 
First GABAergic synapses on the 
stellate/basket interneurons are formed as 
soon as the cells complete their migration 
(Simat et al., 2007). Simat and coauthors 
also found that KCC2 expression in the 
stellate/basket cells was barely detectable 
at P10, became prominent at P15, and 
reached high levels at P20. Thus, similar 
to PCs and GCs, KCC2 expression in the 
stellate/basket interneurons arose only in 
the differentiated cells. 
The time course of the KCC2 
upregulation in developing rat cerebellum 
was similar to that in mouse (Li et al., 
2002; Mikawa et al., 2002; Blaesse et al., 
2006). Premature cells in EGL did not 
express KCC2 throughout neurogenesis, 
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while PCs revealed a strong KCC2-ir 
already at P1 (Mikawa et al., 2002; Li et 
al., 2002). At P7, KCC2 expression was 
strong in PCL, but very weak in IGL, 
which only starts to form at that time. On 
P14, both the PCL and IGL revealed a 
strong KCC2-ir; KCC2 expression reached 
its adult levels in rat cerebellum at P21. In 
adult cerebellum, KCC2 mRNA was 
expressed in most neurons, including PCs, 
GCs, stellate cells, and basket cells 
(Mikawa et al., 2002). 
In sum, analysis of KCC2 expression 
in the developing cerebellum leads to 
several conclusions: (1) KCC2 mRNA 
expression is induced at the same time 
when neurons arrive at their final 
destinations (Mikawa et al., 2002), (2) 
formation of excitatory synapses is 
required to induce KCC2 expression in a 
target cell, while the neuronal differen-
tiation per se, although necessary, is not 
sufficient (Takayama & Inoue, 
2006;Takayama & Inoue, 2007), and (3) 
GABAergic synaptogenesis plays an 
important role in the maturation of 
cerebellar interneurons and, as a 
consequence, in the KCC2 upregulation 
(Simat et al., 2007). Li and coworkers 
originally found that not all TUJ1-positive 
cells (marker of neuronal differentiation) 
do obligatory express KCC2 (Li et al., 
2002). Thus, these new three conclusions 
don’t contradict but rather complement the 
hypothesis that KCC2 expression follows 
neuronal maturation. 
1.3.6.6 Hippocampus 
The first description of the developmental 
upregulation of KCC2 expression in 
hippocampus was obtained by Kai Kaila’s 
group (Rivera et al., 1999). Northern blot 
hybridization with a 635-bp long probe, 
corresponding to the most 5’-part of 
KCC2 cDNA, revealed that KCC2 
expression in rat hippocampus was barely 
detectable  at  P0,  rather  weak  at  P5,  but  
very prominent already at P9. Finally, 
KCC2 expression reached its adult levels 
around P15. Rivera and coworkers 
confirmed these results by in situ 
hybridization analysis with a probe 
corresponding to nucleotides 1-835 of the 
rat KCC2 cDNA. KCC2 mRNA was 
detected in hippocampus neither at E20 
nor at P0, but was prominent at P5, and 
very strong at P16 (Rivera et al., 1999). 
Wang and coworkers, using their own in 
situ probes, obtained very similar results: 
only very weak KCC2 expression was 
detected in rat hippocampus at P1, while at 
P15 it became very strong and comparable 
to that at P40 (Wang et al., 2002). 
Additional in situ hybridization data came 
from  Friauf’s  group:  at  P0  all  rat  
hippocampal areas were devoid of KCC2 
signal, while at P16 the labelling was clear 
in all areas (Balakrishnan et al., 2003). In 
contrast, Li and coworkers, by using in 
situ hybridization, detected weak but clear 
KCC2 expression in mouse hippocampus 
at P0 (Li et al., 2002). This discrepancy 
may be explained by a slightly delayed 
development of rats compared to mice. 
Additional data on the developmental 
expression of KCC2 at the protein level in 
mouse hippocampus came from the group 
of Christian Hübner (Stein et al., 2004). 
Immunoblotting revealed no KCC2-
specific signals in E15.5 and E18.5 
hippocampi, rather weak signal at P3, 
prominent at P7, and very strong at P15. 
Even though the KCC2 protein expression 
at E18.5 was not detected by immuno-
blotting, at the same time a very weak 
KCC2  mRNA  signal  was  revealed  by  in 
situ hybridization (Stein et al., 2004). 
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A steep increase in the KCC2 protein 
levels was further confirmed by the group 
of Darwin Berg, who found that Western 
blot signals from mouse hippocampal 
samples were about 4-fold stronger at P9 
compared to P6 (Liu et al., 2006). 
Interestingly, there was no KCC2 
upregulation detected between P6 and P9 
in KO mice deficient for the ?7 subunit of 
nicotinic acetylcholine receptor. Thus, the 
authors suggested that nicotinic signalling 
might play an important role for the 
developmental increase of KCC2 in 
hippocampus (Liu et al., 2006). 
Recently Sipilä and coworkers, using 
Western blot analysis with a C-terminal 
anti-KCC2 antibody (Ludwig et al., 2003), 
have demonstrated that KCC2 protein 
expression in mouse hippocampus was up-
regulated slightly between P3/4 and P6/7, 
but steeply (~3-fold) between P6/7 and 
P20 (Sipila et al., 2009). The authors 
asked whether the developmental up-
regulation of KCC2 depends on the 
NKCC1-mediated depolarizing actions of 
?-aminobutyric acid (GABA). For this 
they analyzed the developmental course of 
the KCC2 upregulation in mice deficient 
for the NKCC1 protein. The authors found 
that KCC2 expression did not differ 
significantly in KO compared to wild type 
mice (Sipila et al., 2009). Similar results 
were reported by another group (Pfeffer et 
al., 2009), using a 15N-KCC2 antibody. 
Developmental upregulation of 
KCC2 expression in CA1 and CA3 
hippocampal areas has also been studied 
by Delpire and coauthors, who exploited 
Western blot with their own anti-KCC2 
antibody (Lu et al., 1999), and found that 
KCC2 expression appeared in CA1 area 
earlier than in CA3 (Zhu et al., 2008). 
The above mentioned in situ hybrid-
ization and immunoblotting data have 
been confirmed by two IHC studies 
(Gulyas et al., 2001; Blaesse et al., 2006). 
Blaesse and coworkers, using an N93-
KCC2 antibody (see above), observed 
almost no KCC2 signal in P4, but strong 
expression in P12 rat hippocampus. In 
addition, detailed IHC analysis of the 
developmental KCC2 expression in rat 
hippocampus was performed by Gulyas 
and coauthors. Only very faint and diffuse 
KCC2-ir was detected in the hippocampus 
at P0; later, KCC2 expression gradually 
increased and reached adult levels at P12. 
Interestingly, similar to the situation in 
cerebellum, the authors found that the 
KCC2 upregulation possibly takes place in 
an input-specific manner: KCC2 
expression in DG neurons correlated with 
the level of innervation of these neurons 
by entorhinal cortical axons. The fact that 
KCC2 expression reached its adult levels 
at P12 was in agreement with the view that 
the layer specific inputs formed by the 
perforant path and the commissural 
afferents are established by P12 (Gulyas et 
al., 2001). Another interesting finding 
mentioned by Gulyas and coauthors was a 
very strong KCC2 expression in 
parvalbumin (PV)-containing inter-
neurons. These cells receive in average 
about 8 times more excitatory input 
compared to other interneurons (Gulyas et 
al., 1999). Whether the significantly 
increased KCC2 expression in the PV-
containing interneurons was a result of this 
strong excitatory input remains to be 
determined. 
One hypothesis to explain the 
developmental upregulation of KCC2 
expression was suggested by the group of 
Fernando Aguado (Aguado et al., 2003). 
They generated mice overexpressing 
brain-derived neurotrophic factor (BDNF) 
and demonstrated that KCC2 mRNA 
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expression was ~4-fold higher in the E18 
transgenic embryos compared to their wild 
type littermates; semiquantitative RT-PCR 
was performed with primers correspond-
ing to nucleotides 4-479 of the mouse 
KCC2 coding sequence, and normalized to 
GAPDH. In situ hybridization with a 
probe obtained with the same primers 
revealed almost no KCC2 mRNA in 
hippocampus of wild type embryos at E18, 
but detected high levels of KCC2 
expression in the littermates over-
expressing BDNF, thus confirming results 
of the RT-PCR (Aguado et al., 2003). Few 
years later, the same group generated mice 
deficient for the tropomyosin receptor 
kinase  B (TrkB)  –  the  receptor  kinase  for  
BDNF (Carmona et al., 2006). KCC2 
expression was assessed in these TrkB-/- 
mice by Northern blot and by in situ 
hybridization with the KCC2 probe 
described previously (Aguado et al., 
2003). Both methods revealed a moderate 
reduction of the KCC2 mRNA levels in 
hippocampal and cortical areas of the P10 
TrkB-/- mice compared to wild type 
littermates (Carmona et al., 2006). The 
consistent results obtained from the 
BDNF-overexpressing and TrkB-deficient 
mice suggest an importance of the TrkB-
signalling for the developmental up-
regulation of KCC2, although indirect 
effects of the above manipulations on the 
TrkB pathway cannot be excluded. 
To sum up, KCC2 expression in 
rodent hippocampus develops mainly 
during first two postnatal weeks. The 
mechanisms responsible for the 
developmental KCC2 upregulation in 
hippocampus remain unclear. GABA-
mediated depolarization seems dispens-
able for the developmental upregulation of 
KCC2 (Pfeffer et al., 2009; Sipila et al., 
2009). However, glutamatergic activity 
and intrinsic excitability of CA3 
pyramidal neurons in the NKCC-/- animals 
are enhanced compared to the wild type 
mice via unknown compensatory 
mechanism, which may be sufficient to 
keep KCC2 expression at the level found 
in wild type mice. Similarly, Gulyas and 
coworkers observed a correlation between 
the KCC2 expression level and the 
excitatory input obtained by neurons, thus 
also suggesting the importance of neuronal 
activity for the KCC2 expression during 
development (Gulyas et al., 2001). The 
results presented by Aguado et al. and 
Carmona et al.  may  suggest  a  role  for  
BDNF in regulating the KCC2 induction 
in the developing hippocampus. However, 
BDNF-overexpressing mice show 
increased spontaneous activity, correlated 
network activity, synaptogenesis, and 
expression of GABA-synthesizing enzymes 
glutamic acid decarboxylases 65 and 67 
(GAD65/67) (Aguado et al., 2003). 
Similar problems persist in TrkB-/- mice, 
as spontaneous activity, number of 
GABAergic synapses, expression on 
GAD65/67 enzymes, glutamate and 
GABA  release,  as  well  as  expression  of  
several AMPA and GABAA receptor 
subunits were also affected in these mice 
(Carmona et al., 2003;Carmona et al., 
2006). Thus, it is difficult to conclude 
whether the observed changes in KCC2 
expression is a direct result of the 
impaired BDNF signalling or an indirect 
consequence of other BDNF-mediated 
changes occurring in brains of these mice. 
1.3.6.7 Cortex 
The first demonstration of the 
developmental KCC2 upregulation in 
cortex was published by the group of 
Roderic Smith (Clayton et al., 1998). 
Using in situ hybridization, this group 
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analyzed KCC2 mRNA abundance in E18, 
P0, P7, P21, and adult rat cortex. No 
KCC2 mRNA expression was detected at 
E18, very low signal was seen at P0, but it 
was significantly increased at P7. High 
levels of the KCC2 expression were 
observed at P21 and in adult samples 
(Clayton et al., 1998). Analogous in situ 
hybridization results were obtained by 
groups of Fukuda (Shimizu-Okabe et al., 
2002) and Sato (Wang et al., 2002). 
Shimizu-Okabe and coauthors analyzed 
KCC2 expression in P0, P4, P10, and P28 
rat cortex: it was very low at P0-P4, and 
became significant only after P10. No 
KCC2 mRNA expression was detected in 
the ventricular zone at any developmental 
stage (Shimizu-Okabe et al., 2002). In 
their turn, Wang and coauthors could not 
detect the KCC2 expression at P1, 
whereas it was dramatically increased at 
P15, reaching its adult levels at that time 
(Wang et al., 2002). Ikeda and coworkers 
also used in situ hybridization to compare 
the developmental course (P0, P4, P7, 
P14, P28) of the KCC2 expression in rat 
visual cortex to that in dorsal lateral 
geniculate nucleus (Ikeda et al., 2003). 
They found that KCC2 mRNA level in 
visual  cortex  was  very  low  at  P0,  but  
gradually upregulated at P28. In contrast, 
no change in the KCC2 mRNA level was 
detected in the geniculate nucleus 
throughout postnatal development. 
Western blot analysis of the KCC2 
expression in developing cortex has been 
presented so far only by two reports (Stein 
et al., 2004; Dzhala et al., 2005). Stein and 
coworkers could not detect any KCC2 
expression in mouse brain at E15.5, found 
it very weak at E18.5, prominent at P3, 
getting stronger at P7, and very strong at 
P15. Importantly, the KCC2 antibody used 
in this experiment recognizes the most N-
terminal 15 amino acid sequence of the 
KCC2 protein. Dzhala and coauthors have 
analyzed developmental upregulation of 
KCC2 in rat and human cortical samples. 
In rat, KCC2 expression was first detected 
at P11 and then steeply increased until 
adulthood. In human cortex, the KCC2 
protein levels were barely detectable 
during the entire fetal period. In addition, 
KCC2 expression was about 2-25% of 
adult levels between gestational weeks 31 
and 41, and then increased during the first 
year after birth (Dzhala et al., 2005). 
 Kanold and Shatz used cat visual 
cortex as a model to test the hypothesis 
that KCC2 expression is regulated by 
neuronal activity (Kanold & Shatz, 2006). 
Using in situ hybridization and 
quantitative RT-PCR, the authors showed 
that KCC2 expression in the cat visual 
cortex increased gradually from P0 until 
P35. Intriguingly, the developmental 
upregulation of KCC2 expression was 
distorted in subplate-ablated cats. Subplate 
neurons are known to be innervated by 
axons from the lateral geniculate nucleus 
and are among first neurons innervating 
the cortical layer 4. Ablating of the 
subplate neurons leads to the decreased 
synaptic input to the layer 4. In subplate-
ablated cats, KCC2 expression 
substantially decreased in the layer 4, but 
not in other cortical layers. At P5, the 
KCC2 mRNA level in the cortical layer 4 
was about 70% lower in the subplate-
ablated compared to the unmanipulated 
animals; moreover, a significant (~50%) 
difference still persisted in cats at P50 
(Kanold & Shatz, 2006). Another 
important result of this paper was that the 
developmental upregulation of KCC2 in 
layer 4 was prevented by chronic blockade 
of glutamatergic transmission. Subplate 
neurons are known to provide largely 
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glutamatergic, excitatory inputs to cortex 
(Finney et al., 1998), thus the develop-
mental upregulation of KCC2 in the 
cortical layer 4 requires the intact 
glutamatergic transmission mediated via 
subplate neurons. 
Interesting results on the mechanism 
of KCC2 expression during cortical 
development have been recently presented 
by the group of Gord Fishel (Batista-Brito 
et al., 2008). They generated transgenic 
mice expressing enhanced GFP (EGFP) 
under the Dlx5/6 promoter, thus 
specifically marking cortical interneuronal 
precursors. The authors dissected the 
cortical areas at E15.5, isolated the EGFP-
positive interneurons by FACS, and 
analyzed a genome-wide gene expression 
profile of the EGFP+ neurons by 
microarray analysis. Surprisingly, 
SLC12A5 gene, encoding KCC2 protein, 
was found among other genes (including 
GAD67, VGAT, GABAR?2), whose 
expression was highly enriched in the 
cortical interneuron precursor populations 
at E15.5. The microarray results were 
confirmed by in situ hybridization with a 
probe that contained mostly the 3’UTR 
part of the KCC2 (Batista-Brito et al., 
2008). These results suggest that cortical 
interneurons may start to express KCC2 
already during their migration, before 
being fully integrated into a local synaptic 
network. 
In sum, KCC2 upregulation in 
rodents reaches its maximum levels by the 
3rd postnatal week. KCC2 expression is 
significantly slower in cat and human 
cortical samples, where the adult levels are 
reached only at ~P40 and ~1 year 
postnatally, respectively. Two reports 
(Ikeda et al., 2003; Kanold & Shatz, 2006) 
are in agreement with the hypothesis that 
the developmental expression of KCC2 (at 
least in cortex) might be increased by 
neuronal activity. Ikeda and coworkers 
found that KCC2 expression in the dorsal 
lateral geniculate nucleus and in the visual 
cortex correlates with establishing of final 
axonal projections into these areas. In their 
turn, Kanold and Shatz revealed that 
KCC2 upregulation in the cortical layer 4 
requires an intact glutamatergic trans-
mission mediated via subplate neurons. In 
cortical interneurons, KCC2 expression 
appears to be induced even before 
neuronal migration is completed (Batista-
Brito et al., 2008). Using in situ 
hybridization and microarray analysis, the 
authors detected prominent KCC2 
expression in the migrating cortical 
interneuronal precursors in the developing 
cortex already at E15.5. Of note, most 
previous reports had failed to appreciate 
KCC2 expression in the cortex before 
E18.5. Detection of the KCC2 mRNA by 
in situ hybridization may be explained by 
a high sensitivity of the probe. Another 
possible explanation is that the 3’UTR 
probe recognized certain KCC2 splice 
isoform, but not the full length KCC2 
mRNA. This possibility is suggested by 
the report of Akan and coauthors, who 
predicted one new KCC2 promoter in the 
3’UTR part of the SLC12A5 gene (Akan et 
al., 2009). The early expression of KCC2 
in migrating interneuronal precursors has 
been confirmed by Dante Bortone and 
Franc Polleux, who revealed a weak 
KCC2-ir at E16.5 in interneuronal 
precursors, but not in pyramidal neurons 
of the cortical plate (Bortone & Polleux, 
2009). The authors have also determined 
that even though KCC2 expression in the 
interneuronal precursors was hetero-
geneous, it was still much stronger than in 
pyramidal neuronal precursors. Moreover, 
KCC2 expression in average appeared in 
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interneurons about 1 week earlier than in 
pyramidal neurons. Although the 
migrating interneurons increased KCC2 
expression steeply only upon reaching the 
cortical area, they did express KCC2 
already during their migration from the 
ganglionic eminence to the cortical area 
(Bortone & Polleux, 2009). 
1.3.6.8 Retina 
KCC2 mRNA expression in mouse retina 
can be detected as early as E14.5 and its 
levels increase slowly by P0 (Li et al., 
2002). Immunoblotting showed that KCC2 
expression in rat retina continued to 
increase after birth: it constituted ~25% of 
adult level at P3, ~75% at P7, and finally 
reached the adult level at P14 (Vu et al., 
2000). Moreover, IHC analysis detected 
KCC2 protein first in inner retina around 
P1, and in outer retina only around P10. 
KCC2-ir was clearly visible in both inner 
and outer retina at P14. KCC2 immuno-
reactivity became more punctuate after 
P14, but the total expression level did not 
change much between P14 and P32 (Vu et 
al., 2000). Whether the delayed KCC2 
expression was a reason or a consequence 
of the delayed synaptogenesis in the outer 
retina is an open question. 
Mechanisms of KCC2 upregulation 
have also been studied in the inner 
plexiform layer (IPL) of turtle retina 
(Sernagor et al., 2003). The authors 
reported that the fraction of the KCC2-
positive IPL constituted ~60% one week 
before hatching, ~95% around time of 
hatching, and the same ~95% by 3rd week 
post hatching. Interestingly, the KCC2-ir 
fraction was found to be ~20% smaller in 
the IPL of turtles kept for three weeks post 
hatching in dark-rearing compared to 
normal conditions, suggesting a role of 
neuronal activity for the developmental 
upregulation of KCC2. In agreement with 
the proposed role of KCC2 in modulation 
of GABA responses, GABA retained a 
substantial excitatory component after 4 
weeks of dark-rearing, while in normal 
conditions the hyperpolarizing GABA 
responses were observed during the first 
week post hatching (Sernagor et al., 
2003). To address whether GABA-
signalling was important for the develop-
mental upregulation of KCC2 in turtle 
retina, the same group performed a series 
of experiments, in which GABAA 
receptors were chronically blocked in vivo 
by antagonist bicuculline (Leitch et al., 
2005). The authors detected a down-
regulation of the KCC2-ir inside the IPL 
after 28 days of the chronic blockade. 
However, the effect of blockade was 
rather modest: the intensity of the KCC2-ir 
decreased only by 15%, and the percent-
age occupancy of KCC2 within IPL 
decreased only by 12% (Leitch et al., 
2005). 
Developmental upregulation of 
KCC2 in ferret retina was studied by the 
group of Vardi (Zhang et al., 2006). 
Immunoblotting with a C-terminal anti-
KCC2 antibody demonstrated a low KCC2 
protein expression before P28 (less than 
10% of adult level) and a very steep 
upregulation after P28. Totally, the KCC2 
protein level increased three orders of 
magnitude from P10 to adult (Zhang et al., 
2006). Interestingly, a similar upregulation 
course was observed for synaptophysin: 
KCC2/synaptophysin ratio did not change 
significantly during the whole develop-
mental period analyzed. IHC confirmed 
that overall KCC2 expression was 
upregulated in retina with age, but also 
revealed that the time course was different 
for different cell types. A very weak 
KCC2-ir appeared in the IPL at P3, and 
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became prominent at P10, when ganglion 
cell  processes  start  to  stratify  in  the  IPL.  
At P14, the KCC2-ir divided into two 
strata corresponding to future ON and 
OFF sublaminae, and at P18 the 
expression reached a level corresponding 
to 40% of the adult one (Zhang et al., 
2006). Like in the turtle retina, KCC2-ir in 
the ferret outer retina was significantly 
delayed compared to the inner retina. 
Weak KCC2 signal in the outer plexiform 
layer (OPL) was detected only around 
P10, and then gradually increased until 
adulthood. KCC2 expression was more 
delayed in the bipolar cells. These cells are 
well-formed already at P28, however no 
KCC2-ir could be detected before P37 
(Zhang et al., 2006). 
The same group has also presented a 
very detailed analysis of KCC2 expression 
in the developing mouse retina (Zhang et 
al., 2007). Western blot analysis could not 
detect KCC2 expression in mouse retina 
before P8. After P8, the KCC2 levels 
steeply upregulated peaking at P24 and 
constituting ~25% and ~80% of the peak 
level at P12 and P14, respectively. IHC 
analysis detected KCC2-ir already at P0 in 
the IPL. At P10, the KCC2 staining 
divided into two strata corresponding to 
the future ON and OFF sublaminae 
(Zhang et al., 2007). KCC2 expression in 
the outer retina appeared around P7, when 
OPL is formed, and thereafter the 
expression continued to increase up to 
P20. Based on this analysis, Zhang and 
coworkers suggested that in general KCC2 
expression correlated with a differentiation 
of diverse cell types in retina. 
In sum, KCC2 upregulation in retina 
has been revealed in several model 
organisms. One common property for all 
these systems is a very steep course of the 
KCC2 upregulation. Another common 
feature is the pronounced delay of the 
moment when KCC2 expression starts 
between the inner and outer retina. The 
fact that the dark-rearing is able to retard 
KCC2 expression in the IPL points at 
some light-/activity- dependent mecha-
nism regulating KCC2 expression during 
retinal development. This activity-
dependent mechanism may be partially 
controlled by GABAA receptors, as the 
chronic blockade of these receptors by 
bicuculline decreases KCC2 expression in 
the turtle IPL. The relatively modest effect 
of bicuculline indicates that there are 
additional mechanisms controlling the 
KCC2 developmental upregulation in 
retina. 
1.3.6.9 Dissociated neuronal cultures 
The dissociated neuronal culture is a 
popular model to study the developmental 
shift of GABA responses from 
depolarizing to hyperpolarizing (D/H 
shift) that occurs during neuronal 
maturation. Somewhat surprisingly, the 
developmental expression of KCC2 – the 
main proposed molecule responsible for 
the shift – in the dissociated cultures has 
been studied only by a few reports. These 
reports have suggested interesting but 
contradictory hypotheses on the mecha-
nisms governing the KCC2 upregulation 
(see below). 
A careful characterization of the 
KCC2 developmental upregulation in 
mouse hippocampal organotypic and 
dissociated cultures was performed by 
Claudio Rivera’s group (Ludwig et al., 
2003). The authors generated a new C-
terminal anti-KCC2 antibody and used it 
for ICC and for Western blot analysis. 
Immunoblotting revealed a gradual 
increase (~5-fold) of KCC2 protein level 
in mouse hippocampal dissociated cultures 
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between div4 (day in vitro) and div15; 
KCC2 signals were normalized to ?-
tubulin. More prominent KCC2 up-
regulation (~8-fold) was detected by the 
immunoblotting in organotypic cultures 
cultivated from div3 to div14 (Ludwig et 
al., 2003). ICC showed very similar 
results: KCC2-ir was very weak in div3 
neurons and gradually increased until 
div15, constituting about 20% at div6, 
40% at div8, and 70% at div10 of its 
maximal level at div15. Additional 
experiments were performed to clarify the 
role of neuronal activity and synaptic 
transmission in the developmental 
upregulation of KCC2. Surprisingly, a 
chronic (from div2 to div15) blockade of 
action potentials, GABAA receptors, and 
ionotropic glutamate receptors separately 
or in different combinations did not 
influence the KCC2 protein expression. 
Similar results were obtained for the 
organotypic cultures. Thus, the authors 
suggested that other mechanisms (e.g. 
cell-to-cell or cell-to-matrix interactions) 
may be necessary for the developmental 
increase of KCC2 (Ludwig et al., 2003). 
Developmental upregulation of the 
KCC2 protein expression has been 
observed in dissociated mouse cortical 
cultures by ICC (Zhu et al., 2005) and in 
mouse hippocampal cultures by Western 
blot (Fiumelli et al., 2005). Immuno-
blotting, which was performed with the 
KCC2 antibody from Upstate and 
normalized to ?-tubulin, detected a 3-fold 
upregulation of KCC2 between div6 and 
div15 cultures. Although three bands were 
seen on the blot - two minor bands of 
~140 kDa (corresponding to KCC2 
monomer) and one major band of ~240 
kDa (putative KCC2 dimer), Fiumelli and 
coworkers quantified only the KCC2 
monomers. Three similar bands were 
detected by Western blot from lysates of 
HEK293 cells transfected with a KCC2 
expression but not an empty vector, thus 
proving the specificity of the KCC2 
antibody. 
An intriguing yet contradictory 
hypothesis has been suggested by the 
group of Mu-ming Poo that GABA 
signalling itself activates KCC2 
expression and thus induces D/H shift in 
GABA responses during neuronal 
maturation (Ganguly et al., 2001). To test 
their hypothesis, the authors chronically 
blocked GABAA receptors  in  rat  
hippocampal dissociated cultures starting 
at div3 and demonstrated that KCC2 
mRNA levels were significantly reduced 
at div9 (by ~25%) and at div12-15 (by 
~70%) in the treated compared to the 
untreated cultures. It is important to note, 
that the chronic blockade of GABAA 
receptors was unable to completely cease 
the developmental upregulation of KCC2: 
KCC2 mRNA levels were still ~4-fold 
higher in both div9 and div12-15 treated 
cultures compared to div3 treated cultures 
(Ganguly et al., 2001). A similar 3-5 fold 
upregulation of the KCC2 mRNA level 
was previously described in control 
untreated dissociated hippocampal 
cultures (Ludwig et al., 2003; Fiumelli et 
al., 2005). Of note, in the absence of 
GABAA receptor inhibitors, Ganguly and 
coauthors detected a much more 
prominent (about 15-fold) increase of the 
KCC2 mRNA expression between the 
div3 and div15 cultures. Such a strong 
KCC2 mRNA upregulation has been 
reported so far only for hippocampal 
neurons in vivo (Rivera et al., 1999), but 
neither for dissociated nor for organotypic 
hippocampal cultures in any other study. 
Ganguly and coauthors have not 
presented data showing that KCC2 mRNA 
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expression can be directly activated by 
GABA (Ganguly et al., 2001). Instead, 
they elevated neuronal, including 
GABAergic activity, by chronic depolari-
zation of the cultures with 10 mM KCl. 
This treatment resulted in ~2-fold 
upregulation of the KCC2 mRNA 
expression in div9 mouse hippocampal 
cultures. It is interesting to note, that a 
similar KCl treatment was unable to 
change the KCC2 protein expression level 
in rat hippocampal dissociated cultures as 
reported by the group of Melanie Woodin 
(Balena et al., 2008). The authors cultured 
hippocampal neurons for two weeks in 
either 2.6 mM or 18.7 mM extracellular 
KCl, but found no difference in KCC2 
protein levels upon the treatment. 
To sum up, the available literature 
has not revealed consensus mechanisms 
regulating KCC2 expression in dissociated 
neuronal cultures. On the one hand, a 
blockade of the GABAergic signalling 
decreases KCC2 expression in dissociated 
hippocampal cultures (Ganguly et al., 
2001). On the other hand, the KCC2 
inhibition observed by Ganguly et al. is 
partial and has not been confirmed by the 
subsequent study performed in a similar 
model system (Ludwig et al., 2003). One 
possible explanation for the controversy is 
that Ganguly et al. used neuronal cultures 
~10 times more dense than those used by 
Ludwig et al. It has previously been 
shown that a higher density of astrocytes 
in dissociated cultures results in a 
significant acceleration of D/H shift in 
cultured spinal cord neurons (Li et al., 
1998). Given that ionotropic glutamatergic 
signalling has not demonstrated any effect 
on the KCC2 developmental upregulation 
in dissociated cultures (Ganguly et al., 
2001;Ludwig et al., 2003), Ludwig and 
coauthors suggested a new idea that cell-
to-cell or cell-to-matrix interactions may 
be responsible for the developmental 
increase of KCC2 (Ludwig et al., 2003). 
In addition, one common conclusion has 
been made by both groups: experiments 
with tetrodotoxin (TTX) exclude the 
possibility that the KCC2 developmental 
increase is potentiated by action potentials 
(Ganguly et al., 2001; Ludwig et al., 
2003). 
1.3.7 Developmental upregulation of 
the KCC2 expression: conclusions 
The available data clearly demonstrate that 
KCC2 expression inevitably increases 
during CNS development. Two reports 
have observed downregulation of the 
KCC2 mRNA level during normal 
development, but only in certain brain 
regions (Wang et al., 2002; Lohrke et al., 
2005). Of note, the time of induction of 
KCC2 expression during development 
depends strongly on the CNS areas and 
species analyzed. The earliest KCC2 
expression in mouse CNS has been 
detected in hindbrain at E9.5 (Chambers et 
al., 2009). Once started, KCC2 expression 
grows steeply and, upon reaching adult 
levels, remains mostly unchanged. 
Several associations have been noted 
for the developmental upregulation of 
KCC2 expression: 
 
1) KCC2 expression follows 
neuronal maturation (Li et al., 
2002; Wang et al., 2002; Shimizu-
Okabe et al., 2002; Stein et al., 
2004; Zhang et al., 2007). 
2) KCC2 expression develops in a 
caudal-to-rostral direction (Li et 
al., 2002; Stein et al., 2004). 
3) KCC2 expression develops in a 
ventral-to-dorsal direction 
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(Hubner et al., 2001; Li et al., 
2002; Delpy et al., 2008). 
 
At least, five mechanisms have been 
suggested to be important for the develop-
mental upregulation of KCC2 expression: 
 
1) GABAergic signalling (Ganguly 
et al., 2001; Leitch et al., 2005; 
Simat et al., 2007). 
2) Glutamatergic signalling (Gulyas 
et al., 2001;Sernagor et al., 
2003;Takayama & Inoue, 
2006;Kanold & Shatz, 2006;Sipila 
et al., 2009). 
3) Cholinergic signalling (Liu et al., 
2006). 
4) Cell-to-cell and/or cell-to-matrix 
contacts (Li et al., 1998; Ludwig 
et al., 2003). 
5) Neurotrophins (Aguado et al., 
2003; Carmona et al., 2006). 
 
Unfortunately, the proposed mechanisms 
are still inconclusive and often 
contradicting to each other, thus impeding 
generation of the consensus mechanism 
that underlies the developmental up-
regulation of KCC2. For example, while 
several studies highlighted the role of 
GABAergic signalling in KCC2 develop-
mental upregulation (Ganguly et al., 
2001;Leitch et al., 2005;Simat et al., 
2007), other reports have excluded this 
possibility (Ludwig et al., 2003;Wojcik et 
al., 2006;Sipila et al., 2009). Similarly, 
whereas some authors suggested the 
importance of glutamatergic signalling for 
the KCC2 upregulation during 
development (Gulyas et al., 2001;Sernagor 
et al., 2003;Takayama & Inoue, 
2006;Kanold & Shatz, 2006;Sipila et al., 
2009), blocking of neither glutamatergic 
transmission nor action potentials was able 
to change KCC2 expression in dissociated 
neuronal cultures (Ganguly et al., 
2001;Ludwig et al., 2003). Hypotheses 
explaining the KCC2 upregulation by 
cholinergic signalling (Liu et al., 2006) or 
by cell-to-cell contacts (Li et al., 1998; 
Ludwig et al., 2003) have got so far little 
experimental confirmation. A major 
problem of the hypothesis that KCC2 is 
regulated by neurotrophins (Aguado et al., 
2003;Carmona et al., 2006) is that 
spontaneous and correlated network 
activities, as well as maturation of 
GABAergic signalling are significantly 
changed in the TrkB-pathway affected 
embryos (Aguado et al., 2003;Carmona et 
al., 2003;Carmona et al., 2006). Thus, it is 
difficult to conclude whether the observed 
KCC2 upregulation is a direct result of 
BDNF regulation or just a consequence of 
the abovementioned changes. In general, 
the apparent interconnection between the 
several potentially important factors 
makes it challenging to decipher the role 
of each of them in mediating the 
developmental KCC2 upregulation. 
1.3.8 Neuronal subpopulations lacking 
KCC2 in adult brain 
As reviewed in the previous sections, 
KCC2 (mRNA and protein) is expressed 
very broadly among adult CNS neurons. 
However, a few neuronal subpopulations 
in adult rodent brain are reported as not 
expressing KCC2: 
 
1) Dorsolateral part of the 
paraventricular nucleus (Kanaka 
et al., 2001). 
2) Dorsomedial part of the 
suprachiasmatic nucleus (Kanaka 
et al., 2001; Belenky et al., 2008; 
Belenky et al., 2009). 
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3) Ventromedial part of the 
supraoptic nucleus (Kanaka et al., 
2001; Leupen et al., 2003). 
4) Reticular thalamic nucleus 
(Kanaka et al., 2001; Bartho et al., 
2004). 
5) Medial habenular nucleus 
(Kanaka et al., 2001; Wang et al., 
2006; Kim & Chung, 2007). 
6) Mesencephalic trigeminal nucleus 
(Kanaka et al., 2001; Toyoda et 
al., 2005). 
7) Dopaminergic neurons in the 
substantia nigra pars compacta 
(Gulacsi et al., 2003). 
 
The last sections will be dedicated to the 
analysis of these KCC2-negative regions. 
An attempt will be taken to identify 
certain commonalities between these 
neuronal subpopulations lacking KCC2 
expression that might help us to dissect the 
transcriptional mechanisms regulating the 
SLC12A5 gene activity. 
1.3.8.1 Paraventricular nucleus of 
hypothalamus 
The fact that KCC2 is not expressed in the 
dorsolateral part of the paraventricular 
nucleus (PVN) was first reported by 
groups of Sato and Fukuda (Kanaka et al., 
2001). The authors analyzed the KCC2 
expression in adult rat nervous system by 
in situ hybridization and found no KCC2 
mRNA in the dorsolateral part of PVN. 
Since PVN is known to be enriched with 
vasopressin (VP) neurons, the authors 
compared the distribution of VP neurons 
(assessed by IHC with an anti-vasopressin 
antibody) with that of KCC2-positive 
neurons (analyzed by in situ hybridization 
with two different KCC2 probes). The VP-
positive neurons, preferentially located in 
the dorsolateral part of PVN, were devoid 
of KCC2 expression (Kanaka et al., 2001). 
However, no independent confirmation of 
the KCC2 absence in PVN has been 
obtained so far. 
1.3.8.2 Suprachiasmatic nucleus 
The same report also provided evidence 
that KCC2 was not expressed in the 
dorsomedial part of the suprachiasmatic 
nucleus (SCN) (Kanaka et al., 2001). 
Mutually exclusive patterns of the KCC2 
and VP containing neurons were observed 
there: VP expressing neurons, detected 
mostly in the dorsomedial part of the SCN, 
showed no hybridization signals 
corresponding to the KCC2 mRNA 
(Kanaka et al., 2001). 
The absence of KCC2 in the 
dorsomedial part of SCN was indepen-
dently confirmed by the group of Pickard 
(Belenky et al., 2008). They exploited 
double IHC with antibodies against KCC2 
(C-terminal) and VP to show that the VP-
positive neurons in the dorsomedial part of 
rat SCN lack KCC2 protein expression. In 
contrast, KCC2-ir was very prominent in 
the ventral and ventrolateral parts of SCN 
and coincided with the distribution of 
neurons containing the vasoactive 
intestinal peptide (VIP) and the gastrin-
releasing peptide (GRP). Of note, VP-
positive neurons, which lack KCC2, 
expressed strongly GABAB but not 
GABAA receptors. In addition, while 
GABA-ir was detected in most of the SCN 
neurons, irrespective of their peptidergic 
phenotype, expression of GAD65/67 and 
vesicular GABA transporter was 
significantly stronger in the ventral part of 
SCN (Belenky et al., 2008). Next year 
Belenky and coauthors confirmed these 
results (Belenky et al., 2009). In addition, 
they demonstrated that KCC1, similar to 
KCC2, is expressed preferentially in VIP 
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but not in VP neurons, whereas KCC3 and 
KCC4 are expressed exclusively in VP 
neurons. The authors suggested that 
depolarizing GABA responses could be 
more likely observed in the VP but not in 
the VIP and GRP neurons (Belenky et al., 
2009). 
1.3.8.3 Supraoptic nucleus 
Information about KCC2 expression in the 
ventromedial part of the supraoptic 
nucleus (SON) is more controversial. 
Kanaka and coauthors were not able to 
detect  KCC2 mRNA in  adult  rat  SON by  
in situ hybridization with two different 
probes corresponding to exons 9 and 24 of 
the SLC12A5 gene (Kanaka et al., 2001). 
SON, similar to PVN and SCN, is known 
to contain many VP neurons. Thus, 
Kanaka and coauthors were the first who 
noted the negative correlation between 
KCC2 and vasopressin expression. In 
contrast, Leupen and coworkers reported 
that up to 98% of the VP-positive neurons 
in adult mouse SON did express KCC2 
(Leupen et al., 2003). The reason for this 
controversy is unclear; both studies 
exploited in situ hybridization to detect 
KCC2, albeit using different probes. The 
probe used by Leupen et al. was partially 
homologous to the KCC1 mRNA 
sequence that might explain the 
discrepancy. Leupen and coauthors, in 
addition, reported that ~35% of the 
gonadotropin-releasing hormone (GnRH) 
neurons in both male and female mouse 
adult brain expressed KCC2 (Leupen et 
al., 2003). However, another study, using 
the same IHC/in situ technique revealed 
that only 5% of the GnRH neurons express 
KCC2 (DeFazio et al., 2002). 
1.3.8.4 Reticular thalamic nucleus 
Kanaka and coauthors also revealed the 
absence of KCC2 mRNA expression in the 
reticular thalamic nucleus (nRt) (Kanaka 
et al., 2001). A more detailed analysis of 
the KCC2 protein expression in rat 
thalamus and in nRt particularly, was 
performed by Bartho and coauthors 
(Bartho et al., 2004). They confirmed the 
lack of KCC2 in most of the nRt, but 
found that the dorsal and the most anterior 
parts of nRt still expressed KCC2 at levels 
similar to those in the neighbouring 
thalamic nuclei. To verify their results, 
Bartho and coworkers performed double 
IHC with antibodies against KCC2 and 
parvalbumin. They revealed that KCC2-ir 
and PV-ir were colocalized in the dorsal 
and anterior parts of nRt, but not in other 
nRt areas (Bartho et al., 2004). The 
authors also noted that the KCC2 
expression pattern in these parts of nRt 
follows the distribution of calretinin (CR) 
neurons (Lizier et al., 1997). By using 
double IHC against KCC2 and CR, they 
confirmed this observation not only for the 
dorsal and anterior parts of nRt, but for the 
whole nRt (Bartho et al., 2004). 
1.3.8.5 Habenular nucleus 
Three groups have so far demonstrated the 
lack of KCC2 expression in the medial 
habenular nucleus (MHb) (Kanaka et al., 
2001; Wang et al., 2006; Kim & Chung, 
2007). Kanaka and coworkers were unable 
to detect the KCC2 mRNA by in situ 
hybridization in the MHb, while they 
detected a very prominent expression in 
the lateral habenular nucleus (LHb). Their 
results were confirmed on the protein level 
by the group of Xu (Wang et al., 2006), 
who exploited IHC with the KCC2 
antibody from Upstate and revealed a 
strong KCC2-ir in the LHb, but not in the 
MHb. Interestingly, similar to the situation 
in the SCN, a very strong expression of 
GABAB receptors was detected in the 
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MHb. The GABAB receptors in MHb were 
functional, as detected by application of 
GABAB-specific agonist baclofen. 
Another similarity to the SCN was the 
absence of the GABA-producing enzyme 
GAD65 in MHb. Nevertheless, GABA 
was present in MHb at levels similar to 
LHb because of the other GAD isoform-
GAD67, which is known to be responsible 
for GABA synthesis in cell soma and 
dendrites (Wang et al., 2006). Absence of 
KCC2, very strong expression of GABAB 
receptors, and prominent GABA-ir in 
MHb were confirmed by another study 
(Kim & Chung, 2007). Kim and Chung 
reported dual GABAergic responses in 
MHb: GABAA receptors mediated fast 
excitation, while GABAB receptors 
generated a strong low-threshold slow 
inhibition (Kim & Chung, 2007). 
1.3.8.6 Mesencephalic trigeminal nucleus 
Rat trigeminal nervous system consists of 
two sensory components: the trigeminal 
ganglion (TG) and the mesencephalic 
trigeminal nucleus (Me5). TG and Me5 
contain cell bodies of primary sensory 
neurons, similar to the dorsal root ganglia 
(DRG) (Lazarov, 2002). While TG is 
located outside the brain, Me5 is situated 
in the brainstem and thus represents an 
exceptional case of primary sensory 
neurons positioned inside the brain. 
Importantly, Me5 originates from neural 
crest cells, similar to DRG (Hoover et al., 
2000; Lazarov, 2002), and thus it is not 
surprising that KCC2 mRNA was not 
detected in Me5 (Kanaka et al., 2001). A 
more detailed analysis of the KCC2 
mRNA in the trigeminal nervous system 
was performed by the group of Fukuda, 
and they confirmed the absence of KCC2 
expression in Me5 and TG (Toyoda et al., 
2005). 
1.3.8.7 Substantia nigra 
By using a C-terminal KCC2 antibody and 
a tyrosine hydroxylase (TH) antibody as a 
marker of the dopaminergic neurons, 
Gulacsi and coworkers revealed two 
nonoverlapping patterns in the substantia 
nigra (SN): none of the TH-positive 
dopaminergic dendrites or somata were 
outlined by KCC2-ir, while all KCC2-
positive neurons were TH-negative 
(Gulacsi et al., 2003). The authors 
demonstrated that the KCC2 protein was 
expressed in a subset of GABAergic 
neurons of substantia nigra pars reticulata 
(SNr), identified by parvalbumin staining. 
Interestingly, the dopaminergic neurons of 
the substantia nigra pars compacta (SNc), 
which is devoid of KCC2 immuno-
reactivity, were found to express a 
chloride channel ClC-2 (Gulacsi et al., 
2003). Gulacsi and coauthors suggested 
that  ClC-2  and  a  Na+-dependent anion 
exchanger (NDAE), by creating a driving 
force for Cl-, might maintain hyper-
polarizing GABA responses in the 
dopaminergic neurons of the SNc (Gulacsi 
et al., 2003). 
1.3.9 Neuronal subpopulations lacking 
KCC2 expression: conclusions 
A strong expression of vasopressin (VP) is 
observed in neuronal subpopulations 
lacking KCC2 in the dorsolateral part of 
the PVN, the dorsomedial part of the SCN, 
and the ventromedial part of the SON 
(Kanaka et al., 2001;Belenky et al., 2008). 
One possible explanation for this fact 
might be that VP somehow downregulates 
KCC2 gene activity: the strongest VP 
expression in adult rat brain is observed in 
the PVN, SCN, and SON (Hallbeck et al., 
1999) – exactly in the areas where KCC2 
is absent. Among other neuronal 
subpopulations expressing VP robustly 
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are: the anterodorsal part of the medial 
nucleus of the amygdala, the bed nucleus 
of the stria terminalis, and the nucleus of 
the diagonal band (Hallbeck et al., 1999). 
However, these areas are known to 
express KCC2 at high levels (Kanaka et 
al., 2001), thus, suggesting that VP 
downregulation of KCC2 expression is 
hardly probable. 
Another possibility is that the lack of 
KCC2 expression leads to certain 
intracellular conditions that favour the VP 
gene expression. Binding sites for several 
activity-dependent TFs have been 
identified in the VP promoter: AP1, CRE, 
and multiple E-boxes (Grace et al., 1999). 
Depolarizing GABA responses observed 
in the absence of KCC2 might lead to 
increased neuronal activity and as a 
consequence to the activation of c-FOS, 
CREB, and/or multiple basic helix-loop-
helix (e.g. upstream stimulatory factors 
USF1/2) factors. The upregulation of the 
VP promoter by these TFs has been 
demonstrated previously (Burbach, 2002). 
In agreement with this, a substantially 
increased expression of c-FOS was 
detected in genetically modified mice 
expressing only 5% of the wild type 
KCC2 level (Woo et al., 2002). 
Instead of a direct link between the 
KCC2 and VP expression, both genes 
could be regulated by a common TF that 
activates VP and inhibits KCC2 
expression in PVN, SCN, and SON. An 
expression pattern of such a candidate TF 
should be restricted to the KCC2-negative 
neuronal subpopulations. One possible 
candidate is Clock, which is strongly 
expressed not only in the SCN, PVN, and 
SON, but also in the MHb (Shieh, 2003). 
Clock is known to bind E-box sites in the 
VP promoter and to upregulate the VP 
gene expression (Jin et al., 1999). 
However,  it  is  still  remains  to  be  
determined whether Clock is able to 
directly downregulate the KCC2 gene 
expression. 
Three groups have also reported a 
strong expression of GABAB receptors in 
the KCC2-negative neuronal 
subpopulations in SCN and MHb (Wang 
et al., 2006; Kim & Chung, 2007; Belenky 
et al., 2008). In addition, high levels of the 
GABAB receptor expression were detected 
in adult rat brain in magnocellular 
neurosecretory cells of the PVN and SON 
(Richards et al., 2005). Nevertheless, it is 
difficult to make further conclusions about 
a possible link between KCC2 and 
GABAB expression. Functional GABAB 
receptors are heterodimers, which consist 
of GABAB1 (with two major isoforms 
GABAB1a and  GABAB1b) and GABAB2 
subunits (Ulrich & Bettler, 2007). Even 
though expression of the 
GABAB1a/GABAB1b/GABAB2 subunits has 
been carefully studied (Fritschy et al., 
1999; Martin et al., 2004; Fritschy et al., 
2004), these data do not allow one to 
conclude what parts of the adult brain 
possess functional GABAB signalling. 
Another problem is the heterogeneity of 
the GABAB responses: (1) modulation of 
synaptic vesicle priming mediated by 
adenylate cyclase (Sakaba & Neher, 
2003), (2) inhibition of Ca2+ channels 
(Mintz & Bean, 1993), and (3) activation 
of K+ channels (Luscher et al., 1997). This 
heterogeneity significantly complicates 
analysis of the possible influences of 
GABAB signalling on the KCC2 promoter 
activity. More experiments are required to 
reveal a possible link between GABAB 
signalling and KCC2 gene expression. 
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1.4 MECHANISMS OF NEURON-
SPECIFIC GENE EXPRESSION  
1.4.1 Neuron-specific genes  
What are the mechanisms mediating 
neuron-specificity of gene expression? 
First attempts to answer this question were 
undertaken about twenty years ago 
following characterization of several 
neuronal genes (Mandel and McKinnon, 
1993). In the next chapter, current models 
and hypotheses explaining mechanisms of 
neuron-specific gene expression will be 
reviewed.  
From the very beginning it is 
important to agree on the terminology; 
sometimes the available data does not 
clearly specify whether expression of a 
certain gene is indeed neuron-specific or 
just neural/brain-specific. Obviously, a 
neural pattern of gene expression does not 
necessarily imply neuron-specificity 
because of, for example, expression in 
glial cells. Similarly, the brain-specific 
expression pattern does not always imply 
that the gene of interest is expressed 
exclusively in neurons; and vice versa, 
many of neuronal genes may be expressed 
outside brain. Thus, to avoid uncertainties 
in terminology, this review will rather 
focus on genes that are known to be 
expressed predominantly in neurons and 
not in other cell types.  
Among first genes shown to be 
strongly suppressed in nonneural tissues 
were: neuron growth-associated protein 43 
(GAP-43) (Goslin et al., 1988), superior 
cervical ganglion-10 (SCG10) (Stein et al., 
1988; Mori et al., 1992), type II sodium 
channel (NaII) (Maue et al., 1990; Kraner 
et al., 1992), synapsin I (Ueda and 
Greengard, 1977; Kilimann and 
DeGennaro, 1985), peripherin (Thompson 
and Ziff, 1989), and dopamine ?-
hydroxylase (Ishiguro et al., 1993). 
Nowadays, using advantages of the 
microarray technology, expression of 
many other genes is known to be neuronal 
and strongly suppressed outside nervous 
system (Wu and Xie, 2006). 
1.4.2 NRSF-mediated silencing of 
neuronal genes in nonneuronal cells 
Soon after first neuronal genes had been 
characterized, the question arose concerning 
promoter elements mediating the neuron-
specificity. A classical approach to 
identify such elements is to clone the 
promoter region and to place a reporter 
gene under control of this region. The 
reporter activity of the neuronal promoter 
is supposed to be much weaker in 
nonneuronal compared to neuronal cells. If 
deletion of some promoter region results 
in a derepression of the reporter activity in 
nonneuronal but not in neuronal cells, then 
the deleted DNA fragment is the necessary 
repressor. Using this approach, several 
groups identified that deletion or mutation 
of a short ~20-25 bp promoter element 
often resulted in a strong activation of the 
reporter in nonneuronal cells (Kraner et 
al., 1992; Mori et al., 1992; Thompson et 
al., 1992; Ishiguro et al., 1993; Li et al., 
1993; Pathak et  al., 1994). This DNA 
element was named as neuron restrictive 
silencing element (NRSE)/repressor 
element-1 (RE1). 
To identify TFs binding NRSE/RE1 
DNA element, two groups independently 
screened HeLa cDNA library and cloned 
neuron-restrictive silencer factor 
(NRSF)/RE1-silencing transcription factor 
(REST) (Chong et al., 1995; Schoenherr 
and Anderson, 1995). Both groups 
revealed that NRSF/REST is expressed at 
high levels in nonneuronal but not in 
neuronal cells. The NRSF/REST protein is 
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related to the Krüppel-like TF family and 
contains one isolated (Chong et al., 1995) 
and 8 adjacent zinc fingers (Chong et al., 
1995; Schoenherr and Anderson, 1995). In 
vitro experiments confirmed that the 
exogenously over-expressed NRSF/REST 
is able to bind NRSE/RE1 and to decrease 
by ~10-fold the reporter activity of 
constructs carrying NRSE/RE1 sites 
(Chong et  al., 1995; Schoenherr and 
Anderson, 1995). 
To identify functional NRSEs in other 
genes, the group of David Anderson 
searched through GenBank DNA 
sequences available at that moment using 
a composite NRSE consensus derived 
from NRSE sequences of the SCG10, 
NaII, synapsin I, and BDNF genes 
(Schoenherr et al., 1996). This search 
resulted in a set of 25 genes containing 
putative NRSE sites with no more than 
two mismatches to the composite NRSE 
consensus. Functionality of these NRSEs 
was analyzed by electrophoretic mobility 
shift assay (EMSA) and reporter assays. 
Most of the revealed sites were located in 
neuronal genes, thus confirming the 
original idea that NRSE acts as a 
suppressor of neuronal genes in non-
neuronal cells. Interestingly, in addition to 
the neuronal genes, this search has for the 
first time revealed several nonneuronal 
genes containing NRSE sites: adenine 
phosphoribosyltransferase, keratin, bovine 
and human P450-11?, and skeletal actin 
(Schoenherr et al., 1996). The last case is 
especially interesting, since actin is known 
to be expressed in muscle cells in which 
NRSF is also expressed and in which it 
effectively represses the NaII gene. 
How does NRSF inhibit expression of 
neuronal genes outside nervous system? 
Two separate corepressor complexes were 
identified that bind NRSF to mediate gene 
silencing: CoREST (Andres et al., 1999) 
and Sin3A (Grimes et al., 2000). CoREST 
is recruited via the C-terminal part of 
NRSF and this interaction requires the 9th 
zinc finger of NRSF to be intact; a single 
point mutation in this zinc finger motif is 
able to abolish both CoREST-NRSF 
complex formation (Andres et al., 1999) 
and NRSF-mediated repression (Tapia-
Ramirez et al., 1997). In contrast to 
NRSF, CoREST is strongly expressed not 
only in nonneuronal but also in neuronal 
cells (Andres et al., 1999). CoREST 
recruits histone deacetylases 1 (HDAC1) 
(You et al., 2001) and 2 (HDAC2) (Ballas 
et al., 2001), which finally convert 
chromatin into a repressive state to silence 
gene expression. 
Second corepressor complex is formed 
via interaction of the N-terminal part of 
NRSF with Sin3A protein (Grimes et al., 
2000). Similar to the CoREST-NRSF 
complex, Sin3A-NRSF also recruits 
histone deacetylases, which are in their 
turn responsible for subsequent chromatin 
modification and gene silencing (Huang et 
al., 1999; Naruse et al., 1999; Roopra et 
al., 2000). During development, Sin3A 
and NRSF are expressed broadly 
throughout the embryo, while CoREST 
exhibits a much more restricted pattern 
(Grimes et  al., 2000). This suggests that 
the CoREST-NRSF and Sin3A-NRSF 
complexes might act independently.  
In addition to its ability to silence 
neuronal genes in nonneuronal cells via 
chromatin modifications, NRSF can also 
inhibit the RNA polymerase II transcript-
tional machinery directly by interacting 
with TATA-binding protein (TBP) (Murai 
et al., 2004) and with RNA polymerase II 
small CTD phosphatases (SCPs) (Yeo et 
al., 2005). The last case is especially 
interesting, because these SCPs are known 
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to be expressed preferentially outside 
nervous system.  
1.4.3 NRSF-mediated regulation of 
neuronal genes in neurons 
In contrast to the original reports which 
detected NRSF only outside nervous 
system, several groups later on detected 
NRSF expression also in neuronal cells 
(Thiel et al., 1994; Palm et al., 1998; 
Calderone et al., 2003; Zuccato et al., 
2003; Sun et al., 2005). In agreement with 
this, several reports demonstrated that, in 
addition to its silencing role in 
nonneuronal cells, NRSF can also repress 
activity of neuronal genes in neuronal cells 
(Bessis et al., 1997; Kallunki et al., 1998; 
Calderone et al., 2003; Wood et al., 2003; 
Zuccato et  al., 2003). Similarly, a 
retroviral-mediated expression of the 
dominant negative form of NRSF in chick 
embryos resulted in derepression of the 
SCG10, Ng-CAM, and ?4 tubulin genes in 
the infected neurons (Chen et al., 1998).  
Interestingly, several groups have 
also revealed that NRSF may act as an 
activator in neuronal cells (Bessis et  al., 
1997; Kallunki et al., 1998; Seth and 
Majzoub, 2001; Armisen et al., 2002). For 
instance, Armisen and coauthors observed 
a downregulation of neuronal genes in the 
Xenopus spinal cord neurons after 
injection of the morpholino-modified 
antisense oligonucleotides and after 
overexpression of a dominant negative 
form of NRSF (Armisen et al., 2002). 
Thus, the above data suggest that 
NRSF  may  act  not  only  as  a  silencer  of  
neuronal genes outside nervous system but 
also as a modulator (activator and 
repressor) of neuronal genes in neurons. 
1.4.4 Non-NRSF-mediated repression 
of neuronal genes in nonneuronal cells 
The original report published by the group 
of David Anderson (Schoenherr et al., 
1996) showed that two genes (dopamine 
?-hydroxylase (Ishiguro et  al., 1993) and 
Na/K-ATPase ?3-subunit (Pathak et al., 
1994)), which lack NRSE sequences, 
demonstrate largely a neuron-specific 
expression. Similar results have also been 
obtained for the genes encoding synapsin 
II (Chin et al., 1994; Chin et al., 1999), 
brain-specific angiogenesis inhibitor 1-
associated protein 4 (Kim et al., 2004), 
phytanoyl-CoA hydroxylase interacting 
protein (PAHX-AP1) (Kim et al., 2006), 
and dual-specificity tyrosine-(Y)-
phosphorylation regulated kinase 1A 
(DYRK1A) (Kim et al., 2006). These data 
suggested that repressors other than NRSF 
may downregulate expression of neuronal 
genes in nonneuronal cells.  
In agreement with this suggestion, 
several reports have demonstrated that 
deletion or mutation of functional NRSEs 
found in some neuronal genes does not 
activate expression of these genes in 
nonneuronal cells (Bessis et al., 1997; 
Timmusk et al., 1999). Although in one 
case NRSE deletion indeed resulted in the 
ectopic expression, this happened only in a 
minority of nonneuronal cells (Kallunki et 
al., 1997). Moreover, derepression of only 
one neuronal gene carrying NRSE element 
was observed in nonneuronal cells of the 
knockout mice lacking NRSF protein 
(Chen et al., 1998; Jones and Meech, 
1999). The aforementioned facts conform 
to the idea that NRSF may not necessarily 
be the primary determinant of the neuron-
specificity, and that other transcription 
factors may repress neuronal genes outside 
nervous system. 
One of the first candidates for such 
role was reported by the group of Edward 
Ziff (Thompson et al., 1992). Thompson 
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and coauthors identified a negative 
regulatory element (NRE) in the promoter 
of the peripherin gene; this element 
significantly repressed expression of the 
peripherin gene in undifferentiated and 
nonneuronal cells. The NRE-binding 
protein was affinity purified few years 
later and occurred to be a member of the 
CTF/NF-1 TF family (Adams et al., 
1995). Subsequent experiments suggested 
that this TF (NF1-L) is able to assemble a 
multiprotein complex repressing the 
peripherin gene expression in nonneuronal 
cells.   
Another interesting candidate is a 
repressor complex formed by the activator 
protein 4 (AP4) and the corepressor 
geminin (Gem). This complex has been 
shown to recruit histone deacetylase 3 
(HDAC3) and to silence expression of 
neuronal genes in nonneuronal cells (Kim 
et al., 2006). 
A new type of the repressive element 
has been identified in the gene encoding 
growth-associated protein-43 (GAP-43) 
(Weber and Skene, 1997). Mutation of this 
DNA element resulted in up to 10-fold 
upregulation of the GAP-43 promoter 
activity in nonneuronal cells, but had no 
effect either in cultured cortical neurons or 
in neuronal CAD cells. The same motif 
has also been identified in genes encoding 
synaptosomal-associated protein of 25 
kDa (SNAP-25) and neuronal nitric oxide 
synthase (NOS) that together with GAP-
43 predefined the name of the repressor 
motif - SNOG (Weber and Skene, 1997). 
It is important to note that SNAP-25 
promoter has previously been shown to 
behave in a highly neuron-specific manner 
(Ryabinin et al., 1995). 
A strong repressor region has also 
been found in the promoter of the gene 
encoding the 5-HT1A receptor (Ou et al., 
2000). A detailed analysis of that region 
revealed that it contains at least three 
different repressor motifs (Albert and 
Lemonde, 2004). One of these motifs 
occurred to be NRSE; it restricts the 5-
HT1A gene expression to neuronal cells. 
The second repressive motif, called FRE, 
was shown to be preoccupied by the 
corresponding repressor TF mostly in 
neuronal cells expressing 5-HT1A 
receptor. The FRE-binding TF was 
characterized by the same authors and was 
named FRE Under Dual repression 
binding protein-1 (Freud-1) (Ou et al., 
2003). Since Freud-1 interacts with FRE 
motif only in neuronal cells expressing 5-
HT1A, it rather plays a role of a modulator 
of the 5-HT1A gene expression in 
response to different neuronal stimuli (Ou 
et al., 2003). The third repressor motif, 
named TRE, is known to bind the TF 
Freud-2, a homologue of Freud-1, and to 
assemble a repressive complex in both 
neuronal and nonneuronal cells (Ou et al., 
2000; Hadjighassem et al., 2009). 
One more interesting mechanism was 
proposed by Ballas and coworkers to 
explain why neuronal genes maintain a 
CNS-specific pattern sometimes even after 
deletion or mutation of NRSE sites (Ballas 
et al., 2005). The authors revealed that the 
TF MeCP2 is able to bind methylated CG 
dinucleotides (mCpG) in promoters and to 
assemble a repressor complex containing 
Sin3, CoREST, and histone deacetylases 
(HDAC). Importantly, specific stimuli 
(e.g. membrane depolarization) can induce 
a rapid dissociation of MeCP2 from 
mCpGs that leads to the activation of 
neuronal promoters (Ballas et al., 2005). 
This mechanism may be responsible, 
particularly, for derepression of neuronal 
genes during differentiation of ES cells 
into neural progenitors. 
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It has also been noticed previously 
that promoters of several neuronal genes 
contain multiple GT dinucleotide repeats 
(Sakimura et al., 1987; Sudhof, 1990; 
Nedivi et al., 1992; Petersohn et al., 1995). 
Whether these GT repeats mediate 
repression of the neuronal genes outside 
CNS, is a matter for future studies. 
1.4.5 Mechanisms of neuron-specific 
gene expression: conclusions 
Neuron-specific gene expression implies a 
permanent inactivation of the gene activity 
in non-neuronal cells via multiple chroma-
tin modifications. These modifications 
include DNA methylation as well as 
histone acetylation, methylation, phos-
phorylation, and ubiquitination (Li et al., 
2007). Among enzymes known to be 
important for establishing the chromatin 
code are: DNA methyltransferases, histone 
acetyltransferases and deacetylases, histone 
methyltransferases and demethylases, 
ubiquitilases, kinases and phosphatases 
(Kouzarides, 2007). Many of these 
enzymes constitute a part of different 
repressive complexes. For example, NRSF 
is able to assemble a complex containing 
deacetylases (e.g. HDAC1, HDAC2, 
HDAC4, and HDAC5), demethylases (e.g. 
LSD1), and methylases (e.g. G9a) (Ooi 
and Wood, 2007). 
Thus, the repressive TFs reviewed in 
sections 1.4.2-1.4.4 are required to recruit 
the chromatin-modifying complex that in 
their turn silence promoters of neuron-
specific genes in nonneuronal cells. A 
binding site for one such TF (NRSF) has 
been found in the promoter of the Slc12a5 
gene (Karadsheh and Delpire, 2001). A 
possible role of this NRSE element in 
mediating neuron-specific expression of 
the Slc12a5 gene has been studied in paper 
III of the thesis and will be discussed in 
the subsequent chapters.  
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2 AIMS OF THIS STUDY 
 
The major aim of this thesis was to study transcriptional mechanisms mediating the 
KCC2 gene expression in vivo and in vitro. 
 
 
The specific aims were: 
 
 
1. To identify the gene regulatory regions mediating the KCC2 gene transcription. 
 
 
2. To clone and characterize a novel KCC2 isoform. 
 
 
3. To compare the expression of the two KCC2 isoforms. 
 
 
4. To study transcriptional mechanisms underlying the neuronal specificity and 
developmental upregulation of KCC2. 
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3 MATERIALS AND 
METHODS 
3.1 MATERIALS 
3.1.1 Chemicals 
Company names, catalogue numbers, and 
other information concerning chemicals 
exploited in the thesis can be found in the 
original papers (I-VI). Recipes of the 
solutions are described in the “Materials 
and Methods” of the corresponding 
papers. 
3.1.2 Oligonucleotides 
Sequences of oligonucleotides used for 
cloning of expression and reporter 
constructs as well as of in situ and RPA 
probes, quantitative and semiquantitative 
PCRs, mutagenesis, electrophoretic 
mobility shift assay (EMSA), and gel shift 
assay are described in the original papers 
(I-VI). Oligonucleotides were designed 
either with the “Oligo Design and Analysis 
Tools” software (Integrated DNA 
Technologies, idtdna.com) or manually 
with Gene Runner 3.05 (Hastings 
Software, Inc.). Always when possible, 
forward and reverse primers were chosen 
to be located in different exons to control 
the amplification of genomic DNA (except 
for primers used for genotyping) and their 
annealing temperatures were adjusted to 
~60 °C. When restriction sites were 
included into primer sequences, some 
extra nucleotides were usually added to 5’-
ends of the primers to increase efficiency 
of restriction reactions. PAGE purification 
was routinely performed for oligonucleo-
tides utilized in mutagenesis, EMSA, and 
gel shift. Most of the oligonucleotides 
described in the thesis were synthesized by 
either Proligo (Sigma-Proligo) or Oligomer 
OY (Helsinki, Finland). 
3.1.3 Antibodies 
A list of primary antibodies exploited in 
this study is presented in Table 2. Three 
different anti-KCC2 antibodies were used 
that recognize KCC2 isoforms either 
individually (KCC2a and KCC2b 
antibodies) or together (KCC2pan 
antibody). KCC2a antibody was produced 
by Innovagen AB (Lund, Sweden) and 
first characterized by our group (paper I of 
this thesis). Characterization of the 
KCC2b antibody was reported in 2001 by 
Hübner and coauthors (Hubner et al., 
2001) long before the second isoform of 
KCC2 was discovered. Several groups 
used this antibody to study KCC2 
expression not even suspecting, probably, 
that in reality it can detect only one of the 
two existing KCC2 isoforms (Hubner et 
al., 2001; Stein et al., 2004; Chudotvorova 
et al., 2005; Blaesse et al., 2006). 
3.1.4 Probes for in situ hybridization 
and RPA 
Sequences of in situ hybridization probes 
to detect KCC2b isoform (I), both KCC2 
isoforms (III), or luciferase (III) are 
described in the original papers. Lengths 
of the probes varied from ~100 bp up to 
~600 bp. Similarly, sequences of RPA 
probes used to detect KCC2a and KCC2b 
isoforms simultaneously (I) or KCC2b 
isoform only (III) are presented in the 
corresponding papers. 
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Table 2. List of primary antibodies used in the thesis 
 
Abbreviations: WB-Western blotting; ICC-immunocytochemistry; IHC-
immunohistochemistry; CoIP-co-immunoprecipitation; ChIP-chromatin immuno-
precipitation; (p)-polyclonal, (m)-monoclonal. 
3.1.5 Expression and luciferase 
reporter constructs 
Numerous expression and reporter 
constructs were used in the thesis. In most 
of these cases, CMV promoter was chosen 
to drive expression of cDNAs of interest. 
More detailed information about the 
expression vectors can be found in the 
original papers. To produce multiple 
reporter constructs, pGL3-Basic promoter-
less vector, which contains a beetle 
luciferase (Firefly), was selected as a 
backbone. To normalize the Firefly 
luciferase measurements, pRL-TK vector 
was utilized, which contains a sea pansy 
(Renilla) luciferase. Both vectors were 
purchased from Promega. 
3.1.6 siRNA 
Two siRNA duplexes targeting Egr4 
mRNA expression (catalog #16708A: ID 
#200866 and #200867) and one negative 
control siRNA duplex (catalog #4611) 
were ordered from Ambion (Austin, TX). 
3.2 METHODS 
3.2.1 Bioinformatics 
3.2.1.1 Primary sequence analysis 
Basic sequence processing including 
primer design, analysis of cloning 
schemes, analysis of sequencing data, 
prediction of molecular weights and of 
open reading frames for protein products – 
all this was performed using the Gene 
Runner software 3.05 (Hastings Software, 
Inc.). 
3.2.1.2 DNA and protein sequences 
Genomic, mRNA, and protein sequences 
for all genes mentioned in the thesis were 
obtained from Ensembl (ensembl.org) or 
from NCBI (ncbi.nlm.hih.gov) web sites. 
The same resources were used for 
searching and analyzing of EST clones. 
 Host Source Method Used in 
Egr4 rabbit (p) (Zipfel et al., 1997) WB, gel shift IV, V 
GAPDH mouse (m) MAB374 Chemicon WB II 
GFAP mouse (m) Chemicon-Millipore ICC II 
GFP rabbit (p) Invitrogen WB II 
KCC2a rabbit (p) (paper I) WB, IHC, ICC, CoIP II 
KCC2b rabbit (p) (Hubner et al., 2001) WB, IHC II 
KCC2pan rabbit (p) (Ludwig et al., 2003) WB, IHC, ICC I, II , IV, VI 
Luciferase rabbit (p) Cortex Biochem IHC III 
Myc-tag mouse (m) Sigma; 9E10 WB, CoIP II 
SPAK rabbit (p) (Ushiro et al., 1998) WB II 
TUJ-1 rabbit (p) Covance Research 
Products 
ICC II 
USF1 rabbit (p) Santa Cruz; sc-229x ChIP, gel shift V 
USF2 rabbit (p) Santa Cruz; sc-862x WB, ChIP, gel shift V 
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3.2.1.3 Designing of oligonucleotides 
PCR primers were routinely designed 
using the “Oligo Design and Analysis 
Tools” software (Integrated DNA 
Technologies, idtdna.com). This resource 
allows PCR primers with specified 
parameters and locations to be designed. It 
also enables to calculate accurately 
annealing temperatures and to perform 
analysis of putative hairpin structures as 
well as of homo- and heterodimers. 
IDTDNA resource takes into account the 
intron-exon structure of the gene and 
attempts to design primers in different 
exons. In some cases (e.g. mutagenesis of 
TF-binding sites and EMSA), PCR 
primers were designed manually using 
Gene Runner 3.05 (Hastings Software, 
Inc.). 
3.2.1.4 Promoter prediction 
Promoter regions were predicted with the 
PromoterInspector software. This program 
is part of the commercial package of 
bioinformatics tools developed by 
Genomatix (genomatix.de) and is able to 
predict eukaryotic polymerase II 
promoters with a high specificity (Scherf 
et al., 2000). Other programmes (including 
non-commercial) that predict promoter 
regions can be found at 
(linux1.softberry.com/berry.phtml). 
3.2.1.5 CpG islands prediction 
CpG islands are genomic regions that are 
enriched in CG dinucleotides, and are 
frequently associated with promoters of 
actively transcribed genes (Larsen et al., 
1992). Presence of multiple CG 
dinucleotides indicates that these regions 
are usually not methylated in the genome. 
CpG islands were identified using 
CpGPlot program (ebi.ac.uk/Tools/ 
emboss/cpgplot) with standard parameters: 
Window (100), Step (1), Observed 
/Expected (0.6), Minimum Percentage GC 
(50), and Length (200). 
3.2.1.6 TF binding sites analysis 
Analysis of TF-binding sites was 
performed using the MatInspector 
software tool (Cartharius et al., 2005) that 
is part of the Genomatix platform. Some 
information on the TF binding sites was 
obtained via the TRANSFAC 7.0 software 
(gene-regulation.com). 
3.2.1.7 Statistics 
Statistical analysis was performed using 
GraphPad Prism 4.01 (VI), SSPS 15.0 (I), 
and Excel (III, IV, V). Student’s t-test was 
normally used for comparison of two 
means. 
3.2.2 Model systems 
3.2.2.1 Cell cultures 
Several immortalized cell lines were used 
in the study: Neuro2a (N2a) mouse 
neuroblastoma (ATCC CCL-131), C6 rat 
glioma (ATCC CCL-107), NIH3T3 mouse 
fibroblasts (ATCC CRL-1658), and 
HEK293 human embryonic kidney cells 
(ATCC CRL-1573). Of note, a recent 
study by Shaw and coauthors revealed that 
HEK293 cells express  mRNA and protein 
of several neurofilaments (NF-M, NF-L, 
?-internexin), which are normally found 
only in neuronal cells (Shaw et al., 2002). 
In contrast, the cells don’t express filament 
proteins usually found in nonneuronal 
lines (GFAP, desmin, and the higher 
molecular weight keratins) (Shaw et al., 
2002). The authors concluded that HEK293 
cells might not be typical kidney cells; 
moreover, they suggested that these cells 
cannot be used as a nonneuronal control 
cell line. 
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Standard dissociated primary cultures 
of rat cortical neurons (I, IV, V) and 
mouse hippocampal neurons (II, IV, VI) 
were used in the thesis. Mouse cultures 
were prepared from E17 mice as 
previously described (Banker and Goslin, 
1998) with minor modifications indicated 
in the original papers. Density of the 
mouse hippocampal cultures varied from 
2000-5000 cells per cm2 in  the  paper  IV  
up to 50 000 cells per cm2 in the papers II 
and VI. The difference in the density is 
mainly explained by the fact that two 
different techniques for cell culturing were 
used: a sandwich culture technique (paper 
IV) and normal neuronal/glia co-cultures 
(papers II and V). The sandwich technique 
allows maintaining of a relatively low 
density neuronal cultures that makes it 
easier to analyze them by IHC. The major 
drawback of the sandwich technique is its 
relative laboriousness.  
Rat cultures were prepared from E18 
rats and obtained from Neuronal Cell 
Culture Unit (Core Facility at the 
Neuroscience Centre, University of 
Helsinki). Rat neuronal cultures were used 
mainly for biochemical assays requiring a 
sufficient amount of material for reliable 
analysis (Western blot, RT-PCR, 
luciferase assay). Density of the rat 
cortical neuronal cultures was kept 
~200 000 cells per cm2 (papers I, IV, V). 
Solutions and conditions used for 
cultivating of the immortalized lines and 
of the primary neurons are described in the 
original papers. 
3.2.2.2 Transgenic mice 
All animal experiments were approved by 
the Animal Research Ethics Committee of 
the University of Helsinki. Target 
constructs were prepared by cutting vector 
backbone sequences off the corresponding 
luciferase reporter constructs, separating 
them in agarose gel, and subsequently 
purifying the restriction products with a 
gel extraction kit. Injection of the prepared 
DNA target constructs into fertilized 
FVB/N mouse oocytes and subsequent 
implantation of the oocytes into recipient 
pseudopregnant mice was performed by 
personnel of the Transgenic Unit (Core 
Facility at the Neuroscience Centre, 
University of Helsinki). For each 
construct, in average two to three hundred 
oocytes were injected, and about 150 pups 
were genotyped to reveal presence of the 
luciferase cDNA. Totally 5 KCC2(6.8)luc, 
6 KCC2(6.8mut)luc, and 19 KCC2(1.4)luc 
founder lines were obtained. Out of these 
lines, three KCC2(6.8)luc, four 
KCC2(6.8mut)luc, and three KCC2(1.4)luc 
independent lines were chosen for the 
permanent breeding. Genotyping of the 
obtained offspring was performed by PCR 
with primers specific to the firefly 
luciferase cDNA sequence (5’-TGG AAC 
CGC TGG AGA GCA AC-3’ and 5’-ACG 
CAG GCA GTT CTA TGA GGC-3’). 
3.2.3 Basic techniques 
Among basic techniques used in the thesis 
were: restriction, rapid amplification of 
cDNA ends (5’RACE), agarose gel 
electrophoresis, transformation, transfec-
tion, sequencing, and genomic DNA 
isolation. Most of the methods are well 
described in the “Molecular cloning: a 
laboratory manual” by Sambrook and 
Russel (Sambrook and Russell, 2001). 
Restriction enzymes were purchased from 
Fermentas, Promega, and New England 
Biolabs. Immortalized cell lines were 
transfected using either Fugene 6 (Roche) 
or jetPEI (Polyplus Transfection) transfec-
tion reagents. Primary neuronal cultures 
were always transfected with 
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Lipofectamine 2000 (Invitrogen). All 
constructs were sequenced by the DNA 
Sequencing Service (Core facility at the 
Institute of Biotechnology, University of 
Helsinki). Isolation of genomic DNA was 
performed according to a previously 
described protocol (Laird et al., 1991). 
3.2.4 Expression analysis 
Analysis of gene activity was performed 
on DNA, RNA, and protein levels. 
Methods utilized in the thesis for each of 
the levels are listed below. 
3.2.4.1 DNA 
Methylation status of the SLC12A5-1b 
promoter was analyzed by two different 
methods: bisulphite sequencing and 
methyl-sensitive PCR (MS-PCR). Both 
methods include bisulphite treatment of 
genomic DNA as a first step, but differ in 
the subsequent detection of the methylated 
CpG dinucleotides (sequencing versus 
PCR). 
Electrophoretic mobility shift assay 
(EMSA) allows checking in vitro whether 
some part of a promoter region indeed 
binds certain TFs. In the thesis, EMSA 
was used to confirm binding of Egr4 to 
Egr4KCC2 (IV) and upstream stimulatory 
factors USF1/2 to E-boxKCC2 (V). Gel shift 
is  a  modification  of  EMSA  when  a  
specific antibody against a TF of interest is 
added. Interaction of the antibody with TF 
increases a total molecular weight of the 
complex and results in its decreased 
mobility. EMSA and gel shift assays were 
performed according to the “Molecular 
cloning: a laboratory manual” by 
Sambrook and Russel (Sambrook and 
Russell, 2001). 
Chromatin immunoprecipitation 
(ChIP) assesses whether a TF binding site 
is occupied by a corresponding TF. ChIP 
was performed in the thesis to probe 
whether USF1/2 TFs bind E-boxKCC2 in 
cultured rat cortical neurons (V). The 
procedure was performed using ChIP 
assay kit (Upstate Biotechnology) 
according to the manufacturer’s 
recommendations. More detailed informa-
tion on the conditions and solutions used 
can be found in the original paper (V). 
Luciferase assay is a powerful 
method to study promoters in several 
ways. First, it can be used to test whether 
some part of genomic DNA possesses 
promoter activity. This is especially 
important when a new promoter region is 
predicted by bioinformatics and requires 
an experimental confirmation (I, III). 
Luciferase assay can also be used to study 
how individual TF binding sites affect 
transcriptional activity of a certain 
promoter region (III, IV, V, and VI). In 
this case the luciferase reporter constructs 
bearing either intact or mutated TF sites 
are transfected into cells and their 
luciferase activity is analyzed. This 
method is considered to be more adequate 
when studying the role of a particular TF 
compared to a simple overexpression of 
that factor. TF overexpression affects 
simultaneously expression of many other 
genes which in their turn could affect 
promoter activity of the gene of interest. 
Firefly luciferase was used as the major 
reporter in all promoter constructs in the 
thesis. Dual-luciferase reporter system was 
used (Promega) to minimize experimental 
variability caused by differences in cell 
viability, transfection efficiency, lysate 
preparation, and pipetting. Dual reporter 
system implies that a second luciferase 
(Renilla) is cotransfected with the first 
“experimental” reporter (Firefly) for 
normalization. Since Firefly and Renilla 
luciferases use different substrates, this 
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allows their activities to be measured one 
by one from the same lysate. Detailed 
information on the reporter constructs used 
in the thesis can be found in the 
corresponding original papers. 
3.2.4.2 RNA 
RNA was isolated using RNeasy Micro 
(Qiagen) (I, VI), RNeasy Mini (Qiagen) 
(VI), NucleoSpin RNA II (Macherey-
Nagel, Düren, Germany) (I), TRIzol 
reagent (Invitrogen) (III), and RNAwiz kit 
(Ambion) (I, III) according to 
manufacturer’s recommendations. The 
isolated RNA was always treated with 
DNAse I to exclude the possibility of 
genomic DNA interference with 
subsequent RNA-based expression 
analyses. 
Routinely up to 1 µg of total RNA 
was reverse transcribed in a standard 
volume of 20 µl using Moloney murine 
leukemia virus (M-MLV) reverse 
transcriptase (Promega) (III), Superscript 
II Reverse Transcriptase (Invitrogen) (VI), 
or Superscript III Reverse Transcriptase 
(Invitrogen) (I, VI). Except for a one 
special case in the paper I (see below), 
total RNA was reverse transcribed at 37 ºC 
using random primers (I, III, IV, VI). 
Usage of random primers allows 
expression of multiple target genes to be 
analyzed simultaneously and to be 
normalized to expression of certain 
housekeeping genes. One of the possible 
pitfalls of the method is the possibility that 
some RNA secondary structures may not 
be disrupted completely at 37 ºC, thus 
preventing an efficient reverse transcript-
tion reaction. Such a situation was 
described for exon-1b of the SLC12A5 
gene (I), where exon-1b tends to form 
strong hairpin structures (Fig. S1 in I). 
Usage of Superscript III Reverse 
Transcriptase, via its increased stability, 
allows overcoming this problem by 
conducting the reverse transcription at 
higher temperatures (50-55 ºC). Following 
the reverse transcription reaction, RNA 
template was always eliminated by RNAse 
H treatment. 
One of the key methods used to 
quantify gene expression was real-time 
PCR. ABI Prism 7000 (Applied 
Biosystems) (I, III, IV) and CFX96 (Bio-
Rad) (VI) platforms were used. In both 
cases the SYBR Green based reagents 
were exploited. cDNA samples obtained 
after reverse transcription were diluted 
1/100 to 1/10 and amplified in triplicate 
using the DyNAmo Flash SYBR Green kit 
(Finnzymes)  (I),  the  SYBR  Green  PCR  
Master Mix kit (Applied Biosystems) (III, 
IV), or the iQ SYBR Green Supermix kit 
(Bio-Rad Laboratories) (VI). Importantly, 
one  of  the  pitfalls  of  the  SYBR  Green  
based quantification is that this dye may 
incorporate into any double stranded DNA 
present in a reaction. Thus, primer dimers 
and unspecific amplification may 
substantially distort the real-time PCR 
results. To ensure that no other products 
were amplified in the real-time PCR 
reactions, a standard melting curve 
analysis was performed after every run. 
Ribonuclease protection assay was 
done using RPA kit (Ambion) (I, III) as 
described previously (Timmusk et al., 
1993). Compared to the real-time PCR 
quantification, RNAse protection assay is 
a more direct and more accurate method. 
This  method  is  especially  useful  for  a  
relative quantification of different splice 
isoforms  of  a  gene  (I),  as  it  allows  a  
simultaneous detection of the signals 
corresponding to the different isoforms on 
the same gel. Since RPA probes are 
usually labelled along their whole length, 
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it is important to take into account sizes of 
the protected fragments corresponding to 
the different splice isoforms. More 
detailed information on the design of RPA 
probes can be found in the original papers 
(I, III). 
In situ hybridization was used in the 
original paper I to study KCC2b 
expression pattern as well as in the paper 
III to assess luciferase and KCC2total 
mRNA distributions. In both cases sagittal 
sections of fresh-frozen mouse brains were 
processed as described previously (Lauren 
et al., 2003). The sections were briefly 
postfixed in 4% PFA and rinsed in PBS 
and water. Then, the sections were 
subsequently treated with HCl for 10 min; 
addition of HCl increases detection 
sensitivity in PFA fixed samples, possibly 
due to its ability to denature ribosomes, 
thus exposing additional target mRNAs to 
the probe (Ambion’s Technical Bulletin 
#507). After that, the sections were 
acetylated with acetic anhydride in 
ethanolamine to minimize background 
staining, dehydrated with ethanol, and air-
dried. The sections were hybridized 
overnight at 52°C with 35S-labelled 
hybridization probe. Length of the probes 
varied from ~100 up to ~600 bp (I, III). 
3.2.4.3 Protein 
Several methods were used in the thesis to 
analyze gene activity on the protein level: 
Western blot, IHC, and ICC. Western blot 
was used to assess protein expression 
quantitatively  (II,  IV,  VI)  as  well  as  
qualitatively (II, V). Two other methods 
were mainly exploited for analysis of 
protein distribution in brain sections (IHC) 
or in cultured neurons (ICC). 
Briefly, Western blot technique 
included a preparation of protein lysates 
and their subsequent separation on Tris-
HCl  (IV,  V)  or  Criterion  XT precast  Bis-
Tris (Bio-Rad) (II) polyacrylamide gels. 
The separated proteins were transferred 
onto Hybond-ECL nitrocellulose 
membranes (Amersham), which were 
subsequently hybridized with different 
antibodies (Table 2). Blots were developed 
with Amersham ECL Plus reagent 
(Amersham Biosciences) (I, IV, V, and 
VI) or with Pierce ECL Western blotting 
substrate (Pierce Biotechnology) (II) and 
visualized with Luminescent image 
analyzer LAS-3000 (Fujifilm). All 
measurements were kept in the linear 
range of the sensitivity of the LAS-3000 
CCD camera. The detected signals were 
quantified with Advanced Image Data 
Analysis (AIDA) software (Raytest). 
Several precautions were taken into 
account during the Western blot analysis 
of KCC2 expression. First, it was noticed 
that standard heating (5 min at 95 ºC) of 
samples before gel loading leads to a 
strong aggregation of KCC2 protein, thus 
resulting in appearance of SDS-resistant 
complexes that correspond to KCC2 
dimers and other higher molecular weight 
KCC2 complexes. Similar SDS-resistant 
aggregates as well as recommendations 
how to avoid their formation were 
described previously (Sagne et al., 1996). 
Thus, the heating step was avoided always 
when possible. Second, it was noticed that 
usage of ?-mercaptoethanol at high 
concentration (up to 10%) in the loading 
buffer  as  well  as  of  Bis-Tris  
polyacrylamide gels significantly 
decreased formation of the aggregates. 
One possible explanation is that both these 
precautions diminish amount of disulphide 
bonds formed between individual KCC2 
protein molecules. Addition of ?-
mercaptoethanol, probably, disrupts 
already pre-existing disulphide bonds 
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formed during lysate preparation. Bis-Tris 
system, on the other hand, has much lower 
pH (pH 7.2 compared to pH 9.5 for the 
normal Tris-HCl sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-
PAGE) system) and thus decreases 
formation of the SDS-resistant aggregates 
during gel running by preventing other 
protein modifications such as deamination, 
alkylation, and oxidation (Sagne et al., 
1996). Of note, Western blot is a very 
versatile tool and is used in the thesis not 
only for analyzing protein expression but 
also as a part of the co-immunoprecipitation 
procedure (CoIP) to probe protein-protein 
interactions (II), to analyze KCC2 
oligomerization (II), to characterize 
expression constructs (I) and antibodies 
(II). In addition, immunoblotting was used 
to analyze fast phosphorylation-mediated 
signalling (VI). 
IHC and ICC methods, similar to 
Western blot, allow analysis of gene 
expression on the protein level (II, III, IV, 
and VI). Antibodies exploited for the 
immunostainings are presented in Table 2. 
Of note, KCC2a antibody produced a 
strong background in PFA-fixed brain 
sections and in PFA-fixed neuronal 
cultures, thus cold methanol was used as a 
fixative in all staining with this antibody. 
Two different protocols for immuno-
staining of either 40-µm thick free-floating 
cryosections (III) or 16-µm thick 
cryosections collected on slides (II, III) are 
described in detail in the original papers. 
Cryosections and cell cultures obtained 
from KO mice served as a negative 
control. In some cases, omitting of the 
primary antibody was the only choice to 
control specificity of the IHC and ICC 
procedures. 
In  some  of  the  experiments  a  
modification of the IHC and ICC methods 
was used that allows simultaneous 
detection of two different proteins in the 
same section or cell (II). Two variants are 
possible: double immunostaining using 
two primary antibodies either from 
different or from the same species. The 
double immunostaining with two primary 
antibodies from different species is very 
similar  to  the  normal  IHC  or  ICC  
procedures; the only difference is that two 
primary antibodies are added simulta-
neously instead of one. The second case is 
more interesting. Initially, a full IHC 
procedure with 1st primary antibody only 
is performed. During this first staining the 
1st primary antibody is strongly diluted 
and the intensity of the signal is then 
compensated by using the tyramine signal 
amplification (TSA) kit (PerkinElmer Life 
Sciences). Next, before 2nd primary 
antibody is being applied, brain sections 
are heated up to the boiling point in PBS 
for 10 min. This heating step denatures the 
1st primary antibody, but presumably does 
not affect much the staining produced by 
the  1st secondary antibody. Then, the 
sections are stained with the 2nd primary 
antibody according to a normal IHC 
procedure. The possibility of cross-
reactivity is strongly diminished by the 
rather high dilution of the 1st primary 
antibody and by the heating step. More 
details concerning the double immuno-
staining procedures can be found in the 
original paper II. 
3.2.5 Functional analysis 
Rubidium has for a long time been used as 
a potassium congener (Kupriyanov & 
Gruwel, 2005). Both demonstrate similar 
sizes for their hydrated ions (Impey et al., 
1983; Fulton et al., 1996) that predeter-
mines their biochemical similarity in terms 
of the cationic transport. In the thesis, the 
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functional 86Rb+ uptake assay was 
exploited to characterize transport 
properties of the KCC2a and KCC2b 
proteins (I). Flux experiments were 
performed in HEK293 cells transfected 
with corresponding expression constructs. 
Two days after the transfection, the cells 
were exposed to the 86Rb+-containing flux 
solution for 3 min; such a short time 
interval was used to ensure that 
measurements were made during a linear 
phase. Fluxes were terminated by several 
washes with an ice-cold solution 
containing 2 mM furosemide, a known 
inhibitor of the KCC cotransporters. More 
specific information about the 86Rb+ 
uptake assay can be found in the original 
paper I. 
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4 RESULTS AND 
DISCUSSION 
4.1 PROMOTER REGIONS OF 
THE MOUSE KCC2 GENE 
4.1.1 Location and structure of the 
SLC12A5 gene 
Identification of regulatory regions for the 
mouse SLC12A5 gene was initially 
hampered by lack of corresponding 
genomic sequences. A genomic fragment 
(~10.3 kb) of the mouse SLC12A5 gene, 
containing exons 1 to 6 and a ~1.5-kb 
region upstream of exon-1, was isolated 
(Haapa et al., 1999) based on rat KCC2 
cDNA (Payne et al., 1996). Alignment of 
the rat and mouse (Ehringer et al., 2001) 
KCC2 cDNA sequences with the 
aforementioned genomic fragment 
allowed to delineate exon-1 boundaries 
and to define a preliminary promoter 
region for the SLC12A5 gene. 
The situation was radically improved 
after the release of the mouse (Waterston 
et al., 2002) and human (Lander et al., 
2001; Venter et al., 2001) genome 
sequences. According to the data, the 
SLC12A5 gene is located on chromosome 
2 in the mouse and on chromosome 20 in 
the human genome. In both cases the 
SLC12A5 gene lies between genes 
encoding for the matrix metalloproteinase 9 
(MMP9) and the nuclear receptor 
coactivator 5 (NCOA5), which are ~45 kb 
apart from each other (Fig. 8). The 
SLC12A5 gene was originally found to 
spread out over ~31 kb; intergenic regions 
between the MMP9 and SLC12A5 as well 
as between the SLC12A5 and NCOA5 
genes were about 13 kb and 1 kb, 
respectively (Fig. 8). 
Human SLC12A5 gene was initially 
reported to encompass 24 exons (Song et 
al., 2002). Nowadays 26 exons are 
predicted for the mouse and human 
SLC12A5 genes (Ensembl Genome 
Browser, Release 56): exons 21 and 22 in 
the initially predicted 24-exon structure 
are now known to consist each of two 
exons, thus resulting in the 26-exon 
structure. 
Interestingly, 27 exons are currently 
predicted by Ensembl for the rat SLC12A5 
gene: mouse exon 21 (108 bp) is split into 
two 54-bp exons (21st and 22nd in the rat 
gene). Rat exon-22 shares substantial 
homology to the second half of mouse 
exon-21 (bp 55-108). Surprisingly, rat 
exon-21 reveals no homology at all to the 
first part of mouse exon-21 (bp 1-54). On 
Figure 8. Genomic organization of the mouse SLC12A5 gene. Mouse SLC12A5 gene, 
encoding KCC2, is located on chromosome 2 between genes encoding for the matrix 
metalloproteinase 9 (MMP9) and the nuclear receptor coactivator 5 (NCOA5). The gene 
structure with 26 exons is shown as it had been known before identification of exon-1a. 
Arrowheads indicate the direction of gene transcription. 
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the contrary, it demonstrates a high degree 
of similarity (~90%) to a fragment of 
mouse intron-20. Thus, the current exon-
intron structure of the rat SLC12A5 gene 
presented by Ensembl might require 
additional correction. 
4.1.2 Bioinformatic prediction of the 
SLC12A5 promoter regions 
The 45-kb mouse genomic fragment 
outlined by the MMP9 and NCOA5 genes 
and bearing the SLC12A5 gene was used 
for a subsequent bioinformatic analysis. 
Since promoter regions are often 
associated with CpG islands (CGIs) 
(Antequera, 2003), the SLC12A5 genomic 
locus was analyzed with the CpGPlot tool 
(Larsen et al.,  1992).  Five  CGIs  were  
identified  (Fig.  1A  in  I):  CGIs  II-IV  –  
nearby the previously characterized exon-
1 of the SLC12A5 gene (Haapa et al., 
1999; Song et al., 2002), CGI I ~7 kb 
upstream of exon-1, and CGI V – inside of 
exon 26. 
The CGI I sequence was further used 
as a query to search a database of 
expression sequence tags (ESTs). Two 
EST clones (DA102113 and DA328785) 
were found that contained a part of the 
CGI I sequence spliced directly to exon-2 
of the SLC12A5 gene. This suggested the 
existence of a novel KCC2 transcript 
bearing a new first exon (Fig. 1A in I). 
This novel putative KCC2 transcript was 
designated as KCC2a to distinguish it 
from the previously characterized KCC2 
isoform (Payne et al., 1996; Ehringer et 
al., 2001; Song et al., 2002) which was re-
designated as KCC2b. The alternative first 
exons of the KCC2a and KCC2b isoforms 
were re-named as exon-1a and exon-1b. 
Furthermore, the putative promoter 
regions upstream of exon-1a and exon-1b 
were designated as SLC12A5-1a and 
SLC12A5-1b, respectively. 
The significance of CGI V is unclear 
given its location in the 3’UTR part of the 
SLC12A5 gene (inside of exon-26). 
Recently, Akan and coauthors confirmed 
existence of the CpG island in the 3’UTR 
part of the SLC12A5 gene (Akan et al., 
2009). They also predicted a new 
promoter and transcription start site (TSS) 
associated with this CpG island. 
Moreover, the authors reported a moderate 
H3K4me3 and a strong H3K4me2 
enrichment on the spot carrying the 3? 
UTR  in  NT2/D1  cells,  thus  suggesting  a  
potentially transcribed region. Akan et al. 
proposed that this novel putative promoter 
might be needed for driving antisense 
RNA transcription to prevent the 
SLC12A5 gene expression in nonneuronal 
cells (Akan et al., 2009). 
4.1.3 Experimental confirmation of 
the SLC12A5 promoter regions 
4.1.3.1 SLC12A5-1a promoter 
To identify possible transcription start 
sites for the KCC2a isoform (TSS-1a), the 
5’-rapid amplification of cDNA ends (5’-
RACE) was performed using E15 mouse 
Marathon-ready cDNA. This yielded a 59 
bp 5’UTR sequence followed by 121 bp of 
exon-1a, which encodes for the first 40 
amino acids of the KCC2a isoform (Fig. 
2A, in I). Similar results were obtained by 
using adult mouse brain RNA and 
GeneRacer 5’-RACE kit (Invitrogen). 
Analysis of EST databases revealed a 
single clone (DA102113) possessing the 
5’UTR sequence longer than the sequence 
obtained by the 5’-RACE (~20 bp longer). 
Interestingly, three mouse EST clones 
(CJ103382 [pooled tissue 7 cDNA 
library], CJ103009 [E15 mouse brain], and 
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CJ098915 [E15 mouse brain]) contained 
an additional 86-bp exon between exons 
1a and 2. Bioinformatics predicted that 
inserting of this exon would produce a 
frame shift and abrupt the KCC2a protein 
peptide at the premature stop codon in 
exon-5. However, RT-PCR analysis of 
mouse brain material with a forward 
primer from exon-1a and a reverse primer 
from any of exons 2, 3, 5, and 7 did not 
reveal this additional 86-bp sequence 
between exons 1a and 2 (Fig. 1B in I, and 
data not shown). Moreover, no PCR 
products were obtained with the forward 
primer from exon-1a and a reverse primer 
from exon-1b, confirming that these exons 
do not splice to each other (Fig. 1B in I). 
To study whether the SLC12A5-1a 
region can mediate promoter activity, a 
luciferase reporter was constructed, in 
which the luciferase was put under control 
of the ~1-kb genomic fragment upstream 
of the predicted TSS-1a. Dissociated 
cortical cultures were transfected at div3 
and div8 with this reporter construct and 
the luciferase activity was measured two 
days later. The reporter activity of the 
SLC12A5-1a construct was ~5-fold 
stronger in div5 and ~15-fold in div10 
cultures, when compared to the promoter-
less reporter (Fig. 5 in I). This suggests 
that the genomic fragment upstream of the 
predicted TSS-1a is able to mediate the 
neuronal transcription of the KCC2a 
isoform. 
4.1.3.2 SLC12A5-1b promoter 
A similar strategy was applied to 
characterize the SLC12A5-1b promoter. 
Preliminary boundaries of exon-1b were 
derived by aligning rat and mouse KCC2 
cDNA sequences (Payne et al., 1996; 
Ehringer et al., 2001) with the correspond-
ing genomic fragment of the mouse 
chromosome 2. Two independent 5’-
RACE experiments pointed at the same 
position for a putative TSS-1b at 131 bp 
upstream of the initiatory methionine of 
the  KCC2b  isoform  (Fig.  1a  in  III).  
Ribonuclease protection assay (RPA) 
confirmed the 5’RACE results: a cluster of 
five TSSs was detected around the -131 bp 
position (Fig. 1a and 1b in III). In 
addition, several minor TSSs were 
revealed by the RPA method further 
upstream of the major TSS-1b (Fig. 1b in 
III) with the most upstream site located at 
the position -247 bp relative to the 
translation start codon. After publication 
of paper III, additional EST clones that 
spread further upstream have been 
deposited in databases. The most 5’ 
position for a TSS-1b is currently defined 
by the EST clone CJ116453, which starts 
at the position -420 bp relative to the 
translation start codon. Since no suitable 
initiatory methionines are present even in 
such a long upstream sequence of exon-
1b, this does not affect the KCC2b open 
reading frame. 
Ability of the SLC12A5-1b genomic 
fragment to mediate transcription was 
assessed both in vitro and in vivo. 
Luciferase reporter activity of the 1.4-kb 
SLC12A5-1b promoter was stronger ~13-
fold in div6 and ~35-fold in div10 
dissociated cortical cultures compared to 
the activity of the promoterless reporter 
(Fig. 5 in I). In Neuro-2a (N2a) 
neuroblastoma cells, the 1.4-kb SLC12A5-
1b reporter was ~12-fold more active than 
the promoterless construct (Fig. 3 in IV). 
A more proximal SLC12A5-1b promoter 
fragment (0.6 kb upstream of TSS-1b) still 
demonstrated a strong reporter activity in 
cultured cortical neurons (Fig. 3 in V) as 
well as in N2a and NIH3T3 cell lines (Fig. 
2 in V). Interestingly, even a 0.3-kb 
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SLC12A5-1b fragment still possessed most 
of the SLC12A5-1b 1.4-kb promoter 
activity  in  N2a  cells  (Fig.  3A  in  IV).  
Ability of the 1.4-kb SLC12A5-1b 
promoter to mediate transcriptional activi-
ty has also been reported in C17 neural 
progenitor cells (Karadsheh & Delpire, 
2001). In these cells, luciferase reporter 
activity of the 1.4-kb SLC12A5-1b 
promoter was ~4-fold higher compared to 
a promoterless control reporter. 
To evaluate whether the SLC12A5-1b 
promoter is transcriptionally active in vivo, 
transgenic mice were generated that carry 
luciferase cDNA under control of the 1.4-
kb SLC12A5-1b genomic fragment (III). 
These mice displayed a strong reporter 
activity in CNS areas, whereas only weak 
or undetectable activity was detected in 
nonneural tissues (Table 3 in III). 
4.1.4 SLC12A5 promoter regions: 
conclusions 
To sum up, the mouse SLC12A5 gene 
(encoding KCC2) is located on chromo-
some 2 between the MMP9 and NCOA5 
genes. Bioinformatics predicts two 
promoter regions mediating transcription 
of two alternatively spliced KCC2 
isoforms. TSSs for both transcripts have 
been confirmed experimentally by RPA 
and/or 5’-RACE methods. Reporter 
experiments have confirmed that both 
SLC12A5 promoters effectively drive 
transcription in cultured neurons and in 
cell lines. The SLC12A5-1b promoter is 
also active in vivo as demonstrated by 
reporter analysis in the transgenic mice 
(Chapter 4.4). 
4.2 CHARACTERIZATION OF 
THE KCC2a ISOFORM 
4.2.1 Cloning of the KCC2a cDNA 
Transcription from the SLC12A5-1a 
promoter results in the KCC2a isoform, 
which in contrast to the previously known 
KCC2b isoform bears the alternatively 
spliced exon-1a. A nearly full-length rat 
KCC2a cDNA (including the full-length 
open reading frame) was amplified by two 
rounds of nested RT-PCR with primers 
located in exons 1a and 26 using total 
RNA isolated from the E18 rat 
hippocampus (Fig. 1C in I). Sequencing 
confirmed that the KCC2a transcript 
differed from the KCC2b only by the 
alternatively spliced first exon; all the 
other exons were spliced similarly in both 
isoforms. The absence of any additional 
splicing between exons 2-26 was 
confirmed by Blaesse et al., who failed to 
detect any aberrant KCC2 splice isoforms 
by two different methods (Blaesse et al., 
2006). The nucleotide sequence corre-
sponding to the rat KCC2a transcript was 
submitted to the GenBank with an 
accession number EF641113. 
KCC2a and KCC2b proteins are 
distinct only in their most N-terminal 
parts: exon-1a encodes a novel 40-aa N-
terminal peptide instead of the 17-aa 
fragment encoded by exon-1b (Fig. 2A in 
I). Amino acid residues 1-13 in the 
mammalian KCC2a orthologs are highly 
conserved and contain a consensus 
binding motif for the OSR1 (oxidative 
stress response-1) and SPAK (Ste20-
related proline alanine-rich kinase) kinases 
(Delpire & Gagnon, 2007) (Fig. 2B). 
To study KCC2a transport properties 
and to assess whether KCC2a interacts 
with SPAK/OSR1 kinases, a KCC2a 
expression construct was prepared. For 
that, a near full-length KCC2a cDNA 
including the predicted 5’UTR, the whole 
KCC2a coding region, and a part of the 
3’UTR sequence was subcloned into 
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pcDNA3.1 expression vector (I). 
Similarly, the KCC2b cDNA (a kind gift 
of John Payne) was cloned into the 
pcDNA3.1 vector that resulted in the 
KCC2b expression construct. Immuno-
blotting with the KCC2pan antibody 
(Ludwig et al., 2003), recognizing a C-
terminal peptide common in both 
isoforms, confirmed that each construct 
was able to express efficiently the 
corresponding KCC2 isoform in HEK293 
cells. KCC2a and KCC2b products of the 
predicted molecular weight (~140 kDa) 
were detected in lysates of HEK293 cells 
transfected with the corresponding 
expression vectors but not in lysates of the 
mock transfected cells (Suppl. Fig. 3 in I; 
Fig. 1C in II).  
4.2.2 KCC2a but not KCC2b can 
interact with SPAK in HEK293 cells 
As mentioned above, the most N-terminal 
part of the KCC2a protein is highly 
conserved among mammalian orthologs 
and contains the OSR1/SPAK binding 
motif at the position 3-12 (Fig. 2B). To 
reveal whether SPAK can bind KCC2a, 
both proteins were overexpressed in 
HEK293 cells and a putative interaction 
was analyzed by CoIP. CoIP with the 
KCC2a antibody (II and Materials and 
Methods) and subsequent immunoblotting 
with the SPAK antibody (Ushiro et al., 
1998) resulted in a strong signal of the 
predicted size (Fig. 8A in II). This 
experiment has demonstrated that KCC2a 
can interact with SPAK in the 
heterologous expression system. 
It has been reported recently that the 
KCC2b transport activity in oocytes may 
be modulated by SPAK (Gagnon et al., 
2006). Since KCC2b isoform lacks any 
apparent SPAK/OSR1 binding motifs, it 
remained unclear whether SPAK may 
regulate the KCC2b transport activity 
directly, through binding to the 
cotransporter in yet undetermined site, or 
indirectly, via modulating other kinases or 
phosphatases. To address this question, 
hemmaglutinin (HA) tagged SPAK 
(HASPAK) expression construct was 
cotransfected into HEK293 cells along 
with either KCC2a or KCC2b expression 
vectors. CoIP was first performed with the 
KCC2pan antibody recognizing both 
isoforms. Immunoblotting of the 
precipitated material with an HA-tag 
specific antibody detected a clear signal 
from lysates expressing KCC2a but not 
KCC2b isoform. A similar result was 
obtained when the HA antibody was used 
for the precipitation, while the subsequent 
immunoblotting was performed with the 
KCC2pan antibody (Uvarov et al., 
unpublished observations).  
4.2.3 Transport activity of the KCC2 
isoforms in HEK293 cells 
Rubidium has for a long time been used as 
a potassium congener (Kupriyanov & 
Gruwel, 2005). The biochemical similarity 
of Rb+ and K+ ions is predetermined by a 
similar radius size of their hydrated ions: 
2.93Å for Rb+ (Fulton et al., 1996) and 
2.76Å for K+ (Impey et al., 1983). 86Rb+ 
was originally used as a substitute of K+ to 
study the KCC2 transport properties 
(KCC2b isoform) in HEK293 cells 
(Payne, 1997). Therefore, the same 86Rb+ 
uptake assay was applied to characterize 
the KCC2a-mediated transport activity in 
HEK293 cells (I). Immunoblotting 
confirmed a strong expression of both 
isoforms in HEK293 cells transiently 
transfected with either KCC2a (KCC2a-
HEK293) or KCC2b (KCC2b-HEK293) 
expression vectors (supplementary Fig. 3 
in I; Fig. 1C in II). The functional 86Rb+ 
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assay revealed ~2.5-fold higher uptakes in 
HEK293 cells transfected with either 
KCC2a or KCC2b, compared to the mock 
transfected cells (Fig. 6 in I). Furosemide, 
a known inhibitor of K-Cl cotransporters, 
completely eliminated this difference. 
Thus, in HEK293 cells, the exogenously 
expressed KCC2a and KCC2b isoforms 
demonstrated a comparable level of the 
furosemide-sensitive K-Cl cotransport. 
Activation of K-Cl cotransport by N-
ethylmaleimide (NEM) was first reported 
in red blood cells (Lauf et al., 1984) and 
was confirmed later in HEK293 cells 
(Gillen et al., 1996). The exact mechanism 
how NEM activates the K-Cl transporter 
function is unknown, but it has been 
suggested that NEM might inhibit certain 
protein kinases and simultaneously 
activate the membrane-associated PP2A 
phosphatase (Bize et al., 2000). In 
addition, NEM is able to modify directly 
thiol groups in the K-Cl cotransporters 
(Lauf et al., 1995), thus perhaps affecting 
their tertiary or quaternary structure. The 
furosemide-sensitive component of 86Rb+ 
flux was significantly enhanced by NEM 
in the KCC2a-HEK293 (~2.6-fold) and 
KCC2b-HEK293 (~1.7-fold) cells, but not 
in the mock transfected cells (Fig. 6 in I). 
This effect of NEM was completely 
blocked by furosemide.  
4.2.4 Characterization of the KCC2a 
isoform: conclusions 
KCC2a  cDNA  was  cloned  following  a  
bioinformatic prediction. The KCC2a 
protein differs from the previously 
characterized KCC2b isoform only by the 
most N-terminal sequence encoded by the 
alternatively spliced exon-1a. In contrast 
to KCC2b, the KCC2a protein contains the 
putative SPAK/OSR1 binding site. CoIP 
analysis shows that SPAK can bind 
KCC2a but not KCC2b in the heterolo-
gous expression system of HEK293 cells. 
In these cells, KCC2a and KCC2b 
isoforms mediate comparable transport 
activity under isotonic conditions that is 
furosemide-sensitive and can be further 
enhanced by NEM. 
4.3 COMPARISON OF KCC2a 
AND KCC2b EXPRESSION  
4.3.1 Neuronal specificity of the 
KCC2a and KCC2b isoforms 
As it has been resumed in the “Review of 
the literature”, KCC2 expression is 
substantially CNS neuron-specific. As 
most of the reviewed reports exploited 
primers, antibodies, and probes that detect 
simultaneously both KCC2 isoforms, the 
individual profiles of the KCC2a and 
KCC2b isoforms should also be CNS 
neuron-specific. Indeed, neither KCC2a 
nor KCC2b expression was detected by 
RT-PCR with primers specific for KCC2a 
and KCC2b in nonneural tissues (kidney, 
liver, and lung) at different developmental 
stages (E17 and P14) (Fig. 4A and 4B in 
I). As a positive control, spinal cord and 
brainstem expressed both KCC2a and 
KCC2b at E17; moreover, both KCC2 
transcripts were detected in all brain 
regions and in spinal cord at P14 (Fig. 4A 
and 4B in I). Furthermore, no KCC2b 
mRNA expression was observed by RPA 
in the samples of adult liver and testis 
(Fig.1B in III), thus confirming the CNS-
specific pattern for the KCC2b isoform. 
RPA reaction, performed with a different 
probe and optimized to sense lower KCC2 
levels, revealed no KCC2 expression in 
liver and only a very weak signal in testis 
(Fig. 3A in I). This signal might represent 
a short aberrant KCC2 transcript reported 
previously (Williams et al., 1999). 
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The  CNS  specificity  of  KCC2a  
expression has been confirmed in addition 
on a protein level. Immunoblotting with 
the KCC2a antibody detected strong 
KCC2a expression in spinal cord and in 
five brain areas, but not in six nonneural 
tissues (Fig.2 in II). Furthermore, double 
immunostainings with the KCC2a and 
TUJ-1 (neuronal b-tubulin) antibodies 
revealed a strict colocalization of the 
corresponding signals in dissociated 
hippocampal cultures, consistent with the 
neuron-specific pattern of KCC2a 
expression (Fig. 5A and 5C in II). In 
contrast, immunostainings did not show 
colocalization between KCC2a and GFAP 
(astroglial marker) proteins (Fig. 5B in II).  
Thus, multiple lines of evidence confirmed 
in vivo and in vitro the exclusively CNS 
neuronal specific patterns for both KCC2 
isoforms. 
4.3.2 Developmental expression of the 
KCC2 isoforms 
As discussed in the “Review of the 
literature”, in general KCC2 expression is 
upregulated during CNS development. 
However, since most of the data were 
obtained using primers, antibodies, and 
probes that cannot distinguish the KCC2 
isoforms, additional experiments were 
performed to study expression profiles of 
the KCC2a and KCC2b isoforms individu-
ally during development. To analyze 
separately the KCC2 isoforms, new 
antibodies, probes, and primers were 
produced and characterized. In addition, 
detection methods were modified to allow 
an adequate comparison of KCC2a and 
KCC2b expression (see “Materials and 
Methods” part). 
4.3.2.1 KCC2a expression 
A relatively weak expression of KCC2a 
mRNA was detected by RPA in mouse 
whole brain samples at E14 (Fig. 3A in I). 
The expression was upregulated gradually 
between E14 and P1, and then maintained 
at the same level for at least up to P60. 
RT-PCR analysis of individual CNS 
regions could detect KCC2a expression in 
spinal cord, brainstem, and olfactory bulb, 
but not in cortex and hippocampus of E17 
mouse embryos (Fig. 4A in I). However, 
KCC2a mRNA was detectable at P14 in 
all brain regions including cortex and 
hippocampus (Fig. 4B in I). More accurate 
real-time RT-PCR quantification revealed 
that at E17 the strongest KCC2a 
expression was in brainstem, while the 
cortical KCC2a level was about 5-fold 
lower (Fig. 4C in I). During postnatal 
development, the KCC2a mRNA 
expression decreased in brainstem ~2.5-
fold, while increased in cortex ~2-fold, 
thus resulting at P14 in approximately 
similar KCC2a mRNA levels (Fig. 4C in 
I). These data were further confirmed on 
the protein level. Immunoblotting with the 
KCC2a antibody revealed that in 
brainstem and spinal cord the KCC2a 
protein expression was decreasing during 
postnatal development and was ~2-fold 
lower in adulthood compared to P2. In 
cerebral cortex, in contrast, KCC2a 
expression was increasing during develop-
ment and was ~2-fold stronger in adult 
compared to P2 mice (Fig. 3B in II). Thus, 
both mRNA and protein data demon-
strated that KCC2a expression was 
moderately increased during development 
in cortical and hippocampal areas, but 
decreased in brainstem and spinal cord. 
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4.3.2.2 KCC2b expression 
The developmental profile of KCC2b 
expression differed radically from that for 
the KCC2a isoform. RPA analysis showed 
a steep upregulation of the KCC2b mRNA 
level in whole mouse brain samples 
between E14 and P60 (Fig. 3A in I). 
Another RPA experiment demonstrated 
similar kinetics for the KCC2b mRNA 
expression in whole mouse brain samples 
between E15 and P60 (Fig. 1B in III). 
These data were additionally confirmed by 
a semiquantitative RT-PCR that revealed 
no KCC2b mRNA in cortex and 
hippocampus at E17, but strong KCC2b 
expression already at P14. As a positive 
control, KCC2b expression in spinal cord 
and brainstem samples was clearly 
detected at both time points (Fig. 4A in I). 
Real-time PCR quantification 
confirmed that mRNA levels of KCC2b, 
in contrast to KCC2a, were increased 
between E17 and P14 in all CNS regions 
analyzed (Fig. 4D in I). The KCC2b 
upregulation was dramatic in neocortex 
(~35-fold) and hippocampus (~10-fold), 
whereas it was rather moderate in spinal 
cord (~2-fold) and brainstem (~1.5-fold). 
The kinetics of KCC2b mRNA 
upregulation was additionally studied by 
real-time PCR in cortical and brainstem 
samples from 1-, 2-, and 4- week-old mice 
(Fig. 5C and 5F in III). Only a minor 
increase of KCC2b was detected in 
brainstem during postnatal development 
(Fig. 5F in III). In cortical samples, in 
contrast, KCC2b mRNA level increased 
steeply up to P14, and then remained 
mostly unchanged (Fig. 5C in III). The 
KCC2b mRNA upregulation was evident 
also in dissociated mouse hippocampal 
neurons: KCC2b mRNA level increased 
~3.5-fold in between div4 and div11 (Fig. 
7A in IV). 
One previously published N-terminal 
antibody against KCC2 (Hubner et al., 
2001) occurred to be specific for the 
KCC2b isoform (Fig. 1C in II). Thus, a 
previous analysis of the developmental 
upregulation of KCC2 protein expression 
in mouse CNS using this antibody (Stein 
et al., 2004) actually shows the expression 
of KCC2b only. In brief, a strong KCC2b 
protein upregulation was observed in 
cerebellum, hippocampus, and cortex 
between E15.5 and adult time points. In 
contrast, only moderate KCC2b protein 
upregulation was detected in spinal cord 
and brainstem (Stein et al., 2004). 
Interestingly, the developmental pro-
file of the KCC2b protein expression to a 
large extent resembled that of the total 
KCC2 expression (KCC2total=KCC2a + 
KCC2b) in many brain areas. For instance, 
immunoblotting with the KCC2pan 
antibody, which recognizes both KCC2 
isoforms, revealed a strong ~17-fold 
upregulation of KCC2total in cortex, but 
only a very moderate ~2-fold increase in 
brainstem during postnatal mouse 
development (Fig. 3A, 3C in II). Similar to 
cortex, a steep increase of the KCC2total 
expression was also observed in hippo-
campus and cerebellum during postnatal 
mouse development (Fig. 2 in IV). 
4.3.2.3 Developmental shift of the 
KCC2a/KCC2b value 
The previous data showed that the 
developmental profiles of the KCC2a and 
KCC2b isoforms differed. For example, 
KCC2a mRNA and protein levels 
decreased in brainstem and spinal cord, 
while KCC2b expression moderately 
increased in the same areas. Moreover, 
although both isoforms were upregulated 
in cerebellum, cortex, and hippocampus, 
the KCC2b mRNA and protein levels 
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grew much stronger compared to KCC2a. 
This suggests that the contribution of 
KCC2a to the total KCC2 expression 
would decrease during postnatal develop-
ment. To measure the relative mRNA 
expression of the KCC2 isoforms, the 
RPA method was used (Fig. 3A in I). As 
determined by RPA, KCC2a comprised 
~20% of the total KCC2 mRNA amount in 
whole mouse brain at E14 and remained 
approximately on the same level at P1. 
However, the KCC2a fraction decreased 
significantly during postnatal mouse 
development: at P60, only ~10% of the 
total KCC2 amount was represented by 
KCC2a in the whole brain and ~5% in 
cerebellum and hippocampus samples 
(Fig. 3A in I). The developmental down-
regulation of the KCC2a mRNA fraction 
was  confirmed  by  real-time  PCR  in  
several brain areas (brainstem, cortex, and 
hippocampus) and in spinal cord (Fig. 3B 
in  I).  The  KCC2a  fraction  in  the  CNS  
regions was relatively high at E17, ranging 
from 45% in spinal cord up to 65% in 
cortex. The fraction was significantly 
smaller at P14 representing only ~15% of 
the total KCC2 in cortex and hippo-
campus, and ~30% in spinal cord and 
brainstem (Fig. 3B in I). 
The developmental decrease in the 
ratio between KCC2a and total KCC2 
expression was independently confirmed 
at the protein level. To quantify the ratio 
of KCC2a/KCC2total in various brain 
areas and at different developmental 
stages, protein lysates containing different 
amounts of KCC2a were used as standards 
(see Materials and Methods). The 
standards were loaded onto SDS-PAGE 
along with the brain lysates, transferred 
onto membrane, and immunoblotted with 
the KCC2a and KCC2pan antibodies (Fig. 
4A in II). Standard curves (Fig. 4C in II) 
allowed estimation of the ratio of KCC2a 
to KCC2total in the analyzed brain lysates 
(Fig. 4B in II). A relatively high (~50-
60%) KCC2a protein content was 
observed in brainstem, cortex, and spinal 
cord samples at P2. In contrast, the 
KCC2a/KCC2total ratio decreased 
significantly in adult mice representing 
only ~5-10% in cortex and cerebellum, 
and ~20% in brainstem and spinal cord 
(Fig. 4B in II). 
In sum, both mRNA and protein data 
showed that the KCC2a fraction represents 
about half of the total KCC2 content in 
embryonic and neonatal brain areas but 
only 5-20% in adult CNS. 
4.3.3 KCC2 isoforms: coexpression 
and heteromerization  
4.3.3.1 Spatial distribution of the KCC2 
isoforms in mouse brain 
To study the spatial distribution of KCC2a 
and KCC2b in mouse brain, in situ 
hybridization was attempted. The KCC2 
mRNA expression pattern, as revealed by 
in situ hybridization with a 3’UTR probe 
detecting both isoforms, was similar to the 
one reported previously (Fig. 3D in III). 
However, in situ hybridization analysis of 
the individual isoforms was complicated 
by the fact that the unique sequences for 
KCC2a and KCC2b are rather short and 
GC-rich (~75% for exon-1a and ~70% for 
exon-1b). The combination of these two 
factors significantly hampered a specific 
detection of the corresponding KCC2 
transcripts. Anyhow, in situ hybridization 
of adult mouse brain sections with the 
KCC2b-specific probe (Suppl. Fig. 2 in II) 
revealed an expression pattern analogous 
to the one obtained with the 3’UTR probe 
(Fig. 3D in III). The strongest hybridiza-
tion signals were detected in cortex, 
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cerebellum, and hippocampus – in those 
areas where the highest KCC2total protein 
expression and the highest KCC2b 
fraction were previously detected by 
Western blot (Fig. 4 in III). 
Since in situ hybridization with the 
KCC2a antisense probe was unsuccessful 
(data not shown), the expression pattern of 
KCC2a was studied by IHC using the 
KCC2a-specific antibody (Fig. 1 in II). 
Patterns produced by the KCC2a and 
KCC2pan antibodies in E18 mouse brain 
were quite similar (Fig. 6A versus 6C  in  
II). Sections from KCC2 KO mice served 
as specificity controls. Both antibodies 
produced strong signals in medulla, 
thalamus, and hypothalamus, while no 
immunoreactivity was observed in cortex 
and hippocampus (Fig. 6A and 6C in II). 
Stainings of adjacent sections of the E18 
mouse brain with the KCC2a and KCC2b 
antibodies also did not reveal any 
substantial difference in the analyzed 
regions (Fig. 6E versus 6F, 6G versus 6H 
in II). At that developmental stage cortical 
and hippocampal areas were negative for 
both isoforms, whereas strong signals 
were detected in olfactory bulb, thalamus, 
and hypothalamus. Of note, although 
neurons in the abovementioned brain areas 
often coexpressed both KCC2 isoforms, 
the distribution of the KCC2a and KCC2b 
proteins in these areas was not identical 
(Fig. 7 in II). Preliminary results indicate 
that this difference between the expression 
patterns of the isoforms becomes more 
evident in the adult mouse brain 
(Markkanen et al., unpublished observa-
tions). For example, the KCC2a 
immunoreactivity is stronger in brainstem 
compared to the cerebellar cortex (Fig. 9). 
These results are consistent with the 
previous Western blot data that showed a 
higher expression of KCC2a (Fig. 2 in II), 
and a higher fraction of KCC2a in total 
KCC2 (Fig. 4B in II), in adult mouse 
brainstem compared to cerebellum. 
KCC2a protein expression is also much 
higher in hypothalamus compared to the 
thalamic region (Fig. 9). 
To sum up, although KCC2a and 
KCC2b were often colocalized in perinatal 
mouse brain, their distributions were not 
always identical. Significantly different 
expression patterns for the KCC2 isoforms 
were detected in some regions of adult 
mouse brain. 
4.3.3.2 Dimerization of the KCC2 
isoforms 
Homo- and heteromerization has been 
demonstrated previously for the CCC 
family members (Mckee et al., 
2000;Moore-Hoon & Turner, 2000;Casula 
et al., 2001;de Jong et al., 
2003;Starremans et al., 2003;Simard et al., 
2004;Blaesse et al., 2006;Parvin et al., 
2007;Simard et al., 2007;Pedersen et al., 
2008;Casula et al., 2009). Given a similar 
distribution of the KCC2a and KCC2b 
proteins in the perinatal mouse brain and 
their apparent colocalization in many 
neurons, the question arose whether the 
KCC2 isoforms also form hetero-
oligomers. To address this question, 
KCC2a and KCC2b isoforms were 
coexpressed in HEK293 cells and their 
possible interaction was studied by CoIP. 
Protein complexes precipitated by the 
KCC2a antibody contained also KCC2b 
isoform, as detected by immunoblotting 
with KCC2b-specific antibody (Fig. 8A in 
II). Reciprocal precipitation of KCC2b and 
a subsequent immunodetection of the 
KCC2a protein showed similar results 
(Fig. 8B in II). As a control, no protein 
interaction was detected between the 
KCC2 isoforms when they were expressed 
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separately and the corresponding lysates 
were combined before the precipitation 
(Fig. 8A and 8B in II). 
Oligomerization of the endogenously 
expressed KCC2a and KCC2b proteins in 
neonatal mouse brainstem was studied 
using the native perfluorooctanoate (PFO)-
PAGE system. In the standard SDS-PAGE 
system, the endogenous KCC2 isoforms 
were usually observed as a ~140 kDa 
monomer (Fig. 1A, 1B, 2, 3A in II). In the 
native PFO-PAGE system, the KCC2a and 
KCC2b proteins in addition to monomers 
formed dimers (Fig. 9A in II). 
Importantly, no other higher molecular 
weight oligomers were detected. The 
KCC2 dimers were SDS-sensitive: brief 
incubation of the lysates in the presence of 
0.5% SDS before loading on the PFO-
PAGE disrupted the dimers (Fig. 9B in II). 
Formation of KCC2a-KCC2b dimers in 
vivo was further examined by CoIP. The 
KCC2a antibody was used to precipitate 
protein complexes containing KCC2a 
from the rat E18 brainstem lysates. 
Subsequent immunoblotting with the 
Figure 9. Areas of high KCC2a protein content in adult mouse brain. Immunostainings 
of adult mouse brain coronal sections demonstrate areas with a high fraction of KCC2a in the 
total KCC2 amount. (A, B) KCC2a immunoreactivity is significantly stronger in brainstem 
compared to cerebellar cortex, while levels of total KCC2 expression in these areas are 
similar. (D, E) Likewise, the KCC2a expression in hypothalamus is much stronger than in the 
thalamic region. A prominent signal detected with the KCC2pan antibody throughout 
thalamus implies a high content of KCC2b but not of KCC2a in this region. (C, F) Directions 
of cutting planes are shown. BS-brainstem, CB-cerebellum, Hb-habenula, HC-hippocampus, 
HY-hypothalamus, IC-inferior colliculus.  
 
68 
 
KCC2b antibody detected KCC2b as a 
KCC2a-interacting partner (Fig. 9C in II). 
In contrast, no KCC2b-specific signals 
were detected when a KCC2a-unrelated 
antibody was used for CoIP. 
Formation of the KCC2a-KCC2b 
oligomers was also studied in transiently 
transfected HEK293 cells using PFO-
PAGE. In contrast to the in vivo situation, 
tri-  and  tetramers  were  observed  in  
addition to monomers and dimers in the 
KCC2a-containing lysates (Fig. 8C in II). 
Similar set of oligomers was also present 
in HEK293 cell lysates overexpressing the 
GFP-tagged KCC2b protein. The N-
terminally-fused GFP increased the 
molecular weight of KCC2b by ~27 kDa, 
resulting in the mono-, di-, tri-, and 
tetramers migrating slower compared to 
the corresponding KCC2a complexes (Fig. 
8C in II). Thus, simultaneous over-
expression of the KCC2a and GFP-
KCC2b constructs resulted in the 
heterooligomeric (KCC2a)-(GFP-KCC2b) 
complexes with intermediate mobility 
(Fig. 8C in II). 
To sum up, endogenous KCC2a and 
KCC2b isoforms are often colocalized in 
the perinatal rodent brain and form SDS-
sensitive homo- and heterodimers. In 
addition to dimers, the KCC2 isoforms 
may form tri- and tetra-oligomers at least 
in the heterologous HEK293 cell system in 
vitro. 
4.3.4 Expression and dimerization of 
the KCC2 isoforms: conclusions 
The exclusively CNS neuron-specific 
expression of both KCC2a and KCC2b 
isoforms has been shown on both mRNA 
and protein levels. Primers, probes, and 
antibodies were designed to target the 
unique first exon sequences of the 
individual KCC2 isoforms, which allowed 
us to detect all KCC2a and KCC2b 
products transcribed by the SLC12A5-1a 
and SLC12A5-1b promoters, including 
those that might have been overlooked in 
previous assays utilizing C-terminal 
antibodies or 3’UTR primers and probes. 
Although both KCC2 isoforms are 
CNS neuron-specific, their expression 
patterns have quite different profiles in 
developing rodent CNS. For example, in 
mice, while KCC2b expression increases 
in all CNS areas between E17 and P14, 
and especially steeply in cortex and 
hippocampus, KCC2a does not increase in 
hippocampus and even decreases in 
brainstem and spinal cord during this time. 
As a consequence, the [KCC2a/KCC2 
total] value changes during postnatal 
development: about 50% of the total 
KCC2 amount is comprised of KCC2a in 
perinatal but only ~ 5-20% in adult mouse 
brain. 
The increasing prevalence of KCC2b 
over KCC2a during development may 
have several implications. The ability of 
the KCC2a and KCC2b isoforms to form 
dimers suggests that the most prevalent 
complex in perinatal mouse brain would 
be KCC2a-KCC2b. On the contrary, 
KCC2b homodimers would be more 
probable in adults, especially in cortical 
areas that express little amounts of 
KCC2a. Even though the transport 
activities of the KCC2a and KCC2b 
isoforms appeared similar in HEK293 
cells, this might not be the case in vivo. If 
so, even in a case when the total KCC2 
amount is constant, the KCC2 activity in 
perinatal and adult neurons may vary 
significantly just because of the different 
composition of the KCC2 dimers. 
How could the KCC2a bearing 
dimers possess a transport activity distinct 
from the KCC2b homodimers? One 
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possibility could be a different regulation 
of the KCC2a and KCC2b isoforms by 
SPAK. In agreement with the presence of 
the SPAK binding motif in KCC2a but not 
in KCC2b, it was KCC2a that interacted 
with  SPAK  in  HEK293  cells.  It  has  been  
shown previously that SPAK regulates the 
activity of other CCC members; moreover 
SPAK/OSR1 binding motifs have been 
identified in all KCC members except 
KCC1. This implies that the KCC2a-
containing dimers could be regulated by 
SPAK in a different way than the KCC2b-
containing homodimers and, as a 
consequence, could display different 
transport activities. Another possibility 
could be a different regulation of the 
KCC2a and KCC2b isoforms by other 
than SPAK/OSR1 kinases. For example, a 
putative PKA phosphorylation site has 
been identified that is highly conserved 
among mammalian KCC2a but absent 
from KCC2b protein sequences, (Fig. 2B 
in I). 
4.4 MECHANISMS MEDIATING 
THE CNS NEURONAL 
SPECIFICITY OF KCC2 
The data presented above demonstrate that 
both KCC2 isoforms are expressed in a 
CNS neuron-specific manner. What are 
the mechanisms suppressing the 
SLC12A5-1a and SLC12A5-1b promoters 
outside CNS? Since the KCC2a isoform 
and the corresponding SLC12A5-1a 
promoter have been discovered only 
recently (I), no studies have been 
performed so far to identify mechanisms 
of the KCC2a neuronal specificity. As for 
the SLC12A5-1b promoter, at least one 
possible explanation has been proposed: a 
binding site for the neuron-restrictive 
silencing factor/repressor element-1 
transcription factor (NRSF/REST) was 
identified in intron-1b of the SLC12A5 
gene (Karadsheh & Delpire, 2001; Song et 
al., 2002). NRSF is known to be strongly 
expressed in nonneuronal tissues, where it 
binds neuron-restrictive silencing element 
(NRSE) and efficiently suppresses 
transcription of NRSE-containing genes 
(Chong et al., 1995; Schoenherr & 
Anderson, 1995; Ooi & Wood, 2007). 
4.4.1 NRSF suppresses activity of the 
SLC12A5-1b promoter in vitro 
The NRSE site in intron-1b of the mouse 
KCC2 gene  (NRSEKCC2) is highly 
conserved among mammalian SLC12A5 
gene orthologs (Fig. 1 in IV). In addition, 
electrophoretic mobility shift assay 
(EMSA) has previously demonstrated that 
endogenous NRSF from C17 nonneuronal 
cells  binds  NRSEKCC2 (Karadsheh  &  
Delpire, 2001). Being artificially placed 
upstream of the 1.5-kb SLC12A5-1b 
sequence, NRSEKCC2 repressed the 
SLC12A5-1b promoter activity in the C17 
cells, as determined by a luciferase 
reporter assay. 
To further assess the role of 
NRSEKCC2 in neuronal specificity of the 
KCC2b isoform, three luciferase reporter 
constructs were cloned (Fig. 2A in III). 
Since location of NRSE relative to TSS is 
known to be important (Bessis et al., 
1997), NRSEKCC2 was studied in its native 
intronic position. Therefore, the 
KCC2(6.8)luc construct contained a 
luciferase sequence under control of the 
~6.8-kb genomic fragment comprising the 
1.4-kb SLC12A5-1b promoter sequence, 
exon-1b, whole intron-1b, and a part of 
exon-2 (Fig. 2A in III). In comparison 
with the KCC2(6.8)luc construct, the 
KCC2(6.8mut)luc reporter lacked 
NRSEKCC2 as a result of a ~340-bp 
deletion in intron-1b (Fig. 2A in III). A 
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third construct - KCC2(1.4)luc - contained 
the SLC12A5-1b promoter and a part of 
exon-1b fused to the luciferase sequence 
(Fig. 2A in III). 
Promoter activity of these constructs 
was first studied in N2a cells, which don’t 
express full-length NRSF endogenously 
(Palm et al., 1998; Palm et al., 1999). The 
KCC2(6.8)luc reporter, which contains 
NRSEKCC2, was inhibited ~2-fold by 
exogenous overexpression of NRSF 
(pcDNA3-REST) (Fig. 2B in III). In 
contrast, the NRSF overexpression did not 
affect the activity of the KCC2(6.8mut)luc 
reporter, which lacks NRSEKCC2 (Fig. 2B 
in III). The luciferase activity of neither 
KCC2(6.8)luc nor KCC2(6.8mut)luc 
construct was affected by overexpression 
of the dominant-negative form of NRSF 
(DN-REST) (Fig. 2B in III), which 
prevents binding of the full-length NRSF 
to NRSE (Chen et al., 1998). 
To sum up, NRSEKCC2 in the intron-
1b of the SLC12A5 gene is conserved 
among the mammalian SLC12A5 
orthologs. Previous experiments in C17 
nonneuronal cells had demonstrated that 
NRSEKCC2 can interact with the 
endogenously expressed NRSF and 
suppress the transcriptional activity of the 
SLC12A5-1b promoter (Karadsheh & 
Delpire, 2001). Experiments presented in 
paper III of the thesis showed that 
exogenously expressed NRSF in N2a cells 
inhibited only partially (~2-fold) the 
SLC12A5-1b promoter. The incomplete 
suppression of the promoter activity in 
N2a cells might be explained by 
endogenously expressed REST4, a short 
form of NRSF (Palm et al., 1998; Palm et 
al., 1999). REST4 has previously been 
shown to interfere with the silencing 
activity of the full-length NRSF (Shimojo 
& Hersh, 2004). NRSF was not able to 
affect the promoter activity of the 
KCC2(6.8mut)luc reporter, in which the 
NRSEKCC2 site was deleted. Thus, 
NRSEKCC2 can repress the SLC12A5-1b 
promoter activity in vitro in the presence 
of either endogenously or exogenously 
expressed NRSF. 
4.4.2 NRSEKCC2 is not critical for the 
CNS neuronal specificity of SLC12A5-
1b in vivo 
To assess  whether  NRSEKCC2 is sufficient 
to mediate the CNS neuronal specificity of 
the SLC12A5-1b promoter in vivo, two 
mouse transgenic lines were generated 
using the KCC2(6.8)luc and 
KCC2(6.8mut)luc constructs. If NRSEKCC2 
is decisive for the neuronal specificity of 
SLC12A5-1b promoter, its deletion should 
result in ectopic expression of the 
KCC2(6.8mut)luc reporter in nonneural 
tissues. In addition to these two lines, a 
third transgenic line, carrying the 
KCC2(1.4)luc construct, was generated 
and analyzed. 
4.4.2.1 SLC12A5-1b promoter activity in 
the KCC2(6.8)luc mice 
Reporter activity in the KCC2(6.8)luc 
mice occurred to be substantially CNS 
neuron-specific. Luciferase activity was 
detected in spinal cord and four brain 
regions (cortex, cerebellum, brainstem, 
and hippocampus), but neither in 
nonneural (liver, kidney, heart, muscle, 
and lung) nor in neuroendocrine (pituitary 
and adrenal glands) tissues (Table 1 in III). 
In situ hybridization confirmed the 
exclusively neuron-specific pattern (Fig. 3, 
column A, in III). High luciferase mRNA 
levels were detected in neurons of all brain 
regions except striatum, whereas no 
reporter expression was detected in glial 
cells of corpus callosum (Fig. 3 column A, 
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in III). The relatively weak hybridization 
signal in the striatum resembled the low 
expression of endogenous KCC2b mRNA 
in this area (Suppl. Fig. 2 in I). Of note, 
expression  levels  of  total  KCC2  mRNA  
(KCC2a+KCC2b) in the striatum and in 
nearby brain areas were similar as 
revealed by in situ hybridization with a 
probe that detects both KCC2 isoforms 
(Fig. 3 column D in III). This fact suggests 
a prevalence of KCC2a over KCC2b in the 
striatum. 
The luciferase mRNA expression in 
the KCC2(6.8)luc mice was also very low 
in granular cell populations of olfactory 
bulb, cerebellum, and dentate gyrus (Fig. 3 
column A, rows c, d, e in III). Of note, 
KCC2b mRNA is highly expressed in 
these cell populations as determined by in 
situ hybridization with the exon-1b 
specific probe (Suppl. Fig. 2 in I). One 
explanation might be that certain elements 
are still required to recapitulate fully the 
endogenous expression of KCC2b in 
granular cells, and that these elements are 
located outside the KCC2(6.8)luc 
sequence. 
An apparent exception from the CNS 
neuron-specific expression of the 
KCC2(6.8)luc reporter was the relatively 
low, yet detectable (~30-50 times lower 
than in cortex), luciferase activity in optic 
nerve and peripheral sensory ganglia 
(trigeminal  and  DRG)  (Table  1  in  III).  
Lack of luciferase mRNA in the optic 
nerve (Suppl. Fig. 1 in III) suggested that 
the reporter activity in the nerve originated 
from neurons in the retina. To examine the 
cellular expression of the reporter in DRG, 
IHC analysis was performed using anti-
luciferase antibody. A small subpopulation 
of luciferase-immunoreactive neurons was 
detected in DRGs of the KCC2(6.8)luc 
mice (Fig. 4E in III) but not of the wild 
type mice (Fig. 4F in III). This experiment 
confirmed the previous data concerning a 
weak KCC2 expression in DRG (Lu et al., 
1999; Rivera et al., 1999; Ledoux et al., 
2006; Gilbert et al., 2007; Funk et al., 
2008). Moreover, this result was also in 
agreement with the previous IHC data 
showing the KCC2 expression in a 
subpopulation of large DRG neurons (Lu 
et al., 1999).  
The KCC2 expression is also known 
to be weak or absent in some neuronal 
populations of adult mouse brain (see the 
“Review of the Literature”). In agreement 
with this, no luciferase immunoreactivity 
was detected in the reticulate thalamic 
nucleus (Fig. 4 A-D in III) and in the 
mesencephalic trigeminal nucleus (data 
not shown) of the KCC2(6.8)luc mice. 
In sum, the 6.8-kb genomic fragment 
comprising the 1.4-kb SLC12A5-1b 
promoter, exon-1b, whole intron-1b, and a 
part of exon-2 (Fig. 2A in III) can largely 
recapitulate the endogenous CNS neuron-
specific pattern of KCC2 expression in 
vivo.  
4.4.2.2 SLC12A5-1b promoter activity in 
the KCC2(6.8mut)luc mice 
Surprisingly, despite the NRSEKCC2 
deletion, the reporter activity in the 
KCC2(6.8mut)luc mice was still 
substantially CNS neuron-specific. It was 
strong in different brain regions and spinal 
cord, but undetectable in nonneural tissues 
(Table 2 in III). A major outcome of the 
NRSEKCC2 deletion was a significant (~12-
fold) upregulation of the absolute 
luciferase activity in the CNS areas of the 
KCC2(6.8mut)luc mice (Table 1 versus 
Table 2 in III). 
Compared to KCC2(6.8)luc, the 
relative luciferase activity of the 
KCC2(6.8mut)luc construct was higher in 
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the peripheral ganglia (DRG and 
trigeminal), optic nerve, and neuro-
endocrine tissues (Table 2 in III) (Table 1 
in III). IHC analysis confirmed that the 
luciferase protein was expressed in a 
subpopulation of large DRG neurons (III, 
data not shown). However, no luciferase 
mRNA was detected by in situ 
hybridization in optic nerve (Suppl. Fig. 1 
in III). Thus, the luciferase activity in the 
optic nerve perhaps results from a 
diffusion of the luciferase protein along 
axons of retinal neurons. The weak 
luciferase activity in other peripheral and 
in neuroendocrine tissues of the 
KCC2(6.8mut)luc mice has probably the 
same explanation. 
The luciferase distribution in brains 
of the KCC2(6.8mut)luc mice was 
analyzed by in situ hybridization. Similar 
to the situation in the KCC2(6.8)luc mice, 
the pattern of luciferase expression in the 
KCC2(6.8mut)luc mice  was  mostly  CNS  
neuron-specific (Fig. 3 columns B and C 
in III). However, in contrast to 
KCC2(6.8)luc, the KCC2(6.8mut)luc 
construct was expressed in striatum and 
granular cell populations. Interestingly, the 
pattern of reporter activity in one of the 
lines (m4) did not differ from the 
endogenous KCC2 mRNA expression 
(Fig. 3 in III, compare columns C and D). 
In  sum,  the  NRSEKCC2 deletion did not 
lead to ectopic reporter activity in 
nonneural tissues. Except for striatum and 
granular cells, the patterns of the 
luciferase expression in KCC2(6.8)luc and 
KCC2(6.8mut)luc mice were similar. A 
major result of the NRSEKCC2 deletion was 
a strong upregulation of the absolute 
reporter activity in CNS areas (~12-fold). 
In combination with the preserved 
neuronal pattern, this upregulation 
suggests that NRSEKCC2 is rather important 
for modulation of the SLC12A5-1b 
promoter activity in neurons than for the 
promoter suppression in nonneural tissues. 
4.4.2.3 SLC12A5-1b promoter activity in 
the KCC2(1.4)luc mice 
To further confirm that NRSEKCC2 is not 
sufficient for suppressing the SLC12A5-1b 
promoter activity in nonneural tissues in 
vivo, KCC2(1.4)luc mice were analyzed. 
The KCC2(1.4)luc construct, in which the 
luciferase reporter is placed under control 
of the 1.4-kb SLC12A5-1b promoter and 
of a small part of exon-1b (Fig. 2A in III), 
revealed a strong reporter activity in brain 
and in spinal cord but not in nonneural 
tissues (Table 3 in III). Similar to the 
situation in the KCC2(6.8mut)luc mice, 
the relative luciferase activity in peripheral 
ganglia, optic nerve, and neuroendocrine 
samples was higher in the KCC2(1.4)luc 
compared to the KCC2(6.8)luc mice. The 
absolute luciferase activity in the CNS 
regions was about 6-fold stronger than in 
the KCC2(6.8)luc mice. 
Brain sections obtained from the 
KCC2(1.4)luc mice were analyzed by in 
situ hybridization using luciferase and 
3’UTR KCC2 probes. The luciferase 
mRNA distribution in the KCC2(1.4)luc 
mice was similar to that in the 
KCC2(6.8mut)luc mice. Granular cells and 
striatal neurons also expressed luciferase, 
but the level of expression was lower than 
in the nearby brain regions (data not 
shown). 
In sum, analysis of the KCC2(1.4)luc 
mice confirmed that NRSEKCC2 is not 
sufficient to mediate the CNS neuron-
specific activity of the SLC12A5-1b 
promoter. The data also showed that the 
1.4-kb proximal SLC12A5-1b promoter 
was largely enough for the CNS neuron-
specific expression of the KCC2b isoform. 
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4.4.3 Transcriptional mechanisms of 
KCC2 neuronal specificity: conclusions 
To sum up, multiple studies have 
previously established the CNS neuronal 
pattern of KCC2 expression. Experiments 
presented in the current thesis fully 
confirm these data and in addition 
demonstrate the CNS neuron-specificity 
individually for the KCC2a and KCC2b 
isoforms. But what are the mechanisms 
repressing KCC2a and KCC2b expression 
outside CNS? Karadsheh and Delpire have 
previously characterized in vitro a binding 
site for NRSF in intron-1b of the SLC12A5 
gene (Karadsheh & Delpire, 2001). The 
authors proposed a model, according to 
which NRSF binds the identified 
NRSEKCC2 site and represses KCC2 
expression in nonneural cells. 
Cumulative in vitro data presented by 
Karadsheh and Delpire (Karadsheh & 
Delpire, 2001) and in this thesis 
demonstrate that NRSEKCC2 could in 
principle be responsible for the CNS 
neuronal pattern of KCC2b expression. 
Indeed, EMSA shows that endogenous 
NRSF binds NRSEKCC2 in C17 cells. 
Moreover, an artificial insertion of 
NRSEKCC2 upstream of the 1.4-kb 
SLC12A5-1b promoter sequence inhibits 
by ~4-fold the reporter activity. In 
addition, NRSF overexpression in N2a 
cells suppresses the reporter activity of the 
KCC2(6.8)luc construct bearing 
NRSEKCC2 but not of the KCC2(6.8mut)luc 
construct lacking this site. 
Yet, in vivo data presented in the 
paper III indicate that NRSEKCC2 is 
dispensable for the CNS neuronal 
specificity of KCC2b expression. Indeed, 
deletion of the NRSEKCC2 site does not 
lead to ectopic expression of the 
KCC2(6.8mut)luc reporter in nonneural 
tissues of the corresponding transgenic 
mice. Moreover, the reporter activity is not 
observed in nonneural tissues of the 
KCC2(1.4)luc mice, in which the reporter 
is controlled by only the 1.4-kb SLC12A5-
1b promoter sequence. Therefore, this 
fragment contains certain intrinsic 
repressor elements that are sufficient to 
prevent KCC2b expression outside CNS. 
Since the NRSEKCC2 deletion increases 
reporter activity in KCC2(6.8mut)luc 
(~12-fold) and KCC2(1.4)luc (~6-fold) 
mice, NRSEKCC2 may still play some role 
in modulating KCC2b expression in 
neurons. 
What are those intrinsic repressor 
elements that silence the 1.4-kb SLC12A5-
1b promoter in nonneural tissues? No 
other canonical NRSE sites were found in 
the 1.4-kb SLC12A5-1b promoter 
fragment. Non-canonical NRSE consen-
suses have recently been discovered that 
bind NRSF and repress gene expression 
(Otto et al., 2007; Johnson et al., 2007). 
These NRSE-like elements demonstrate 
lower binding affinity to NRSF and are 
less effective in gene silencing (Bruce et 
al., 2009). However, none of the NRSE-
like consensuses is present in the 
KCC2(1.4)luc sequence. Moreover, NRSF 
overexpression in N2a cells did not affect 
the reporter activity of the KCC2(1.4)luc 
construct, confirming the absence of 
NRSE-like sites in the 1.4-kb SLC12A5-1b 
promoter (data not shown).  
Several other NRSE-containing 
neuronal genes, similar to SLC12A5, have 
previously failed to derepress their activity 
in nonneural tissues after deletion of the 
corresponding NRSE sites (Bessis et al., 
1997; Timmusk et al., 1999). In a few 
cases when the NRSE deletion indeed 
resulted in ectopic expression, it happened 
only in a minority of nonneural cells 
(Kallunki et al., 1997). Moreover, only a 
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few neuronal genes were derepressed in 
nonneural tissues of NRSF KO mice 
(Chen et al., 1998; Jones & Meech, 1999). 
To explain these results, David Anderson 
proposed a model according to which 
some additional repressors may assist 
NRSF in maintaining the neuron-specific 
expression (Chen et al., 1998). According 
to this model, the NRSEKCC2 deletion 
would not derepress SLC12A5-1b, since a 
yet unidentified repressor (R) still keeps 
the promoter silent (Fig. 10A and 10B). 
Even in a case when NRSF and R are both 
removed, the expression might still be 
weak (Fig. 10C), because certain activators 
are required to get full activation of the 
SLC12A5-1b promoter in neurons (Fig. 
10D). 
What is the nature of the additional 
repressor(s)? One interesting mechanism 
was proposed for genes that lack NRSE 
sites, but whose promoters demonstrate a 
neuron-specific expression in transgenic 
mice (Chin et al., 1999; Kim et al., 2004). 
Kim and coauthors revealed that activator 
protein 4 (AP4) and the corepressor 
geminin (Gem) form a new functional 
complex that is able to silence expression 
of neuronal genes outside CNS (Kim et 
al., 2006). Several putative binding sites 
for the AP4-Gem complex are present in 
the SLC12A5-1b promoter (data not 
shown). 
Another mechanism to explain why 
neuronal genes maintain the CNS-specific 
pattern even after NRSE deletion was 
proposed by Ballas and coworkers (Ballas 
et al., 2005). They found that TF MeCP2 
is able to bind methylated CG 
dinucleotides (mCpG) in promoters and to 
assemble a repressor complex containing 
mSin3, Co-REST, and histone deacetyl-
ases. Specific stimuli (e.g. membrane 
depolarization) induce a rapid dissociation 
of MeCP2 away from mCpGs that leads to 
a reactivation of the promoter (Ballas et 
al., 2005). Several CG dinucleotides, 
methylated in nonneural tissues but 
unmethylated in neurons, were identified 
in the SLC12A5-1b promoter (data not 
shown). 
It has also been noticed previously 
that promoters of several neuronal genes 
contain multiple GT dinucleotide repeats 
(Sakimura et al., 1987; Sudhof, 1990; 
Nedivi et al., 1992; Petersohn et al., 
1995). Interestingly, similar repeats can be 
found in the SLC12A5-1b promoter (Fig. 
1B in IV). Whether the GT repeats 
mediate repression of the neuronal genes 
outside CNS, is a matter for future studies. 
Figure 10. Additional repressor elements 
prevent the SLC12A5 gene expression 
outside CNS in the absence of NRSEKCC2. 
(A, B) Deletion of NRSEKCC2 does not 
derepress the SLC12A5-1b promoter, since a 
yet unidentified repressor (R) keeps the 
promoter silent. (C, D) Even in a case when 
the  effects  of  both  NRSF  and  R  are  
eliminated, the expression might still be 
weak, because certain neuronal activator TF 
(A) is required to get full activation. 
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What is the mechanism of the KCC2a 
repression outside CNS? As mentioned 
above, an influence of the NRSEKCC2 site 
cannot be excluded: in some cases a single 
NRSE  is  able  to  repress  promoters  at  
distances up to 50 kb (Wu & Xie, 
2006;Otto et al., 2007), and even to 
silence several genes in one locus (Lunyak 
et al., 2002). Some other, yet 
uncharacterized, NRSE sites may probably 
exist in the SLC12A5 gene locus. In fact, 
at least two additional NRSE sites have 
been predicted: one in intron-1a (Bruce et 
al., 2004; Wu & Xie, 2006; Johnson et al., 
2007) and the other in intron-7 (Lunyak et 
al., 2002; Bruce et al., 2004; Wu & Xie, 
2006; Johnson et al., 2007). Both NRSE 
sites are conserved among mammalian 
SLC12A5 orthologs (Fig. 11) and located 
outside the KCC2 genomic fragment 
(Haapa et al., 1999) used in paper III. 
Besides NRSE-mediated silencing, the 
SLC12A5-1a promoter, similar to 
SLC12A5-1b, may also have its own 
intrinsic repressor elements. 
A new report (which appeared after 
the previous section had already been 
written) has characterized an additional 
NRSE element in intron-1a (NRSE-1a) of 
the SLC12A5 gene (Yeo et al., 2009). In 
this report Yeo and coauthors have 
demonstrated that overexpression of either 
REST or DN-REST in cultured neurons 
alters the intracellular Cl- concentration. 
On the one hand, this report supports the 
role of NRSE-mediated regulation in 
KCC2 gene expression. On the other hand, 
several uncertainties in the experiments 
presented in this report do not allow 
making a final conclusion about a possible 
role of the NRSE-1a element. These 
uncertainties, in general, can be divided in 
two groups: logical and methodological.  
Among logical worries are, for example, 
experiments with REST and DN-REST 
overexpression that do not allow assessing 
the impact of individual NRSE elements: 
it is not clear whether all three NRSE 
elements (in introns 1a, 1b, and 7) are 
required for the efficient repression of the 
KCC2 expression or whether any one of 
them alone would be enough. In addition, 
overexpression of REST and DN-REST in 
primary cortical neurons definitely affects 
not only the SLC12A5 gene expression but 
also expression of many other genes, some 
of which may also regulate the inter-
neuronal chloride concentration. Thus, 
proper controls are warranted to resolve 
these uncertainties. 
There are also several methodological 
considerations. The first one concerns the 
design of the luciferase constructs used in 
the reporter assays. In some of the 
luciferase constructs, a part of the 
SLC12A5 intron-1b was still present 
between exon-1b and a downstream 
luciferase coding sequence (Yeo et al., 
2009). Thus, translation of the reporter, 
once started from the KCC2 initiatory 
methionine in exon-1b, would be seriously 
retarded (or even ceased) by numerous 
stop codons inside the intronic fragment, 
before even reaching the luciferase coding 
sequence. To overcome this problem, an 
artificial splice acceptor site has to be 
introduced into the 3’-end of the 
abovementioned intronic fragment. 
Another methodological problem is 
found in the description of ChIP 
experiments presented in the report. The 
authors used N2a cells in their ChIP 
assays to demonstrate NRSF binding to 
the NRSE-1a element; two antibodies 
recognizing either N-terminus or C-
terminus of NRSF revealed a strong 
interaction of endogenous NRSF with 
NRSE-1a in N2a cells. However, as it has 
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been shown previously (Palm et al., 1998; 
Palm et al., 1999), N2a cells do not 
express endogenously a full-length NRSF. 
What this cell line indeed expresses is a 
truncated splice isoform REST4, which 
retains only five N-terminal zinc fingers, 
but lacks four C-terminal NRSF fingers. 
Thus, the positive signal observed in the 
ChIP experiment with the C-terminal 
NRSF antibody is inexplicable. Of note, as 
a negative control, the authors used the 
choline acetyltransferase (ChAT) gene and 
revealed no NRSF binding to that gene 
(Yeo et al., 2009). However, the ChAT 
gene has been shown to possess at least 
one functional NRSE site (Lonnerberg et 
al., 1996) and, therefore, should be rather 
used as a positive control in ChIP 
experiments. Thus, the significance of the 
negative control as well as the accuracy of 
the whole ChIP data presented by Yeo and 
coauthors should be taken with great 
concern. 
To conclude, existing data suggest 
that the SLC12A5-1b promoter has its own 
repressing mechanism, although some 
additional silencing is mediated by 
NRSEKCC2. More experiments are 
warranted to understand mechanisms 
repressing the SLC12A5-1a promoter in 
nonneural cells. Conserved NRSE sites in 
introns 1a and 7 may further tighten 
expression of both isoforms, converting 
SLC12A5 into one of the most neuron-
specific genes in mammalian CNS (Wu & 
Xie, 2006).  
Figure 11. Location and conservation of NRSE sites in the SLC12A5 gene. Three NRSE 
sites have so far been predicted for the mouse SLC12A5 gene. NRSE elements in introns 1a 
(Yeo et al., 2009) and 1b (paper III of the thesis) were characterized previously, while analysis 
of NRSE site in intron-7 is warranted. This figure demonstrates schematically a location of the 
NRSE sites and their conservation in the mammalian SLC12A5 orthologs. In contrast to the 
NRSE site in intron-1a, NRSE elements in introns 1b and 7 are highly conserved. Boxed 
nucleotides indicate positions that differ from the consensus. B-(G/T/C), H-(A/C/T), D-
(A/G/T), S-(G/C), N-(A/G/T/C), R-(A/G). 
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4.5 PROMOTER MECHANISMS 
MEDIATING DEVELOPMENTAL 
UPREGULATION OF THE KCC2 
EXPRESSION 
Multiple reports revealed a steep up-
regulation of KCC2 expression in 
developing rodent brain (Chapters 1.3.6; 
1.3.7). However, most of the data was 
obtained using primers, antibodies, and 
probes that cannot distinguish the KCC2 
isoforms. In the current thesis, the 
expression patterns of the KCC2a and 
KCC2b isoforms were assessed 
individually (Chapter 4.3.2). It has been 
established that it is KCC2b expression 
that increases dramatically in cortex, 
hippocampus, and cerebellum postnatally, 
while KCC2a expression changes 
moderately. 
Reporter activity in the KCC2(6.8)luc, 
KCC2(6.8mut)luc, and KCC2(1.4)luc 
transgenic mice largely recapitulated the 
CNS neuronal pattern of endogenous 
KCC2b expression. In addition, the 
reporter activity in KCC2(6.8)luc (Fig. 5A, 
5D in III) and KCC2(6.8mut)luc (Fig. 5B, 
5E in III) mice followed the develop-
mental profile of the endogenous KCC2b 
(Fig. 5C, 5F in III). The reporter 
expression increased dramatically in 
cortical (Fig. 5A, 5B in III) but not in 
brainstem samples (Fig. 5D, 5E in III). 
Therefore, the SLC12A5 genomic fragment, 
present in the KCC2(6.8)luc construct, is 
largely enough for the developmental 
upregulation of KCC2b expression. 
What are these SLC12A5-1b intrinsic 
elements that enhance the promoter 
activity in postnatal rodent brain? One 
possibility may be that the SLC12A5-1b 
promoter is induced by some activator 
TFs, whose expression is also upregulated 
during development (Fig. 10). Another 
possibility might be that the develop-
mental upregulation is caused by a general 
chromatin remodelling and by subsequent 
derepression of the whole SLC12A5-1b 
locus. The transgenic mouse approach 
(Fig. 5 in III), when the reporter constructs 
are incorporated into the genome, does not 
allow to discriminate between the 
chromatin derepression and the action of 
transcriptional activators. Thus, the 
reporter activity was first evaluated in 
cultured cortical neurons transiently 
transfected with the corresponding 
promoter construct (Fig. 5 in I). The 
luciferase activity of the KCC2(1.4)luc 
reporter in div6 neurons was ~13-fold 
stronger compared to the activity of the 
promoterless construct, and further 
increased by ~2.5-fold at div10 (Fig. 5 in 
I). Similar results were recently reported 
by Yeo and coauthors, who observed a 
strong developmental upregulation of the 
(-1649/+49) SLC12A5-1b reporter activity 
in primary cortical neuronal cultures (Yeo 
et al., 2009). In comparison with the 1.4-
kb SLC12A5-1b construct, the (-1649/+49) 
reporter spreads ~0.3 kb further upstream 
of the known TSS-1b, but similarly does 
not contain NRSE elements. Thus, 
mechanisms other than the general 
chromatin derepression contribute to the 
developmental upregulation of the 1.4-kb 
SLC12A5-1b promoter. 
To identify TFs that possibly regulate 
KCC2b expression, a multiple alignment 
was performed for the mouse, rat, human, 
and chimpanzee genomic sequences 
corresponding to the 1.4-kb SLC12A5-1b 
promoter and proximal intron-1b region. 
Ten TF binding sites were found to be 
highly conserved in all four species: by 
two sites for specificity protein 1 (Sp1) 
(Kadonaga et al., 1987) and activating 
enhancer-binding protein (AP2) (Williams 
& Tjian, 1991); by one site for AP1 (Lee 
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et al., 1987), myocyte-enhancing factor 2 
(Mef2) (Gossett et al., 1989), early growth 
response 4 (Egr4) (Swirnoff & Milbrandt, 
1995), neuron restrictive silencing factor 
(NRSF) (Schoenherr et al., 1996), and 
Block (Collart et al., 1991); and E-box site 
(Sawadogo, 1988), which is known to bind 
numerous basic helix loop helix (bHLH) 
TFs (Fig. 1A, 1B in IV). Eight out of the 
ten sites belong to the (-415/+9) region, 
previously predicted to outline a proximal 
SLC12A5-1b promoter (III). Five out of 
the ten binding sites have so far been 
characterized by our group: NRSE (III), 
Egr4 site (IV), E-box (V), and two Sp1 
sites (unpublished observations). The 
revealed TF binding sites, as well as the 
previously described CpG islands CGI’s 
II-IV and TSSs corresponding to the 
SLC12A5-1b promoter are shown in Fig. 
12. Characterization of the NRSEKCC2 site 
has been explained in the previous 
chapter. The role of the E-box and Egr4 
binding sites in the developmental 
upregulation of KCC2b expression will be 
analyzed below. 
4.5.1 Regulation of the SLC12A5-1b 
promoter by Egr4 transcription factor 
Egr4 belongs to the family of early growth 
response (Egr) transcription factors, which 
embraces four members: Egr1 [alias nerve 
growth factor-induced-A (NGFI-A), Krox-
24, zinc finger-interacting 268 (zif268), 
Tis8, and ZENK], Egr2 [alias Krox20], 
Egr3  [alias  Pilot],  and  Egr4  [alias  NGFI-
C]. All Egr members contain three zinc 
fingers, which interact with a 9-bp GC-
rich core sequence. Three additional 
nucleotides that surround the 9-bp core 
(Fig. 5A in IV) add specificity for 
recognition of the binding site by different 
Egr members (Swirnoff & Milbrandt, 
1995). 
Several lines of evidence suggest that 
Egr4 might regulate KCC2 expression. 
Egr4 mRNA expression, similar to KCC2, 
has been shown to display a neural 
specific pattern and to be upregulated 
during the postnatal development (Crosby 
et al., 1992). The “Review of the literature” 
has determined that neuronal activity and 
neurotrophins are among putative factors 
regulating KCC2 expression. Similarly, 
Egr4 expression is robustly induced by 
neurotrophins and by neuronal activity 
(Crosby et al., 1991; Crosby et al., 1992; 
Honkaniemi & Sharp, 1999). 
4.5.1.1 Characterization of the Egr4 
binding site: N2a cells 
To characterize the Egr4 binding site 
found in the SLC12A5-1b promoter 
(Egr4KCC2), a series of reporter constructs 
was used (Fig. 3 in IV); some of the 
constructs lacked the Egr4KCC2 site. 
Luciferase activity was analyzed in N2a 
neuroblastoma cells transiently transfected 
with the corresponding plasmids. The 
basal activity of the 1.4-kb SLC12A5-1b 
promoter construct KCC2(-1398/+42) was 
~12-fold stronger compared to the activity 
of the promoterless pGL3-Basic construct 
(Fig. 3A in IV). Deleting of a substantial 
part of the promoter did not change much 
the basal reporter activity: KCC2(-
309/+42) and KCC2(-180/+42) constructs 
expressed luciferase still ~10-fold stronger 
than pGL3-Basic. However, these 
constructs were differentially induced by 
exogenously overexpressed Egr4 (Fig. 3B 
in IV). Each of the constructs containing 
the Egr4 site was strongly (15-20 times) 
upregulated by Egr4 but not by Egr1, 
another member of the Egr family that  
79 
 
  
Figure 12. Summary of the bioinformatical and experimental data including CpG 
islands, TSSs, and TF binding sites in the SLC12A5-1b promoter and proximal 
intron-1b regions. Three CpG islands (CGI’s II-IV, marked in grey) were revealed via 
bioinformatical analysis in the SLC12A5-1b promoter and proximal intron-1b regions. Ten 
putative TF binding sites and their locations on either the sense (+) or antisense (-) DNA 
strands are shown (boxed). Two transcription start sites (TSS-1b major and TSS-1b minor, 
marked with arrows) were identified previously for the KCC2b transcript by RNAse 
protection assays, 5’RACE experiments, and a subsequent bioinformatical analysis. The 
expressed sequence tag clone farthest upstream (position -288 bp relative to TSS-1b major) 
that is homologous to the KCC2b transcript (CJ116453) is marked with asterisk. Intron and 
promoter regions are presented in lowercase letters, exon-1b sequence appears in capital 
letters, and coding parts of the exons are highlighted in bold. The amino acid translation of 
the coding part of exon-1b is shown above the corresponding nucleotide sequence. 
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binds a different consensus sequence 
(Swirnoff & Milbrandt, 1995). No 
upregulation was observed for the KCC2(-
180/+42) construct, which lacks Egr4KCC2 
(Fig. 3B in IV). To test the possibility that 
Egr1 binds Egr4KCC2 but for some reason 
cannot activate the SLC12A5-1b promoter, 
increasing amounts of Egr1 expression 
plasmid were cotransfected along with a 
constant amount of Egr4 (Fig. 3C in IV). 
However, instead of the expected 
downregulation of the reporter activity 
(dominant negative effect of Egr1), a 
moderate upregulation was detected, thus 
indicating that Egr1 does not compete with 
Egr4 for Egr4KCC2. 
The previous experiments did not 
exclude the possibility that Egr4 activates 
the SLC12A5-1b promoter indirectly via 
regulating expression of other TFs, which 
in their turn affect the promoter. To test 
whether Egr4 can bind directly Egr4KCC2, 
EMSA was performed. N2a cells were 
transfected with the Egr4 expression 
construct and nuclear extracts were 
incubated with a radioactively labelled 
double-stranded DNA oligonucleotide 
carrying the Egr4KCC2 sequence (Fig. 4B in 
IV). Three specific DNA-protein 
complexes were detected (Fig. 4A in IV). 
However, the only DNA-protein complex, 
whose formation was effectively 
prevented by unlabelled intact Egr4KCC2 
but not by unlabelled mutant Egr4KCC2 
oligonucleotides, was complex I (Fig. 4A 
in IV). In addition, Egr4 antibody was able 
to supershift complex I but failed to 
supershift two other complexes. Thus, 
EMSA and the supershift assay demon-
strated that Egr4 can bind the Egr4KCC2 
element. 
To ensure that the Egr4-induced 
upregulation of the SLC12A5-1b promoter 
in the N2a cells was indeed mediated via 
the Egr4KCC2 site, this element was 
mutated and luciferase activity of the 
reporters with intact and mutant Egr4KCC2 
sites was compared. Mutation of Egr4KCC2 
strongly decreased ability of Egr4 to 
upregulate the proximal SLC12A5-1b 
promoter (Fig. 5B in IV). However, this 
mutation was not able to prevent 
completely the Egr4-induced upregulation. 
One possible explanation could be the 
presence of less stringent Egr4-like 
binding sites in the proximal promoter. 
The proximal promoter was reanalyzed 
and one such Egr4-like site was found. Its 
sequence differed from the Egr4 
consensus in positions -1 and +4; 
moreover, it was not conserved in the 
SLC12A5-1b promoters of other 
mammals. Mutation of this site did not 
alter the reporter activity (data not shown). 
So, at least half of the 15-fold upregulation 
of the reporter activity in N2a cells is 
mediated by Egr4 indirectly by regulating 
expression of other TFs controlling the 
SLC12A5-1b promoter. 
To  test  whether  Egr4KCC2 site  is  
sufficient for the Egr4-mediated induction 
of the SLC12A5-1b promoter activity, two 
copies of the Egr4KCC2 sequence were 
inserted into the KCC2(-180/+42) reporter 
construct, which previously failed to 
demonstrate the Egr4-mediated 
upregulation (Fig. 3B in IV). The new 
construct [KCC2(-180/+42)2xEgr4(-)], 
carrying the Egr4KCC2 duplex site in the 
same orientation as the original element 
(on the reverse DNA strand), was strongly 
induced by Egr4 (Fig. 5C in IV). 
Surprisingly, similar construct [(KCC2(-
180/+42)2xEgr4(+)], carrying the same 
duplex but in the opposite orientation (on 
the forward DNA strand), was not induced 
by Egr4 (Fig. 5C in IV). It has been shown 
previously that members of Egr family 
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bind their recognition sites as monomers 
in an anti-parallel configuration (Pavletich 
& Pabo, 1991). Thus, the relative 
orientation of Egr4 might be important for 
its interaction with other TFs. Such an 
interaction between Egr members and 
certain TFs has previously been shown to 
be important for synergistic activation of 
promoter activity (Decker et al., 2003). 
Thus, the Egr4KCC2 sequence in the context 
of the proximal SLC12A5-1b promoter and 
in the correct orientation is able to mediate 
the Egr4-induced upregulation of promoter 
activity. 
Usage of Egr dominant-negative 
isoforms has proved to be an efficient 
approach to analyze mechanisms by which 
Egr family members regulate gene 
expression (Levkovitz et al., 2001; 
Roberts et al., 2005). To study further the 
role of Egr4KCC2 in the regulation of 
endogenous KCC2b expression, a 
dominant negative variant of Egr4 (DN-
Egr4) was produced (Fig. 6A in IV). It 
retained the DNA-binding part of Egr4, 
but lacked the N-terminal activator 
domain. Overexpression of DN-Egr4 had 
no effect on the basal activity of the 
proximal SLC12A5-1b promoter construct, 
but effectively inhibited the Egr4-
mediated induction of the same construct 
(Fig. 6B in IV). 
4.5.1.2 Characterization of the Egr4 
binding site: cultured neurons 
To test whether Egr4 can also regulate 
endogenous KCC2b expression, a model 
of cultured hippocampal neurons was 
used. In this model both KCC2b and Egr4 
mRNA levels were found to be strongly 
upregulated during the culture maturation 
(Fig.  7A  in  IV).  Overexpression  of  DN-
Egr4 significantly downregulated KCC2 
expression as detected by immunostaining 
with the KCC2pan antibody (Fig. 7B, 7C 
in IV). Thus, DN-Egr4 was able to 
downregulate the endogenous KCC2 
expression in cultured neurons presumably 
by preventing Egr4 binding to the 
Egr4KCC2 site. 
According to the previous data, 
KCC2b and Egr4 mRNA levels increased 
steeply in cultured hippocampal neurons 
between div4 and div11 (Fig. 7A in IV). 
Thus, the maximal effect of the Egr4 
overexpression might be expected at early 
time points, when the endogenous 
expression of Egr4 is low. On the 
contrary, DN-Egr4 should have a stronger 
effect in matured cultures, when the 
endogenous Egr4 level is high. Indeed, 
overexpression of Egr4 increased the 
KCC2(-309/+42) reporter activity at div5, 
when the endogenous Egr4 expression is 
relatively low (Fig. 8A in IV), but had no 
effect at div10 (Fig. 8B in IV), when it is 
already relatively high (Fig. 7A in IV). An 
opposite situation was observed in a case 
of the DN-Egr4 overexpression: 
significant downregulation of the KCC2(-
309/+42) construct activity was achieved 
at div10, when endogenous Egr4 
expression is high, but not at div5, when 
the promoter regulation by the endogenous 
Egr4 is presumably minor (Fig. 8A, 8B). 
One possible drawback of the DN-
Egr4 approach is the relatively low 
transfection efficacy into mature cultured 
neurons that prevents efficient suppression 
of the Egr4-mediated regulation. If true, 
the observed ~30% downregulation of the 
endogenous KCC2b expression (Fig. 7A 
in IV) and the reporter activity of the 
KCC2(-309/+42) construct (Fig. 8B in IV) 
might represent a significant under-
estimation of the Egr4 contribution to the 
SLC12A5-1b promoter regulation. Another 
way to assess the Egr4 impact is to affect 
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the endogenous Egr4 level by RNA 
interference (RNAi)-mediated knockdown. 
Two different anti-Egr4 siRNA duplexes 
decreased the luciferase activity of the 
KCC2(-309/+42) reporter by ~35% and 
~25%, correspondingly (Fig. 8C in IV). 
Thus, the attenuation of the endogenous 
Egr4 level by RNAi and the prevention of 
the Egr4 binding to Egr4KCC2 by DN-Egr4 
significantly downregulated activity of the 
SLC12A5-1b proximal promoter region. 
To assess a role of Egr4KCC2 in the 
developmental upregulation of the 
SLC12A5-1b proximal promoter, the 
reporter activity of the KCC2(-309/+42) 
construct was compared to that of the 
[KCC2(-309/+42)Egr4mut] construct, in 
which this site was mutated. Being 
analyzed in cultured hippocampal neurons 
at div5 and div10, the reporter activities of 
the KCC2(-309/+42) and KCC2(-
309/+42)Egr4mut constructs increased 4.2-
fold (±0.2) and 2.7-fold (±0.3), respectively 
(p<0.05; Student’s t test). Thus, the 
mutation of Egr4KCC2 significantly affected 
(~35%) the developmental upregulation of 
the SLC12A5-1b promoter activity. 
4.5.1.3 Egr4KCC2 is required for the 
BDNF-mediated upregulation of the 
SLC12A5-1b activity in immature 
neurons 
Previous studies have indicated that the 
BDNF-TrkB signalling pathway might 
play an important role in the 
developmental upregulation of KCC2 
expression (Aguado et al., 2003; Carmona 
et al., 2006). It has also been known that 
expression of Egr family members can be 
rapidly induced by neurotrophins (Crosby 
et al., 1991; Harada et al., 2001; Roberts 
et al., 2005; Roberts et al., 2006; Calella et 
al., 2007). Thus, could it be that BDNF 
increases expression of Egr4 that in its 
turn via Egr4KCC2 activates the SLC12A5-
1b promoter? 
To test this hypothesis, dissociated 
hippocampal neurons cultured for 5-6 days 
in vitro were  treated  with  BDNF  (50  
ng/ml). The ERK pathway was strongly 
activated already 5 min after the BDNF 
application (Fig. 3A, 3B in VI). Moreover, 
Egr4 mRNA expression increased ~20-
fold 2h after BDNF application (Fig. 3C in 
VI). Both effects were substantially 
blocked by a specific MEK inhibitor 
U0126, thus suggesting that the ERK 
pathway is involved into the BDNF-
mediated induction of Egr4 expression 
(Fig. 3A-3C in VI). 
The KCC2(-309/+42) reporter 
construct was used to study whether the 
BDNF-induced increase in Egr4 
expression affects SLC12A5-1b promoter 
activity (Fig. 4A in VI). Indeed, the 
luciferase activity of the reporter was 
significantly increased after brief 
treatment of hippocampal cultures with 
BDNF  (Fig.  4B  in  VI).  The  effect  of  
BDNF on the reporter activity was 
blocked by inhibition of TrkB with K252a 
and of MEK with U0126, but not by 
inhibition of sodium channels with TTX 
(Fig. 4B in VI). 
The KCC2(-309/+42)Egr4mut reporter, 
in which the Egr4KCC2 site is mutated (Fig. 
4A in VI), was further used to study the 
BDNF-mediated upregulation of the 
SLC12A5-1b promoter. Compared to the 
KCC2(-309/+42) construct, mutation of 
Egr4KCC2 decreased basal promoter activity 
(Fig. 4C in VI). In addition, the KCC2(-
309/+42)Egr4mut reporter was not anymore 
induced by BDNF (Fig. 4C in VI). The 
endogenous level of KCC2b mRNA was 
also rapidly upregulated by BDNF 
treatment (Fig. 2A in VI). Interestingly, 
while the KCC2b mRNA was upregulated, 
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the KCC2a mRNA expression slightly 
decreased after BDNF application (Fig. 
2A  in  VI).  The  mRNA  data  were  
confirmed on a protein level (Fig. 1, 2B). 
The KCC2 protein upregulation was not 
observed in the mature neurons (Fig. 1A). 
To sum, the above experiments 
demonstrate that a brief application of 
BDNF rapidly induces the ERK signalling 
pathway, increases Egr4 expression, and 
upregulates (via the Egr4KCC2 site) the 
SLC12A5-1b promoter activity in 
immature dissociated neuronal cultures. 
4.5.2 Regulation of the SLC12A5-1b 
promoter by Egr4: conclusions 
Multiple in vitro experiments performed in 
N2a cells and in dissociated cultured 
neurons have shown that Egr4KCC2 can 
regulate activity of the SLC12A5-1b 
promoter. Reducing Egr4KCC2 function by 
decreasing Egr4 expression (using RNAi), 
by preventing Egr4 binding to Egr4KCC2 
(using DN-Egr4), or by mutating the 
Egr4KCC2 site was able to downregulate the 
SLC12A5-1b promoter activity as well as 
the endogenous KCC2b expression in 
vitro. 
Additional experiments are needed to 
address the role and relative importance of 
Egr4 in the SLC12A5-1b promoter 
regulation in vivo. An obvious approach 
would be to analyze whether KCC2b 
expression is reduced in Egr4 KO mice. 
Such mice have been generated by the 
group of Milbrandt (Tourtellotte et al., 
1999). The major phenotype reported for 
the Egr4 KO mice was infertility in males 
but not in females as a consequence of the 
impaired male germ cell maturation. This 
result is surprising, as in vivo Egr4 
demonstrates mostly neural specific 
expression. Tourtellotte and coauthors 
have not reported any phenotypic 
abnormalities in the nervous system of the 
Egr4 KO mice. There are two possible 
explanations to this fact. 
First, it has been shown previously 
that Egr1 is strongly (~9-fold) upregulated 
in the Egr4 KO mice (Tourtellotte et al., 
1999), thus compensation by Egr1 cannot 
be excluded. However, Egr1-Egr4 double 
KO mice have also failed to demonstrate 
any obvious CNS abnormalities; the major 
phenotype reported was just a complete 
infertility of these mice (Tourtellotte et al., 
2000). Unfortunately, no systematic 
behavioural analysis of Egr1-Egr4 KO 
mice has been performed to reveal 
putative mild brain abnormalities. In 
addition, compensation by two other Egr 
family members cannot be excluded. 
Second, even in a case of the 
decreased KCC2b expression in the Egr4 
KO mice, this downregulation might be 
insufficient to produce any obvious 
phenotypic abnormality. The maximum 
downregulation of the SLC12A5-1b 
promoter activity, achieved by mutating 
the Egr4KCC2 site,  was  ~50%  (Fig.  5B  in  
IV); other methods resulted only in ~25-
50% decrease (papers IV and VI). Thus, 
the KCC2b level in the Egr4 KO mice 
may still be ~50% of the wild type level. 
Is the ~50% downregulation of KCC2 
expression level enough to be somehow 
reflected in the behaviour of these mice? 
Several KCC2-deficient mice models exist 
nowadays. Two complete KCC2 KO 
models have been generated by deleting 
either exon-4 (Vilen et al., 2001; Tornberg 
et al., 2005) or exon-5 (Hubner et al., 
2001) of the SLC12A5 gene. Mice 
homozygous for the mutant allele die 
immediately after birth due to abolished 
respiration. However, no obvious pheno-
typic abnormalities have been detected in 
mice heterozygous for the null allele, 
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which retain 50% of the wild type KCC2 
expression (Hubner et al., 2001). 
Moreover, hypomorphic KCC2 mice 
retaining only ~30% of the wild type 
KCC2 level (Vilen et al., 2001) are still 
viable and display no gross histological 
abnormalities. Surprisingly, adult mice 
doubly heterozygous for KCC2 null and 
hypomorphic alleles, expressing only 
~15%  of  the  wild  type  KCC2  level,  
display no gross histological abnormalities 
either (Tornberg et al., 2005). Only a 
thorough behavioural analysis of these 
mice revealed some deviations from the 
normal behaviour: increased anxiety-like 
behaviour, higher susceptibility to 
pentylenetetrazole-induced seizures, 
impaired water maze learning, and 
reduced sensitivity to tactile and noxious 
thermal stimuli (Tornberg et al., 2005). Of 
note, the KCC2 null and hypomorphic 
alleles affect expression of both KCC2a 
and KCC2b isoforms, while the Egr4 
deficiency should only affect KCC2b 
expression. Thus, even in a case of a 
complete prevention of the KCC2 
regulation by Egr4, the expected decrease 
of KCC2b expression seems not to be 
sufficient to produce any pronounced 
behavioural abnormality. A more 
conclusive strategy to study the role of 
Egr4 in the regulation of the SLC12A5-1b 
promoter in vivo would be to generate 
knock-in mice with the Egr4KCC2 site 
mutated/deleted and to measure the 
KCC2b expression level in these mice. 
4.5.3 Regulation of the SLC12A5-1b 
promoter by USF1/2 transcription 
factors 
E-box binding site (E-boxKCC2), highly 
conserved among mammalian SLC12A5 
gene orthologs, has been identified in the 
proximal SLC12A5-1b promoter (IV, V). 
Bioinformatical analysis predicted that 
multiple TFs are able to bind E-boxKCC2: 
USF1/USF2, the hypoxia inducible factor, 
PAS family members, N-myc, 
Clock/BMAL1, and NPAS2/ BMAL1. 
Many of these TFs are known to be 
expressed in CNS and thus could 
potentially regulate KCC2b expression. 
USF1/2 proteins were chosen to be 
characterized first for several reasons. 
Both USF1 and USF2 KO mice display a 
predisposition for spontaneous epileptic 
seizure activity (Sirito et al., 1998) – the 
phenotype observed in the SLC12A5 
deficient mice. Moreover, several reports 
have demonstrated that USF1/2 factors are 
able to mediate activity-induced promoter 
regulation (Tabuchi et al., 2002; Chen et 
al., 2003; Steiger et al., 2004). As 
discussed in the “Review of the literature”, 
GABAergic (Ganguly et al., 2001;Leitch et 
al., 2005;Simat et al., 2007), glutamatergic 
(Gulyas et al., 2001; Sernagor et al., 
2003;Takayama & Inoue, 2006;Kanold & 
Shatz, 2006;Sipila et al., 2009), and 
cholinergic neuronal activity (Liu et al., 
2006)  may play an important role in the 
SLC12A5 gene regulation. On the other 
hand, USF1/2 TFs may contribute to 
neuron-specific and mitogen-activated 
protein kinase (MAPK)-mediated regula-
tion of gene expression (Park et al., 2008). 
Neuron-specificity and MAPK-regulation 
of the SLC12A5-1b promoter have been 
established in papers III and VI, 
respectively. 
A possible role of the USF1/2 TFs in 
the SLC12A5-1b promoter regulation was 
assessed first in cell lines. Immunoblotting 
detected endogenous USF2 expression in 
C6 rat glioma cells, NIH3T3 fibroblasts, 
and mouse neuroblastoma N2a cells (Fig. 
1A in V). USF2 expression in brain tissue 
was much stronger than in the cell lines. 
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EMSA was used to study further whether 
the endogenously expressed USF1/2 
proteins are able to bind E-boxKCC2. A 
strong DNA-protein complex was detected 
after incubation of a 20-bp radioactively 
labelled probe bearing E-boxKCC2 (Fig. 1B 
in V) with N2a nuclear extracts (Fig. 1C in 
V). Formation of the complex was 
effectively prevented by a 100-fold molar 
excess of unlabelled (cold) double 
stranded oligonucleotides bearing the 
intact E-boxKCC2 site  (Fig.  1C  in  V),  but  
not by cold oligonucleotides bearing 
mutated E-boxKCC2 (Fig. 1C in V). To 
confirm that USF1 and USF2 indeed 
participated in the DNA-protein complex 
formation, the nuclear extracts were 
preincubated with either USF1 or USF2 
antibodies. Both USF1 and USF2 
antibodies completely supershifted the 
DNA-protein complexes, while a control 
Egr4 antibody was ineffective (Fig. 1C in 
V). Similar results were obtained in 
NIH3T3 cells (Fig. 1D in V). In agreement 
with the lower USF2 expression level in 
NIH3T3 cells compared to N2a cells (Fig. 
1A in V), DNA-protein complexes were 
weaker. Formation of the radioactively 
labelled complexes was efficiently 
competed by cold oligonucleotides 
containing intact but not mutant E-boxKCC2 
site (Fig. 1D in V). Similar to the situation 
in N2a cells, both USF1 and USF2 
antibodies but not Egr4 antibody 
completely supershifted the DNA-protein 
complexes (Fig. 1D in V). Thus, EMSA 
experiments confirmed that endogenous 
USF1/2 proteins are able to bind the E-
boxKCC2 site. Gel shift experiments also 
showed that E-boxKCC2 interacts 
preferentially with USF1/USF2 proteins, 
as USF1/2 antibodies supershifted 
completely the DNA-protein complexes. 
Of note, all TFs predicted previously by 
bioinformatics as potential candidates for 
binding the E-boxKCC2 site (USF1, USF2, 
N-myc, CLOCK, NPAS2, hypoxia 
inducible factor, and BMAL1) are 
expressed in the N2a and NIH3T3 cell 
lines. Thus, USF1/2 proteins seem to have 
higher binding specificity to E-boxKCC2 
compared to other bHLH TFs in N2a and 
NIH3T3 cell lines. 
To test whether USF1/2 TFs regulate 
the SLC12A5-1b promoter activity via the 
E-boxKCC2 site, two reporter constructs 
were  made.  First  construct  [KCC2b(0.6)] 
contained a luciferase coding sequence 
under control of the ~0.6-kb SLC12A5-1b 
proximal promoter region, which bears the 
E-boxKCC2 site. Second construct 
[KCC2b(0.6)E-box-mut] was identical to the 
first except that E-boxKCC2 was mutated. 
Luciferase assays with these constructs 
revealed that mutation of the E-boxKCC2 
site decreased the SLC12A5-1b proximal 
promoter activity by ~25% in N2a (Fig. 
2A in V) and by ~35% in NIH3T3 (Fig. 
2B in V) cells. These results were further 
confirmed by using A-USF, a dominant-
negative mutant of USF1/2 TFs. A-USF 
forms heterodimers with USF1 and USF2, 
but these dimers are unable to bind E-box 
elements (Qyang et al., 1999; Chen et al., 
2003). Overexpression of A-USF decreased 
the reporter activity of the KCC2b(0.6) 
construct both in N2a and NIH3T3 cells to 
the level of the KCC2b(0.6)E-box-mut 
construct. The overexpression had no 
effect on the reporter activity of the 
KCC2b(0.6)E-box-mut construct, in which the 
E-boxKCC2 was mutated, thus excluding the 
possibility that A-USF acted indirectly on 
the SLC12A5-1b promoter. This 
experiment confirmed that E-boxKCC2 is 
the only E-box site in the SLC12A5-1b 
proximal promoter that mediates 
regulation by USF1/USF2 TFs. 
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To provide evidence that USF1/2 TFs 
regulate the SLC12A5-1b promoter via 
binding E-boxKCC2 also in primary 
neurons, ChIP using USF1 and USF2 
antibodies was performed. ChIP demon-
strated that USF1 and USF2 both interact 
with E-boxKCC2 in  div8  cultured  rat  
cortical neurons (Fig. 3A in V). To 
examine whether USF1/2 TFs also regulate 
activity of the SLC12A5-1b promoter in 
primary neurons, luciferase assays with the 
KCC2b(0.6) and KCC2b(0.6)E-box-mut 
constructs were performed. Reporter 
activity of the SLC12A5-1b proximal 
promoter in cultured rat cortical neurons at 
div6 was downregulated significantly by 
mutation of the E-boxKCC2 site (Fig. 3B in 
V). Interestingly, no difference between 
the reporter activities of the KCC2b(0.6) 
and KCC2b(0.6)E-box-mut constructs was 
detected in more matured cultured neurons 
at div10 (data not shown). This suggests 
that USF1 and USF2 factors might be 
more important in the developmental 
upregulation of the SLC12A5-1b promoter 
activity in immature than in mature 
neurons. 
4.5.4 Regulation of the SLC12A5-1b 
promoter by USF1 and USF2: 
conclusions 
The above experiments revealed that 
USF1 and USF2 TFs can bind E-boxKCC2 
and regulate the SLC12A5-1b promoter in 
vitro in cultured rat cortical neurons. 
Comparison of the KCC2b(0.6) and 
KCC2b(0.6)E-box-mut reporter activities 
suggested that the impact of the E-boxKCC2 
site on the promoter activity is ~30% in 
cell lines and in div6 cultured neurons.  
Interestingly, mutation of the E-
boxKCC2 site had no effect in more matured 
neurons at div10. What could explain this? 
One possibility is that in more mature 
neurons E-boxKCC2 is masked by certain 
TFs whose binding sites are located 
nearby. Such a situation has been 
described previously for the GABABR1b 
promoter, where E-box and CRE 
consensus binding sites are situated in a 
close proximity from each other (Steiger et 
al., 2004). In that case USF1/2 complex is 
able to interact with the corresponding E-
box only in the absence of CREB binding 
to the CRE site. To address this possibility 
for the SLC12A5-1b promoter one would 
use EMSA and gel shift  to check whether 
TFs other than USF1/2 are also able to 
interact with the E-boxKCC2 in matured 
neurons. 
Another possible explanation could 
be that the USF1/2 complex is 
transcriptionally active in immature 
neurons even at basal conditions, but 
requires some additional activation in 
div10 neurons. This hypothesis is based on 
the fact that phosphorylation of USF1/2 is 
needed for its efficient binding to E-box 
(Cheung et al., 1999; Galibert et al., 2001; 
Xiao et al., 2002; Chen et al., 2003). The 
USF phosphorylation is known to be 
mediated by ERK1/2, p38, PKA, CaMKII, 
and CaMKIV in neurons (Chen et al., 
2003) as well as by p38, PKA, PKC, cdk1 
in other cell types (Cheung et al., 1999; 
Galibert et al., 2001; Xiao et al., 2002). 
Thus, analysis of the USF1 and USF2 
phosphorylation status might help to 
unveil the functionality of the USF-E-
boxKCC2 pathway in regulation of the 
SLC12A5-1b promoter in div10 cultured 
neurons. 
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5 CONCLUSIONS 
 
The major finding of the thesis is the discovery of the second KCC2 transcript (KCC2a). 
Up to recently, only one KCC2 isoform (KCC2b) was thought to exist, thus many 
authors studied the KCC2 expression using primers, probes, and antibodies detecting 
both isoforms simultaneously. This fact substantially entangled analysis of the 
mechanisms regulating the SLC12A5 gene activity. Presented results demonstrate that 
KCC2a and KCC2b differ in their most N-terminal parts and that their expression is 
regulated by separate promoters, hence requiring a revision of the previous data. 
 
Another important result of the thesis is the characterization of the spatio-temporal 
patterns of the KCC2a and KCC2b expression. To do that, isoform-specific antibodies, 
PCR primers, as well as in situ and RPA probes were exploited. Both isoforms were 
detected exclusively in CNS neurons and displayed similar levels of expression in 
embryonic and early postnatal development. Subsequently, KCC2a fraction in the total 
KCC2 expression decreased in most of CNS areas, constituting only ~10% in adult 
neurons. In cerebral cortex, the decline of the KCC2a/KCC2total ratio was a result of a 
dramatic upregulation of the KCC2b expression. 
 
To elucidate mechanisms of the neuronal specificity and of SLC12A5-1b promoter 
activation during postnatal development, the corresponding genomic sequence was 
analyzed by bioinformatics. The neuron-restrictive silencing element in the intron-
1b (NRSEKCC2) was suggested as a candidate to explain the neuronal profile of 
KCC2 expression. Preliminary in vitro data confirmed this hypothesis; however 
subsequent in vivo experiments showed that this element is not sufficient for the 
KCC2 neuronal specificity. Additional experiments revealed that the upstream 1.4-
kb fragment of the SLC12A5-1b promoter is enough for the neuronal specificity. 
Thus, yet to be defined mechanism (e.g. methylation) may act either alone or in 
synergy with NRSEKCC2 to suppress the SLC12A5-1b promoter outside CNS 
neurons. 
 
Two transcription factor binding sites important for SLC12A5-1b promoter 
activation have been characterized in the thesis. Mutation of either of them 
decreased activity of SLC12A5-1b promoter by ~35%. E-boxKCC2 site mediated the 
SLC12A5-1b upregulation via binding the upstream stimulatory factors 1 and 2 
(USF1/2), while the Egr4KCC2 site required specific interaction with early growth 
response 4 (Egr4) transcription factor. In addition, the data presented in the thesis 
suggested that the Egr4KCC2 site might participate in the BDNF-induced ERK-
mediated upregulation of KCC2b expression in early postnatal neurons. 
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